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v. Scientific Abstract 
 The choroid plexuses are largely responsible for cerebrospinal fluid (CSF) 
secretion and therefore play a fundamental role in brain homeostasis. The membrane 
proteins involved in CSF secretion are not fully known. Several electroneutral 
transporters have been identified by molecular methods in choroid plexus epithelial 
cells but there is a lack of functional data to support their expression making it 
impossible to elucidate their role in CSF secretion fully. The activity of many of these 
transporters can be observed in cell volume regulation. Thus, the main aim of the 
present study was to determine the ability of mammalian choroid plexus epithelial cells 
to regulate their volume in response to anisosmotic challenge and to investigate the 
transporters involved. 
Experiments were performed on cells isolated from the mouse fourth ventricle 
choroid plexus. Cells were isolated using a combination of manual perturbation, the 
enzyme dispase and a Ca
2+
 free incubation to disrupt tight junctions. Cell volume was 
measured using a video-imaging method. Cells used in this study were all of a similar 
morphology and had a mean volume of 0.71 pL. 
Cells exhibited a HCO3
-
 dependent regulatory volume increase (RVI) in response 
to hypertonic challenge. Strong evidence is presented that the Na
+
/H
+
 exchanger (NHE1) 
and the Cl
-
/HCO3
-
 exchanger (AE2) contribute to the RVI but the Na
+
K
+
2Cl
-
 cotransporter 
(NKCC1) and the epithelial Na
+
 channel (ENaC) do not.  
Choroid plexus cells exhibit a HCO3
-
 dependent regulatory volume decrease 
(RVD) in response to hypotonic challenge. The RVD was unaffected by DIOA (an inhibitor 
of KCC activity), the K
+
 channel inhibitors TEA
+
, Ba
2+
 or 4AP or the Cl
-
 channel inhibitors 
DIDS or NPPB. However removal of extracellular Ca
2+
 completely abolished cell swelling 
in response to hypotonic challenge. This sensitivity of volume change to Ca
2+
 was 
specific to cell swelling as cell shrinkage in hypertonic artificial CSF was unaffected by 
removal of extracellular Ca
2+
. 
Thus functional evidence is presented to further elucidate the role of several 
proteins in the choroid plexus cell volume regulatory response to anisosmotic challenge. 
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vi. Lay Abstract 
The brain is surrounded by salty liquid which provides physical and chemical 
support and protection to the brain. This liquid, called cerebrospinal fluid, also fills 
ventricles within the brain where it is mainly produced by the choroid plexus tissues. 
The choroid plexus cells form a tight barrier which prevents cerebrospinal fluid and 
blood from mixing and thereby disrupting brain function. The components of 
cerebrospinal fluid are moved across this barrier by several proteins located in the cell 
membranes of the choroid plexus cells. To investigate the interactions between mouse 
choroid plexus cells and their surrounding environment, visible changes in cell volume 
were measured when cells were exposed to different bathing solutions.  
Choroid plexus cells are able to regulate their volume. When induced to shrink 
they activate mechanisms to re-swell to their approximate normal volume, this process 
is known as a regulatory volume increase. Conversely, a regulatory volume decrease 
occurs when choroid plexus cells are induced to swell and need to correct their volume 
back towards normal. The identity of several proteins involved in a regulatory volume 
increase was determined using drugs which inhibit volume regulation. A surprising 
observation is that calcium must be present for choroid plexus cells to swell but is not 
necessary for the cells to shrink. This is surprising since previous studies on other cell 
types have shown that the regulatory volume decrease requires calcium, but have not 
commented on the calcium dependency of the cell swelling.  
The present study contributes new knowledge to the growing understanding of 
the mechanisms which help to keep the brain healthy. Improved knowledge of the 
proteins involved will enable the development of drugs with fewer side effects and 
may help in the development of therapies for illnesses as varied as meningitis, 
Alzheimer’s disease and hydrocephalus.  
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1.1. The choroid plexus and cerebrospinal fluid system 
Brain homeostasis is vital for normal neurological functioning. The cells of the 
brain are surrounded by interstitial fluid (ISF) which is continuous with the 
cerebrospinal fluid (CSF) that fills the ventricles within the brain (Wright, 1978). 
Significant pathology results from perturbations in brain homeostasis for example, 
bacterial meningitis can cause coma and death in a few hours through homeostatic 
disruption caused by infection of the meninges and CSF (Gerber and Nau, 2010). A 
better understanding of the tissues and fluids which contribute to brain homeostasis 
should reveal potential therapeutic strategies. The blood brain barrier (BBB) and blood 
cerebrospinal fluid barrier (BCSFB) separate the ISF and CSF respectively from blood 
plasma. The endothelial cells of the blood capillaries which are linked together by tight 
junctions constitute the BBB. The BCSFB is less well studied and is composed of the 
choroid plexus epithelial cells linked by tight junctions and the arachnoid membrane 
(Quay, 1966; Wright, 1978).  
 
1.2. The CSF is critical for brain homeostasis  
CSF provides physical support for the brain and a constant environment for 
neuronal activity (Wright, 1978). In adult humans, the CSF has a total volume of about 
140 ml and comprises approximately 40% of the extracellular fluid in the central 
nervous system (Segal, 1993). The constant production and flow of CSF disperses 
hormones and other signalling molecules and removes waste products from the CNS 
and as a result maintains the constant milleu around the brain (Johanson C. E. et al., 
2005). 
New CSF is secreted by the choroid plexuses (Davson and Segal, 1970), and  
circulates in the lateral ventricles from where it flows via the interventricular foramen 
(foramen of Monro) into the third ventricle and on through the cerebral aqueduct to 
the fourth ventricle (Figure 1.1). CSF leaves the fourth ventricle via the foramina of 
Luschka and Magendie (Wright, 1978) to circulate around the spinal cord and around 
the outside of the brain in the sub-arachnoid space from where it is absorbed across 
the arachnoid villi into the venous circulation. The arachnoid villi act as a ‘one way’ 
  
Alexandra Hughes                                                                                                Page 26 of 174 
system permitting absorption of CSF to the veins but not flow of blood back across the 
meninges (Wright, 1978) (Figure 1.1).  
 
 
Figure 1.1 The anatomy of the cerebroventricular system. The light blue shading shows the spaces filled 
with CSF. The choroid plexuses are shown in yellow. 
 
 
CSF composition is highly consistent in healthy individuals (Wright, 1978). 
Mammalian blood plasma and CSF are of similar osmolalities and contain similar 
concentrations of Na
+
 but CSF is not simply an ultrafiltrate of plasma since its 
concentrations of K
+
, HCO3
-
 and Ca
2+
 are lower than plasma while Cl
-
 and Mg
2+
 
concentrations are slightly raised with respect to plasma (Wright, 1978). CSF protein 
and amino acid concentrations are much lower than in blood plasma (Table 1.1), but 
perhaps the most significant difference is that while blood plasma composition varies 
considerably, CSF composition does not (Husted and Reed, 1976, 1977). CSF 
composition is maintained by active transport mechanisms which respond to, and 
compensate for, variation in plasma composition (Husted and Reed, 1976, 1977). The 
mechanisms by which this active secretion occurs, however, are only beginning to be 
understood.  
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Solute Plasma CSF 
Na
+
 150 147 
K
+
 4.6 2.9 
Ca
2+
 2.4 1.2 
Mg
2+
 3.2 4.5 
Cl
-
 99 113 
HCO3
-
 27 23 
Glucose 5.2 3.4 
Glycine 0.22 0.02 
Protein (mg/100ml) 6800 28 
pH 7.4 7.31 
Omolarity 289 mOsm.L H2O
-1
 289 mOsm.L H2O
-1
 
 
Table 1.1. Solute concentrations (mM) in human plasma and CSF. 
(from (Wright, 1978) ’The average estimates of CSF composition.’) 
 
 
At least 60-70% of the cerebrospinal fluid is thought to be produced by the 
choroid plexuses (Segal, 2001). The rate of fluid secretion is proportional to blood Na
+
 
and Cl
-
 concentration entering the choroid plexus (Davson and Segal, 1970; Maren and 
Broder, 1970) and has been estimated to be 0.4 ml g
−1
 min
−1
. This is equivalent to, and 
in many cases greater than, the rate of secretion in exocrine glands (Brown et al., 
2004). Thus over 500ml of CSF are produced per day in the average human.  
 
1.3. The structure of the choroid plexuses 
In mammals, the four choroid plexuses of the cerebral ventricles develop at 
four separate sites in the roof of the neural tube shortly after it becomes enclosed 
(Dziegielewska et al., 2001). The fourth ventricle (mylencephalic) choroid plexus 
develops first followed by the lateral (telencephalic) plexuses and finally the third 
ventricle (diencephenphalic) choroid plexus (Dziegielewska et al., 2001). Each choroid 
plexus consists of an inner fibrovascular stroma (Figure 1.2) which is closely associated 
with the single layer of cuboidal epithelial cells (Brown et al., 2004; Praetorius, 2007). 
During their maturation, the choroid plexus cells show an increase in total 
mitochondrial volume and their apical brush border becomes more extensively 
developed (Keep and Jones, 1990). Both of these changes are characteristic of highly 
active secretory epithelia. As a very active secretory tissue, choroid plexus receives an 
abundant blood supply, so much so that the choroid plexuses pulse slightly with each 
heart beat (Bering, 1955). 
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Figure 1.2. Choroid plexus structure. A single villus showing the epithelial barrier composed of epithelial 
cells linked by tight junctions with the underlying fibrovascular stroma including capillaries and 
extracellular matrix. 
 
 Unlike most other areas of the central nervous system the capillary endothelial 
cells in the choroid plexus do not form a “blood–brain barrier”. Instead the barrier 
between the blood and the CSF is formed by the single layer of cuboidal epithelial cells 
which cover each plexus (Brown et al., 2004; Praetorius, 2007). The interactions 
between the mammalian choroid plexus epithelial cells are maintained through 
adherin and tight junctions which restrict the movement of most compounds and ions 
via the paracellular pathway (Lippoldt et al., 2000) resulting in a very high 
transepithelial resistance. Maintaining the integrity of the choroid plexus as a barrier 
relies heavily on maintaining a tight epithelial sheet and therefore an efficient barrier 
between the CSF and blood (Abbott, 2005). The choroid plexus epithelial cells express 
a wide range of membrane transport proteins which facilitate the transcellular 
movement of ions and nutrients from the blood to the CSF (Brown et al., 2004; 
Praetorius, 2007). The polarised arrangement of these transporters and channels in 
the choroid plexus cells is maintained by cytoskeletal arrangements, targeting to 
specific cell compartments and controlled endocytosis/recycling to enable cells to 
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maintain the polarised arrangement of channels and transporters necessary for CSF 
secretion. 
 
1.4. Mechanisms of CSF secretion 
1.4.1. Secretion by choroid plexus epithelia  
CSF secretion, like fluid secretion in other epithelia, involves the transport of 
ions from blood to the luminal space (i.e. the cerebral ventricles). This creates an 
osmotic gradient which drives the movement of water, mediated by the aquaporin 
class of water channels (Verkman et al., 1996). Aquaporin 1 (AQP1) is highly expressed 
in rat choroid plexus cells (Nielsen et al., 1993) and CSF secretion is greatly reduced in 
AQP1 null mice (Oshio et al., 2003). Ions are secreted (blood to ventricle) to create the 
osmotic gradient by the combined actions of a variety of transport proteins. Wright 
(1978) showed that the main ions secreted are Na
+
, Cl
-
 and HCO3
-
. During the secretory 
process, ions must cross both the basolateral and apical membranes. This can be 
achieved by the actions of different types of protein which are expressed in either the 
apical or basolateral membrane or both. Work over the last three decades has 
determined the identity, location (apical or basolateral membrane expression) and, to a 
lesser extent, the function of the transport proteins expressed in choroid plexus 
epithelial cells.  
The choroid plexuses are unusual epithelia since Na
+
K
+
ATPase is expressed in 
the apical membrane (Quinton et al., 1973). This is in contrast to the vast majority of 
other epithelial cells in which the Na
+
K
+
ATPase is expressed in the basolateral 
membrane, the functional significance of this localisation is still unknown (Damkier et 
al., 2010).  A second difference between the choroid plexus and most other secretory 
epithelia is the prominent role of HCO3
-
 ions. Despite the relatively low concentration 
in the final CSF (compared to Na
+
 and Cl
-
), HCO3
-
 also makes an important contribution 
to the overall process of CSF secretion (Husted and Reed, 1977). This has led to recent 
interest in the expression of Na
+
/HCO3
-
 cotransporters (NBC’s, see section 1.5.6), and 
the influence of carbonic anhydrase (CA) on CSF production. In wild type mice, 
application of the carbonic anhydrase inhibitor acetazolamide decreases the rate of 
CSF production (Maren and Broder, 1970; Oshio et al., 2003). CAII is found in the 
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cytoplasm of choroid plexus cells (Masuzawa et al., 1984; Sly and Hu, 1995) along with 
CAIII (Nogradi et al., 1993) and the membrane bound CAIV (Maren et al., 1997). These 
enzymes catalyse the conversion of water and carbon dioxide to bicarbonate ions and 
protons and the rate of this reaction clearly has important implications in terms of pH 
regulation as well as its contribution to CSF secretion. 
 
1.4.2. Identification of ion transporters in choroid plexus epithelial cells 
The first step towards understanding the mechanisms by which CSF is secreted 
was to investigate ion fluxes across the choroid plexus and to examine the effects of 
transport inhibitors on these fluxes and on the rate of CSF secretion. This enabled an 
understanding of the net ion movements across the choroid plexus epithelial sheet, 
revealing the secretion of Na
+
 and Cl
-
 with a net absorption of K
+
 (Wright, 1978). 
However, an incomplete knowledge of transport protein diversity coupled to a lack of 
specific transport inhibitors meant that precise identity of many of the proteins 
responsible for these fluxes could not be elucidated. Cell physiological methods such 
as patch clamp electrophysiology did however enable the precise characterisation of 
the K
+
 and Cl
-
 channels which contribute to CSF secretion (Brown et al., 1988; Garner 
and Brown, 1992; Kajita et al., 2000; Kibble et al., 1996; Speake et al., 2004). 
 
  
Alexandra Hughes                                                                                                Page 31 of 174 
 
Figure 1.3.Transporters and ion channels identified in mammalian choroid plexus cells. 
 
 
In the last fifteen years or so, knowledge of the molecular structures of most 
ion transport proteins has greatly improved. This has enabled molecular localisation 
studies which have clarified transport protein expression in the choroid plexus 
(Damkier et al., 2010). These studies have confirmed the expression of transporters 
identified in the earlier flux studies, but have also introduced several proteins (see 
Figure 1.3) the functions of which remain unknown in the choroid plexus. The 
following section will discuss the evidence for the expression of each of the proteins in 
Figure 1.3 and comment on the potential role of these transporters in the process of 
CSF secretion. 
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1.5. Ion transport protein expression in mammalian 
choroid plexus epithelial cells 
1.5.1. Na
+
K
+
ATPase 
The Na
+
K
+
ATPase or ‘sodium pump’ is critical for CSF secretion since it drives 
Na
+
 efflux at the apical membrane. It also creates the K
+
 and Na
+
 gradients across the 
cell membrane which drive numerous other secondary transport processes (Davson 
and Segal, 1970; Pollay et al., 1985; Wright, 1978). Accordingly, inhibition of 
Na
+
K
+
ATPase by cardiac glycosides causes a significant reduction of CSF secretion 
(Neblett et al., 1972). The choroid plexus expresses α1β1 and α2β1 Na
+
K
+
ATPase 
isozymes (Zlokovic et al., 1993). This variety of subunits may enable the pump to 
respond to a wider range of Na
+
 and K
+
 concentrations (Damkier et al., 2010).  
Quinton and colleagues (1973) used radioactive ouabain binding to present 
some of the earliest convincing evidence of Na
+
K
+
ATPase being present in the apical 
membrane of frog choroid plexus (Quinton et al., 1973). Subsequent 
immunocytochemical studies localised Na
+
K
+
ATPase to the apical membrane of the 
mammalian choroid plexuses (Gonzalez-Martinez et al., 1994; Masuzawa et al., 1985; 
Praetorius and Nielsen, 2006). The apical localisation of Na
+
K
+
ATPase in choroid plexus 
cells is highly unusual since it is usually found basolaterally  (Alper et al., 1994). At 
present the significance of its apical expression in choroid plexus cells is not 
understood. 
 
1.5.2. Anion exchanger 2 (AE2)  
Deng and Johanson concluded that an anion antiporter is likely to be involved 
in mediating Cl
-
 transport across the choroid plexus epithelium since DIDS reduces the 
rate of CSF renewal (Deng and Johanson, 1989). Shortly after, the anion exchanger 2 
(AE2) was cloned from a rat choroid plexus library and its expression caused Cl
-
 and 
bicarbonate dependent changes in intracellular pH which were independent of Na
+
 
(Lindsey et al., 1990). Alper and colleagues characterised AE2 isoform specific 
antibodies and confirmed that AE2 is expressed on the basolateral membrane of CP 
cells (Alper et al., 1994) where it makes a significant contribution to Cl
-
 influx into the 
cells (Damkier et al., 2010).  
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1.5.3. Na
+
/H
+
 Exchanger 1 (NHE1) 
Functional evidence for the expression of a Na
+
/H
+
 exchanger (NHE) in choroid 
plexus cells has been known for some time as amiloride decreases CSF secretion, 
decreases Na
+
 secretion and modulates intracellular pH (Murphy and Johanson, 1989, 
1990). Since amiloride abolishes the pH dependent uptake of Na
+
 from the blood to 
choroid plexus in vivo in adult rats, a Na
+
/H
+
 exchanger was predicted to be 
basolaterally located in choroid plexus epithelial cells from both the lateral and fourth 
ventricles (Murphy and Johanson, 1989, 1990). However molecular identification of 
the NHE family member in the choroid plexus has been a matter of some debate. A 
Na
+
/H
+
 exchanger, thought to be NHE1 was identified in rat, pig and human choroid 
plexus through RT-PCR methods combined with amiloride binding kinetics (Kalaria et 
al., 1998). However NHE1 protein has been difficult to detect (Alper et al., 1994). 
Recently (during my PhD studentship) molecular localisation of the NHE1 to the apical 
membrane of the mouse and human choroid plexus epithelial cells was reported 
(Damkier et al., 2009). The role of apical NHE1 is not obvious since it is unlikely to 
contribute directly to CSF secretion, however, apical NHE1 may contribute to either pH 
or volume regulation in choroid plexus cells. 
 
1.5.4. K
+
 channels 
K
+
 channels are expressed alongside Na
+
K
+
ATPase in all cells including epithelia. 
Electrophysiological studies have identified two types of K
+
 conductance in the apical 
membranes of rat choroid plexus cells (Garner and Brown, 1992). Subsequent 
molecular studies have enabled the identification of the proteins responsible. An 
inward rectifying K
+
 conductance is mediated by Kir7.1 in mammalian choroid plexus 
cells. Kir7.1 is highly expressed on the apical membrane of rat choroid plexus epithelial 
cells (Doring et al., 1998; Nakamura et al., 1999). A delayed rectifying K
+
 conductance 
has been identified in rat choroid plexus by electrophysiological techniques (Kotera 
and Brown, 1994). This conductance is activated by depolarising potentials and also 
displays subsequent inactivation at extreme depolarising potentials (Kotera and 
Brown, 1994). The conductance is now known to be mediated by Kv1.1 and Kv1.3 
(Speake et al., 2004).  
In addition to the mammalian channels described above, BKCa channels are 
functionally evident in the apical membrane of the third ventricle choroid plexus of the 
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amphibian Necturus (Brown et al., 1988; Christensen, 1987). This channel is highly K
+
 
selective and the opening probability is modulated by intracellular Ca
2+
, pH and 
membrane potential (Brown et al., 1988). However, BKCa channels have not been 
detected in the mammalian choroid plexuses (Millar et al., 2007).  
All the K
+
 channels described above are expressed in the apical membrane of 
choroid plexus cells, where they act as a leak pathway for K
+
 pumped in by 
Na
+
K
+
ATPase. They also contribute to the membrane potential which is an important 
driving force for other channels and transporters including Cl
-
 channels. As yet, no K
+
 
channels have been identified on the mammalian basolateral membrane. 
 
1.5.5. Cl
-
 channels 
Two Cl
-
 conductances have been identified by electrophysiological methods in 
choroid plexus epithelial cells: 1) an inwardly rectifying anion conductance and 2) a 
volume sensitive anion conductance. The inwardly rectifying anion conductance is 
thought to be the main route by which Cl
-
 and HCO3
-
 cross the membrane during CSF 
secretion but it is not regulated by volume (Speake et al., 2002; Speake et al., 2001). 
The molecular identity of this channel remains to be determined. 
The volume regulated anion channel (VRAC) in choroid plexus  (Speake et al., 
2001), is similar to VRAC detected in numerous cell types (Okada, 1997). It is activated 
by cell swelling and may play a role in cell volume regulation (Kibble et al., 1997). The 
molecular identify of VRAC  remains to be elucidated (Nilius and Droogmans, 2003).  
 
1.5.6. Na
+
 HCO3
-
 cotransporters (NBC’s) 
The Na
+
/HCO3
-
 family of cotransporters were identified at the molecular level 
relatively recently (Romero et al., 2004; Romero et al., 1997). They mediate either 
electroneutral or electrogenic transport of Na
+
 and HCO3
-
 and there is good evidence 
to indicate that three members of the family are expressed in choroid plexus epithelial 
cells (Damkier et al., 2010).  
NBCn1 mediates Na
+
/HCO3
-
 cotransport and was initially localised to the 
basolateral membrane of the rat and mouse choroid plexus (Praetorius et al., 2004) 
where it was thought to mediate most of the Na
+
 dependent HCO3
-
 influx into the 
choroid plexus cells (Bouzinova et al., 2005). However it now appears that NBCn1 
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membrane localisation is not exclusively basolateral (Praetorius and Nielsen, 2006) and 
it is not DIDS sensitive so is unlikely to be the mediator of DIDS sensitive Na
+
/HCO3
-
 
cotransport at the basolateral membrane. In addition, choroid plexus cells from NBCn1 
knockout mice and their wild-type litter mates have similar Na
+
/HCO3
-
 cotransport 
(Damkier et al., 2010). 
A Na
+
 driven electroneutral anion cotransporter NCBE (sometimes called 
NBCn2) was cloned from human brain and found to be blocked by DIDS (Grichtchenko 
et al., 2001). NCBE is also located in the basolateral choroid plexus membrane 
(Praetorius et al., 2004). In contrast to NBCn1 knock out mice, NCBE knock out mice 
have very small cerebral ventricles indicating reduced CSF secretion (Jacobs et al., 
2008). 
In addition to the two basolateral NBC's the electrogenic NBCe2 is also 
expressed in the choroid plexus but in the apical membrane (Bouzinova et al., 2005; 
Praetorius, 2007). In mouse fourth ventricle choroid plexus the NBCe2 cotransporter 
operates with a 3 HCO3
-
:1 Na
+
 moving HCO3
-
 and Na
+
 across the apical choroid plexus 
to the CSF contributing to HCO3
-
 efflux (Millar and Brown, 2008). Confusingly, NBCe2 
does not appear to be expressed in human choroid plexus (Damkier et al., 2007). 
 
1.5.7. Na
+
K
+
Cl
-
 cotransporter 1 (NKCC1) 
There are two members of the NKCC family (NKCC1 and 2) and, with the Na
+
 Cl
-
 
cotransporter (NCC), they comprise the Na
+
 driven cation chloride cotransporter family 
(Gimenez, 2006). NKCC2 is specifically expressed in the kidney where it is thought to 
play a role in Na
+
 reabsorption in the thick ascending limb of Henle (Gimenez, 2006). 
NKCC1 has been identified in a wide variety of vertebrate cells (Haas and Forbush, 
1998). 
NKCC1 is known to be basolaterally located in almost all secreting epithelia 
(Javaheri, 1991), so it was initially assumed that the protein would be located 
basolaterally in choroid plexus cells. NKCC1 was therefore predicted to be involved in 
the net movement of Na
+
 and Cl
-
 into choroid plexus cells for their further secretion as 
part of CSF (Javaheri, 1991). Subsequently, Keep and colleagues suggested, on the 
basis of detailed flux studies, that NKCC1 may be located in the apical membrane of 
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the choroid plexus and may mediate ion efflux from choroid plexus cells (Keep and 
Xiang, 1995; Keep et al., 1993). More recent data has indeed localised NKCC1 protein 
to the apical membrane of choroid plexus cells (Plotkin et al., 1997; Praetorius and 
Nielsen, 2006), however whether the transporter mediates ion influx or efflux remains 
to be determined. In the most recent study of NKCC1 activity, (Wu et al., 1998) 
evidence was presented to indicate that NKCC1 contributes to the maintenance of cell 
volume by mediating ion influx, this observation remains to be substantiated. 
Therefore, establishing whether or not NKCC1 is involved in influx of ions into the cells 
contributing to cell volume regulation or efflux of ions contributing to CSF secretion 
will be a major step forward in understanding the function of this protein.  
 
1.5.8. K
+
Cl
-
 cotransporters (KCC’s) 
The K
+
Cl
-
 cotransporters are four members of the cation chloride cotransporter 
superfamily which mediate K
+
 and Cl
-
 coupled efflux due to the K
+
 concentration 
gradient. They are closely related in molecular structure to NCC, NKCC1 and NKCC2 
(Hebert et al., 2004). KCC activity is regulated by phosphorylation and 
dephosphorylation and they are activated by hypotonic challenge (Adragna et al., 
2004). There is good molecular evidence for the expression of KCC3 and KCC4 in 
mammalian choroid plexus cells. 
The gene encoding KCC3 was first identified in 1999 (Hiki et al., 1999). In the 
same year the protein was cloned from human placenta (Race et al., 1999) and both 
mouse and human KCC3 were also cloned by another group (Mount et al., 1999). KCC3 
has two major splice variants – KCC3a is expressed most significantly in the brain while 
KCC3b is expressed in the kidney (Pearson et al., 2001). KCC3a is expressed in a 
number of sites in the brain including in the base of the choroid plexus epithelium, 
presumed to be the basolateral epithelial membrane where it may play a role in K
+
 
reabsorption from CSF to blood (Pearson et al., 2001). Human KCC4 was cloned in 1999 
(Mount et al., 1999) and the mRNA is expressed in the embryonic mammalian choroid 
plexus (Li H. et al., 2002). In the adult mouse, KCC4 is also expressed in the apical 
membrane of choroid plexus cells (Karadsheh et al., 2004).  
The role of KCC3 and KCC4 in the choroid plexus is yet to be established. Early 
mammalian choroid plexus K
+
 and Cl
-
 flux data is unclear (Javaheri, 1991; Keep and 
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Xiang, 1995; Keep et al., 1994) and no recent functional studies have investigated their 
role in the choroid plexus epithelia. No K
+
 channels have been identified in the 
basolateral membrane of mammalian choroid plexus cells (Millar and Brown, 2008) 
and so the basolateral location of KCC3 suggests it may play a role in net K
+
 absorption 
across the choroid plexus. KCC4 is located on the apical membrane and may play a role 
in K
+
 recycling to permit continued Na
+
K
+
ATPase activity and maintain a constant CSF 
K
+
 concentration. These hypotheses remain to be confirmed. 
 
1.5.9. Transient Receptor Potential (TRP) channels 
Two of the most recently identified transport proteins in the choroid plexus are 
members of the transient receptor potential (TRP) superfamily of cation channels. TRP 
channels were first identified in Drosophila (Montell and Rubin, 1989). Cloning by 
homology has resulted in 28 mammalian members of the superfamily and these are 
divided into six subfamilies: classical (C) (sometimes called canonical), vanilloid (V), 
melanostatin (M), ankyrin (A), polycystin (P) and mucolipin (ML) families (Clapham, 
2003). TRPV4 and TRPM3 are both osmosensitive, Ca
2+
 permeant ion channels and 
both are expressed in the mammalian choroid plexuses (Millar et al., 2007). 
 
1.5.9.1. TRPV4  
A study looking for mammalian homologs of a known osmosensor in 
Caenorhabditis elegans (OSM-9) identified the vanilloid receptor-related, osmotically 
activated channel (VR-OAC), which is now known as TRPV4 (Liedtke et al., 2000). 
TRPV4 is a broad selectivity cation channel which mediates the influx of Ca
2+
 ions and is 
activated by a number of factors including: low extracellular osmolality, arachidonic 
acid, poly unsaturated fatty acid (PUFA) derivatives and the agonist 4alpha-phorbol 
12,13-didecanoate (4α-PDD) (Liedtke, 2007). Recently, it was observed that 
phosphorylation of TRPV4  by protein kinases A and C enhances its activation (Fan et 
al., 2009). The channel is blocked by ruthenium red in the low micromolar range 
(Reiter et al., 2006; Watanabe et al., 2003).  
Two groups have reported studies in which they generated TRPV4 
-/-
 knock out 
mice to investigate the role of TRPV4 in osmotic homeostasis (Liedtke and Friedman, 
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2003; Mizuno et al., 2003). Direct comparison of their conclusions is complicated by 
differences in experimental design, however, both groups agree that TRPV4 plays a 
role in osmotic sensing in the central nervous system (Liedtke and Friedman, 2003; 
Mizuno et al., 2003).  
The ability of TRPV4 to act as a cellular sensor of osmotic challenge was 
observed when CHO cells transfected with TRPV4 mediated a regulatory volume 
decrease in response to hyposmotic stimuli, a response absent in wild type CHO cells 
(Liedtke et al., 2000). Since then, several studies have presented evidence that Ca
2+
 
influx through TRPV4 triggers a cellular response to hyposmotic challenge (Becker et 
al., 2005; Fernandez-Fernandez et al., 2008; Liu et al., 2006; Pan et al., 2008; Phan et 
al., 2009; Reiter et al., 2006). However, the potential role of TRPV4 in volume 
regulation/osmosensation in choroid plexus cells has not yet been investigated. 
 
1.5.9.2. TRPM3  
Three groups have cloned TRPM3 and reported molecular and functional 
characteristics when the protein is expressed in HEK293 cells (Grimm et al., 2003; Lee 
et al., 2003; Oberwinkler et al., 2005). Drawing firm conclusions about the properties 
of TRPM3 has been complicated by the expression of many splice variants of TRPM3, 
each of which differs slightly in its biophysical properties (Fonfria et al., 2006). 
However it is generally agreed that TRPM3 is permeable to Ca
2+
 and does not show 
enzymatic activity. Furthermore, TRPM3 is thought to be an osmosensor as an 
increased Ca
2+
 influx is detected when HEK293 cells expressing TRPM3 are exposed to 
lowered osmolarity (Grimm et al., 2003; Grimm et al., 2005).  
TRPM3 mRNA and protein localisation studies carried out by Oberwinkler and 
colleagues demonstrated abundant TRPM3 expression in the mouse brain, particularly 
in the choroid plexuses (Oberwinkler et al., 2005). Whole cell patch clamp studies 
carried out on intact choroid plexus fragments from the fourth ventricle of mice have 
also demonstrated a TRPM3-like current which shows pharmacological sensitivity 
similar to that reported for TRPM3 (Millar et al., 2007). Studying the potential roles of 
TRPM3 (and TRPV4) in the control of volume regulation in choroid plexus cells was an 
important aim of my PhD studentship.  
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1.5.10. Summary of ion transport protein expression in the choroid 
plexus  
The functional relevance of several of the proteins known to be present in the 
choroid plexus cells has not yet been identified. The cation chloride co-transporters 
(NKCC1, KCC3 and KCC4) are all likely to contribute to maintaining choroid plexus cell 
volume rather than directly contributing to CSF secretion. A similar role for these 
cotransporters has been noted in other cell types and so their activity in choroid plexus 
cells may be investigated by perturbing cell volume. In addition TRPV4 and TRPM3 also 
have a potential role in volume regulation and so investigating changes in cell volume 
is a convenient method for studying the function of these proteins. A major aim of the 
present study was therefore to investigate the ability of choroid plexus epithelial cells 
to regulate their volume in response to hypertonic and hypotonic challenge and 
identify the ion transporters involved in any volume regulation. 
 
1.6. Volume regulation in the choroid plexus 
The blood/CSF barrier in the choroid plexuses comprises a single layer of 
epithelial cells linked by junctional complexes. The integrity of this barrier may be 
compromised by changes in epithelial cell volume placing stress on the cell/cell 
junctions. Breakdown of the blood/CSF barrier has serious consequences and 
contributes significantly to the pathology of CNS inflammation (Engelhardt et al., 
2001). Except in pathological circumstances, choroid plexus cells are unlikely to be 
subjected to substantial changes in extracellular osmolarity because plasma osmolarity 
is regulated by the kidneys and CSF composition is kept constant. However, the 
choroid plexus cells express a very high number of ion transporters. A potential 
problem with such high numbers of transporters and rapid rates of transport is the 
balancing of ion fluxes entering and leaving the cells at the basolateral and apical 
membranes respectively. If these fluxes are not balanced disturbances in cell volume 
may occur in choroid plexus cells in a manner similar to that observed in other cell 
types (Diamond, 1982). For example, decreases in cell volume have been observed in 
salivary gland (Foskett et al., 1994) and lacrimal gland acinar cells (Speake et al., 1998) 
when stimulated by secretagogues such as acetylcholine. Whereas, the volumes of 
proximal tubule cells (Beck J. S. and Potts, 1990), and small intestinal enterocytes 
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(MacLeod and Hamilton, 1991) increase during the absorption of glucose and amino 
acids. It is therefore essential that choroid plexus cells are capable of regulating their 
cell volume (Strange, 1993).   
 
1.6.1. Regulatory volume decrease (RVD) 
Animal cells are not constrained by a cell wall and may swell either because of 
an increase in the accumulation of intracellular ions or a decrease in the extracellular 
osmolality (Figure 1.4). Both circumstances lead to the influx of water into the cell 
resulting in cell swelling and, in extreme circumstances, will result in the cell bursting. 
Most cells therefore have the ability to actively regulate their volume to return 
towards normal by a process known as a regulatory volume decrease (RVD) (Tinel et 
al., 2002). RVD occurs by expelling osmolytes from the cell and this induces the 
osmotically obliged egress of water.   
The expelled osmolytes may be organic molecules such as taurine (Wehner et 
al., 2003a) or they may be inorganic ions such as K
+
 (Park et al., 1994), Cl
-
 (Bond et al., 
1998) or HCO3
-
 (Lopes and Guggino, 1987; Volkl and Lang, 1988). Onset of RVD occurs 
very quickly and can be initiated at very low thresholds of osmotic challenge  (Kuang et 
al., 2006). These fast onset RVD’s are commonly mediated by channels or transporters 
causing movement of inorganic ions rather than organic osmolyte efflux. With the 
notable exception of some kidney cells, most challenges to mammalian cell volume 
arise from imbalances in intracellular handling of ions however the experimental 
superfusion of cells with hypotonic bathing solutions combined with pharmacological 
modulators of ion transport is an effective method of studying cell volume regulation.  
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Figure 1.4. Volume regulation mechanisms. An osmotic or metabolic challenge triggers cell swelling or 
shrinkage. Volume regulation mechanisms initiate a RVD or RVI to return the cell to normal size. 
Illustrations of the typical changes to cell volume observed over time are shown when a cell is exposed to 
extracellular hypotonicity (lower left) or extracellular hypertonicity (lower right). 
 
 
1.6.2. Regulatory volume increase (RVI) 
A decrease in intracellular ion concentrations or an increase in extracellular 
osmolality will induce efflux of water causing cells to shrink (Figure 1.4). Cell shrinkage 
is limited by the proportion of the cells’ contents which is osmotically inactive and 
varies with cell type (Lucké and McCutcheon, 1932). Uptake of inorganic ions such as 
Na
+ 
and Cl
-
 induces the osmotically obliged movement of water into the cell resulting 
in a regulatory volume increase (RVI). Alternatively, organic osmolytes such as taurine 
may also be taken up by cells to contribute to an RVI (Wehner et al., 2003a). Some 
organic osmolytes, such as sorbitol, may be synthesised by a hypertonically challenged 
cell to initiate an RVI response (Burg et al., 2007). A RVI mediated by organic osmolyte 
uptake or synthesis takes much longer to return the shrunken cell towards normal 
volume than uptake of inorganic osmolytes (Wehner et al., 2003a). After osmotic 
challenge has stopped, many cells which show an adaptive response to osmotic 
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challenge can return to their pre-challenge size. NKCC1 has been proposed to mediate 
the RVI in choroid plexus cells (Wu et al., 1998) in a similar manner to its actions in red 
blood cells (Matskevich et al., 2005) while the physiologically coupled actions of NHE 
and AE mediate a RVI in a number of other cell types (Hoffmann and Dunham, 1995).  
In experiments employing anisotonic extracellular solutions to study cell 
volume regulation, further characteristic changes in volume may be observed when 
cells are returned to isotonic solutions. Thus, following a RVD, when cells are returned 
to isotonic solutions, they shrink below their initial volume (Figure 1.4) due to 
continued loss of ions. Whereas following a RVI, when cells are returned to isotonic 
solutions, they swell above their initial volume due to continued accumulation of ions. 
These undershoots and overshoots in cell volume are transient because cells are able 
to exhibit post-RVD RVI or post RVI-RVD which involve further transport of osmolytes 
(Kuang et al., 2006).  
 
1.6.3. Measurement of cell volume regulation  
Numerous groups have investigated cell volume changes in a wide variety of 
cell types. A variety of methods to measure cell volume have been devised and these 
techniques may be classified into four types of experiment. 
 
1.6.3.1. Isotope loading 
The volume of a space may be estimated by allowing a known quantity of 
radioactive marker to diffuse freely and then measuring the concentration of the 
marker when it is evenly dispersed. By comparing the volume calculated for a 
radiolabelled marker which will diffuse freely into cells with another radiolabelled 
marker which will only occupy the extracellular space, cell volume may be determined 
(Lyons and Moore, 1968). However, the radioactive isotopes are inconvenient to use 
and it is not possible to follow volume changes of an individual cell because large 
numbers of isolated cells are required for the volumes of the two markers to be 
compared with any accuracy. 
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1.6.3.2. Fluorescence activated cell sorting (FACS) 
The FACS method of measuring cell volume works by passing fluorescently 
labelled cells one at a time in front of a laser. The scattering of the laser light is 
detected by a photomultiplier tube and the scatter pattern enables assessment of the 
cell size (Basu et al., 2010). This method is extremely useful for investigating changes 
to the cell volume of populations of cells but, like the isotope methods, does not allow 
the recording of how an individual cell changes in volume over time. 
 
1.6.3.3. Fluorescent dyes 
A fluorescent dye molecule (such as the calcium sensitive dyes Fura-2 and 
calcein) is commonly attached to an acetoxy methyl ester group (-AM) which enables 
the dye to cross the cell membrane. Once inside the cell, the –AM group is cleaved by 
endogenous esterases resulting in a fixed quantity of dye molecules being trapped 
within the cell (Altamirano et al., 1998). Once excited with light of an appropriate 
wavelength the dye may fluoresce which can be detected with a microscope and 
computer. An estimate of cell volume may be assessed by measuring changes in 
fluorescence intensity (Capo-Aponte et al., 2006). This technique is most reliable when 
large cells which take up and trap fluorescent dyes in a stable and reproducible 
manner are used. However choroid plexus cells are very small and very few reports 
exist of the successful use of fluorescent dyes with choroid plexus cells (Watson et al., 
1995). 
 
1.6.3.4. Optical imaging 
The volume of isolated cells can be measured through optical imaging providing 
the cells for study form a regular shape. Digitized images of the cells for study are 
recorded using a microscope, camera and computer. The borders of the cell can then 
be traced and the area measured with image analysis software. Cell volume can then 
be calculated from the known cell area. Optical imaging has been used successfully in 
the Brown lab group to investigate volume changes in cells of dispersed pancreatic 
islets (Davies et al., 2009; Davies et al., 2007; Miley et al., 1998; Miley et al., 1997) and 
lacrimal acinar cells (Douglas and Brown, 1996; Park et al., 1994; Speake et al., 1998). A 
similar method was used to successfully measure the cell volume changes of isolated 
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choroid plexus epithelial cells (Wu et al., 1998). Thus, optical imaging was the method 
of choice for the present study. 
Optical imaging is most successful when the cells for study are individual, with a 
regular shape and clear membrane. Cultured cells tend to flatten when attached to a 
culture dish while freshly isolated cells remain spherical facilitating analysis of two 
dimensional images. In addition, culture conditions may change protein expression 
(Sandow and Grayson, 2009) and so the first objective of the present study was to 
develop a cell isolation protocol which would yield single isolated choroid plexus cells 
suitable for optical imaging analysis of cell volume. The cell isolation protocol was 
developed for mouse choroid plexus cells to allow future comparisons with data from 
transporter knock out mice. 
 
1.7. Thesis Aims 
The main purpose of the present study is to explore the physiological relevance 
of several transporters for choroid plexus cell physiology. This leads to four specific 
aims: 
− Develop a method of acutely isolating choroid plexus epithelial cells 
from mice to improve the yield of single cells suitable for volume 
regulation experiments. 
− Investigate the ability of choroid plexus epithelial cells to regulate their 
volume in response to hypertonic challenge and identify the ion 
transporters involved in any volume regulation. 
− Investigate the ability of choroid plexus epithelial cells to regulate their 
volume in response to hypotonic challenge and identify the ion 
transporters involved in any volume regulation. 
− Investigate the possible contribution of TRP channels and Ca
2+
 to control 
of choroid plexus cell volume regulation. 
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Chapter Two     
Development of an acutely 
isolated preparation of 
choroid plexus cells  
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2.1. Introduction 
2.1.1. Requirements of an acutely isolated single choroid 
plexus cell preparation 
A major aim of this studentship was to use volume measurement studies to 
investigate cell volume regulation and ion transport protein activities in choroid plexus 
epithelial cells. Single, isolated cells were required to allow volume to be measured 
through video imaging techniques. The best option was to use choroid plexus cells 
which are isolated from an animal, prepared and used in experiments immediately 
(acutely isolated). Mice are good models of human choroid plexus activity since 
expression of a number of their channels and transporters are almost identical to that 
observed in humans (Praetorius and Nielsen, 2006). Ex vivo preparations of cells can be 
investigated very conveniently provided they are used very shortly after removal from 
the animal. Freshly isolated cells have the advantage over cells in culture in that their 
protein expression remains largely unaltered. By contrast, changes occur to cells in 
culture. This is now quite well documented for some types of cells, e.g. for ion channel 
expression in vascular smooth muscle and endothelium (Sandow and Grayson, 2009), 
but it has not been examined systematically in the choroid plexus. 
 
2.1.2. Methods employed for choroid plexus cell 
preparation  
Choroid plexus cells for physiological study have been prepared in several 
different ways. Choroid plexus tissue is very difficult to study in vivo since the choroid 
plexuses are small structures which have considerable freedom of movement within 
the cerebral ventricles. The majority of previously reported methods of isolating 
choroid plexus cells use 1) enzymatic treatment to breakdown proteins in the 
extracellular matrix; 2) disrupt tight junctions through trituration. 
Several enzymes are commonly used in the isolation of choroid plexus epithelial 
cells from a number of mammalian species. Trypsin digestion was used to release 
porcine choroid plexus epithelial cells from the basal lamina by Galla and colleagues 
(Angelow et al., 2004; Gath et al., 1997; Hakvoort et al., 1998a; Hakvoort et al., 1998b; 
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Haselbach et al., 2001). Kitazawa and colleagues also used trypsin in combination with 
EDTA to isolate rat choroid plexus epithelial cells. The intact choroid plexuses were 
passed through a 23 gauge needle followed by dissection with microscissors and 
incubation with trypsin and EDTA. The suspension was triturated intermittently during 
the enzymatic digestion (Kitazawa et al., 2001). This cell suspension was cultured to 
create five immortalised cell lines (Kitazawa et al., 2001).  
Rat choroid plexus cells have also been isolated using the enzyme pronase. 
Choroid plexuses from 3-5 day old rats were treated with pronase and DNase with 
intermittent trituration and the resulting cell suspension was passed through a nylon 
mesh (Villalobos et al., 1997). Pronase incubation in combination with mechanical 
dissociation by forced passage through a 20 gauge needle was used to isolate rat 
choroid plexus cells for both primary culture and establishing an immortalized choroid 
plexus epithelial cell line (Zheng and Zhao, 2002; Zheng et al., 1998). 
DNAse has been used in combination with collagenase to separate small clumps 
of rat choroid plexus epithelial cells from underlying extracellular matrix. The small 
clumps of epithelial cells were then incubated with trypsin to finally break cell-cell 
interactions before culture (Tsutsumi et al., 1989). A similar method was also used for 
the isolation of rabbit choroid plexus cells (Mayer and Sanders-Bush, 1993). A mixture 
of collagenase IV and protease XIV was used to remove the extracellular matrix from 
rat choroid plexus epithelial cells which were then further separated by gentle 
trituration with a pipette (Wu et al., 1998). The cells prepared by Wu and colleagues 
were not cultured but used within six hours for cell volume regulation experiments 
assessed by optical imaging (Wu et al., 1998). 
By contrast, tissue disruption by enzymatic digestion was avoided altogether by 
isolating epithelial cells from foetal mouse choroid plexus tissue incubated with EDTA 
to disrupt tight junctions followed by passing the cell suspension through a Pasteur 
pipette tip to mechanically dissociate the tissue (Peraldi-Roux et al., 1990). A similar 
method was used by Gabrion and colleagues who mechanically dissociated choroid 
plexus fragments from mouse or rat foetuses by passing them through a tapered 
Pasteur pipette. In some cases the tissue was incubated with EDTA prior to mechanical 
dissociation. The resulting suspension was spun in a centrifuge to remove debris and 
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the cells transferred to culture conditions for up to 6 months with twice weekly 
changing of culture media (Gabrion et al., 1998).  
Choroid plexus epithelial cells have been isolated from adult rat tissue in the 
Brown lab group previously (Watson et al., 1995). Incubation of freshly dissected 
choroid plexus tissue with dispase followed by gentle pipetting resulted in a mixture of 
small and large groups of epithelial cells (Watson et al., 1995). These clumps of cells 
were then maintained in culture medium overnight before their use in experiments to 
measure intracellular Ca
2+ 
with the Ca
2+ 
sensitive dye Fura-2. However, optical imaging 
experiments to investigate cell volume regulation require single isolated cells so 
optimisation of the method used by Watson was required.  
 
2.1.3. Chapter aims 
The aim of this chapter was to develop the choroid plexus cell preparation 
protocol to yield high quality single choroid plexus epithelial cells. The cells should be 
suitable for use in cell volume regulation studies to investigate the transporters 
involved in RVI and RVD by optical imaging. 
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2.2. Methods 
2.2.1. Isolation of choroid plexus 
The final method for preparing cells used for volume regulation experiments in 
this study is described here. This method was adapted from an earlier protocol which 
was designed to yield small clumps of cells with some single cells (Watson et al., 1995). 
The adaptations made are discussed in section 2.3.1. 
Choroid plexus epithelial cells were isolated from mouse brain using a method 
based on that described for the preparation of primary cultures of rat choroid plexus 
cells (Watson et al., 1995). Wild type male MF-1 mice (6–10 weeks) were killed 
humanely by inhalation of the anaesthetic iso-fluorane-1 (Isoflurane 100% inhalation 
vapour liquid, IVAX Pharmaceuticals, UK) in accordance with Schedule 1, Animals 
(Scientific Procedures) Act 1986 of U.K. Home Office regulations.  
Each animal was decapitated close to the shoulder blades. Small scissors 
(blades 2cm) were used to cut the skin over the skull from the nape of the neck to the 
snout and the skin flaps were peeled back to expose the skull. Spinal cord and neck 
muscles were trimmed back to the base of the brain stem with small scissors. One tip 
of the small scissors was inserted into the spinal column alongside the brain stem and 
the skull was cut along the left and right fissures. The top of the skull was gently pulled 
back to expose the brain. The brain was removed from the skull by blunt dissection 
and placed in a small beaker containing ice cold isotonic aCSF (see Table 2.1). Using a 
dissection microscope (Kyowa, Japan), the cerebellum was bluntly dissected from the 
brain with forceps to reveal the fourth ventricle choroid plexus. The fourth ventricle 
choroid plexus was teased away from the rest of the brain tissue. The isolated choroid 
plexus tissue was then placed in a small disposable petri dish (35 x 10 mm sterile tissue 
culture dish, Nunc, Denmark).  
All chemicals used in the present study were obtained from Sigma Aldrich, 
Poole, UK unless otherwise stated. Osmolality of solutions was measured using an 
Osmomat 030 osmometer (Gonotec, Germany). All solutions were adjusted with NaOH 
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or HCl as necessary to give a final pH of 7.4. The solutions used to isolate choroid 
plexus cells are described in Table 2.1.  
Solute Isotonic aCSF 
(mM) 
Isotonic Ca
2+
 free aCSF 
(mM) 
NaCl 140 140 
Hepes 5 5 
Mannitol 20 20 
Glucose 4 4 
KCl 5 5 
EGTA 0 1 
CaCl2 1.2 0 
MgCl2 1 1 
Osmolality 302 mOsm.Kg H2O
-1
 306 mOsm.Kg H2O
-1
 
 
Table 2.1. Solutions used in the isolation protocol to obtain single choroid plexus cells from the mouse 
fourth ventricle.  
 
2.2.2. Enzymatic Disruption Of Tissue 
50 µL dispase solution (1.5 units ml
-1 
neutral protease (Dispase - Worthington 
Biochemical Corporation UK) dissolved in isotonic aCSF) was added to the choroid 
plexus tissue and mincing scissors (5mm blades) were used to cut the choroid plexus 
200 times. The resultant choroid plexus tissue suspension was placed in a sterile Falcon 
tube using a 1000 µL Gilson pipette tip. The petri dish and scissors were washed with a 
further 1950 µL dispase solution to ensure all choroid plexus fragments had been 
collected. The tube was tapped to mix contents and left on ice for 15 min. The choroid 
plexus and dispase was mixed vigorously for 10 seconds at the beginning, end and 
three times during a 26 minute incubation in a water bath at 37°C with shaking at a 
frequency of 30 min
−1
. The incubation time was optimised for each new batch of 
dispase. The enzyme reaction was stopped at the end of this period by adding 4 ml of 
ice-cold newborn bovine serum (Autogen Bioclear, Wiltshire, UK) to the tissue 
suspension. The mixture was allowed to settle and the liquid phase was removed using 
a Pasteur pipette.  
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2.2.3. Ca
2+
 Free Incubation 
The tissue pieces were re-suspended in 10 ml of isotonic Ca
2+
 free aCSF (Table 
2.1) and placed on ice for a further 5 min. This process was repeated twice and after 
the third wash the tissue pieces were re-suspended in 500 μL isotonic aCSF which 
contained 1.2mM Ca
2+
. The tissue pieces were fragmented by trituration though a 1 ml 
pipette tip. 50 μL aliquots of the cell suspension were plated onto poly-L-lysine (0.01% 
w/v in water, Sigma-Aldrich) coated coverslips (22x22 mm, Scientific Laboratory 
Supplies, UK) mounted in 30mm plastic culture dishes (Nunc). The dishes were 
maintained at room temperature for between 15 and 40 min in the hepes-buffered 
isolation solution to allow the cells to adhere to the coverslips. All experiments were 
performed within 3 hours of the initial isolation procedure.  
 
2.2.4. Measurement of cell volume 
Cell volume was measured by video-imaging using a Nikon Diaphot 200 
microscope fitted with a Canon Powershot A620 camera to collect images which were 
stored as JPEG files for subsequent analysis. Petri dishes mounted on the microscope 
were superfused with isotonic aCSF while cells were examined at x400 magnification 
and a suitable cell identified for experimentation. Cells chosen for experiments were 
round choroid plexus epithelial cells which were observed to have clear intact 
membranes with no blebbing or extra matter attached to the cell and were of a similar 
size to those in epithelial sheets. During experiments, cells were viewed continually at 
x400 magnification via the imaging software preview screen and cells which lost 
membrane integrity during experiments or blebbed were excluded from analysis. All 
aCSF’s (see Table 2.2) were warmed to 36±1°C and cells were superfused at a rate of 4-
6 mL per minute. 
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Solute 
Hypertonic 
aCSF 
(mM) 
Hypertonic 
aCSF 
(mM) 
Isotonic 
aCSF 
(mM) 
Hypotonic 
aCSF 
(mM) 
Hypotonic 
aCSF 
(mM) 
Hypotonic 
aCSF 
(mM) 
NaCl 140 140 140 125 105 80 
Hepes 5 5 5 5 5 5 
Mannitol 120 60 20 0 0 0 
Glucose 4 4 4 4 4 4 
KCl 5 5 5 5 5 5 
CaCl2 1.2 1.2 1.2 1.2 1.2 1.2 
MgCl2 1 1 1 1 1 1 
Osmolality 384 
mOsm.Kg 
H2O
-1
 
341 
mOsm.Kg 
H2O
-1
 
285 
mOsm.Kg 
H2O
-1
 
242 
mOsm.Kg 
H2O
-1
 
214 
mOsm.Kg 
H2O
-1
 
188 
mOsm.Kg 
H2O
-1
 
 
Table 2.2. Composition of experimental aCSF’s. 
 
2.2.5. Data and statistical analysis 
Images were recorded at 1 minute intervals and analysed using an electronic 
mouse pen and pad (Genius Mouse Pen 8x6 Cordless USB, Bronco Ltd, UK) and ImageJ 
software (NIH, USA). The area of a cell in pixels was determined and the data was 
exported to Excel (Microsoft Office 2003). Cell volume was calculated assuming that 
cells maintain a spherical shape as previously described (Miley et al., 1997) and 
knowing that 1 pixel has an area of 0.00027 μm
2
. This was calculated by taking images 
of a graticule showing a µm scale. The number of pixels per µm was calculated for both 
x and y planes so that the area of the image (μm
2
) of a known number of pixels could 
be calculated. Cell volumes were normalised to the mean volume measured in isotonic 
aCSF at the start of each experiment and are expressed as % relative cell volume. Data 
(mean±SEM) was calculated and plotted using GraphPad Prism 5 for Windows 
(GraphPad Software, USA) which was also used for all statistical analyses.  One way 
ANOVA was used to compare three or more data sets while unpaired Students t tests 
were used to compare two data sets. 
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2.2.6. Boyle-van’t Hoff plot 
To determine the ability of choroid plexus cells to behave as osmometers, cells 
were superfused with solutions with a range of osmolalities from 188 to 384 mOsm.Kg 
H2O
-1
 (see Table 2.2). The maximum or minimum cell volume recorded when cells were 
superfused with hypotonic or hypertonic aCSF respectively were used to create a 
Boyle-van’t Hoff plot. This plots relative cell volume as a function of the reciprocal of 
relative osmolality. A line through the data was fitted by linear regression analysis 
GraphPad Prism 5 for Windows (GraphPad Software, USA). 
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2.3. Results 
2.3.1. Cell isolation protocol development 
The protocol for acute isolation of epithelial cells from the mouse fourth 
ventricle choroid plexus is described in section 2.2 (Methods). This was the protocol 
used for isolating cells for most of the experiments described in the present study. The 
method was adapted from an earlier protocol which was designed to yield small 
clumps of cells with some single cells (Watson et al., 1995). The original protocol was 
used to produce cells for a number of preliminary experiments described in Chapter 4. 
An initial aim of this study was to optimise the cell isolation protocol to increase the 
yield of single cells. The success of the optimisation methods was judged by visually 
inspecting the resulting cell preparation and testing the physiology of available single 
cells with hypertonic challenge. Three aspects of the protocol were examined in an 
attempt to increase the yield of single cells suitable for volume regulation 
experiments: 
 
2.3.1.1. Mechanical disruption of the tissue 
Choroid plexus tissue was mechanically disrupted at two stages in the cell 
isolation process; first when the tissue was finely cut with mincing scissors and 
secondly when the cell suspension was triturated through a 1000 μL pipette tip. The 
number of cuts made to the choroid plexus tissue with mincing scissors was varied in 
increments of 50 cuts. 200 cuts provided numerous small fragments of choroid plexus 
tissue available for further separation via enzymatic methods. More than 200 cuts 
yielded cells damaged by the isolation whereas less than 200 produced fewer 
individual cells.  
The final trituration step was very important for disrupting the epithelial sheets 
into single cells. The cell suspension was drawn up and expelled through a 1000 μL 
pipette tip smoothly and gently. Repeating this process more than 10 times did not 
increase the yield of single cells. The cell suspension was triturated extremely carefully 
to avoid creating air bubbles since these tended to burst once the cell suspension was 
distributed onto coverslips. This left behind a very thin film of cell suspension over a 
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large area of coverslip which tended to dry out before experiments could be 
performed, killing all cells unless additional aCSF was added. Adding extra aCSF diluted 
the cell suspension making it more difficult to find cells suitable for experiments. 
 
2.3.1.2. Enzymatic disruption of the tissue 
The cell preparation protocol used previously in the lab group used dispase, a 
neutral protease from Worthington Biochemical Corporation, UK which had previously 
proved successful for isolating rat choroid plexus cells (Watson et al., 1995). Since the 
underlying matrix which supports the choroid plexus epithelial cells contains collagen 
(Roggendorf et al., 1988), the effects of two forms of collagenase (Sigma Aldrich, 
Poole, UK) were tested. Crude collagenase (Sigma catalogue number C0130) and a 
more purified form of collagenase IV (Sigma catalogue number C5138) both failed to 
increase the yield of small cell clumps and single cells. Both forms of collagenase were 
tested at several different concentrations and incubation times but even at the lowest 
concentrations and shortest incubation time both caused considerable damage to the 
choroid plexus epithelial cells on the outside of small clumps of tissue (Figure 2.1). The 
milder dispase was the much more effective enzyme for separating the choroid plexus 
tissue into smaller clumps and single cells when used at 1.5 units of activity per ml. It 
was observed that dispase batches of low to medium unit activity per mg were most 
successful at isolating small clumps and single cells compared with batches of high unit 
activity per mg although all batches of dispase were used at a working concentration 
of 1.5 units per ml and the incubation time at 37°C optimised for each new batch. 
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Figure 2.1. Choroid plexus cells subjected to collagenase digestion. A) Image taken at x100 magnification 
lens of a group of choroid plexus epithelial cells surrounded by burst cells, (bar=20 μm). B) Image taken 
at x400 magnification of indistinct, badly damaged choroid plexus epithelial cells, (bar=5 μm). C and D) 
Images of single isolated epithelial cells taken at x400 magnification. Cell membranes are unclear in 
places and some vacuoles are visible within the cells, (bar=5 μm).  
 
2.3.1.3. The use of a Ca
2+
 free incubation to break tight junctions  
Tight junctions are one of the major types of junctional complex which 
connects choroid plexus cells into epithelial sheets (Lippoldt et al., 2000). Tight 
junctions are Ca
2+
 sensitive so a common step in the isolation of numerous cell types is 
an incubation in Ca
2+
 free solutions chelated with 1mM EGTA (Evans G. S. et al., 1992; 
Gall and Bhathal, 1985; Niapour et al., 2010). The efficacy of the Ca
2+
 free step for 
single cell isolation was tested at several different points during the cell isolation 
protocol. Incubating the freshly dissected tissue in Ca
2+
 free aCSF followed by 
replacement of Ca
2+
 and subsequent enzyme treatment caused a small improvement 
in the yield of single cells. When the dispase incubation and Ca
2+
 free step were 
combined, the yield of single cells was mildly improved over an isolation protocol 
which did not include a Ca
2+
 free step. By far the most effective strategy for increasing 
the yield of single cells was the protocol mentioned in section 2.2.3. Where the 
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enzymatic disruption of the underlying cell matrix was followed with a 10 minute Ca
2+
 
free incubation to break tight junctions. 
 
2.3.2. Single choroid plexus epithelial cells may be 
isolated from epithelial sheets 
The cell preparation produced by the dispase isolation method contained small 
sheets of epithelial cells (Figure 2.2A), and single cells (Figure 2.2B) which adhered 
loosely to the poly-lysine coated coverslips. A significant number of much smaller red 
blood cells were also visible in the preparation. The edge of one can be seen in the top 
left corner of Figure 2.2B.  
 
Figure 2.2. Isolated cells from a mouse fourth ventricle choroid plexus. A) A group of epithelial cells taken 
at x100 magnification (bar=20 μm). B) A single isolated cell taken at x400 magnification (bar=5 μm).  
 
2.3.3. Choroid plexus cells used for experiments belong 
to a single population 
Single cells of a size similar to those in the epithelial sheets were selected for 
experiments to investigate cell volume. Figure 2.3 shows a distribution of the volumes 
for 175 of these cells. The data are fitted with a Gaussian curve, suggesting that the 
cells belong to a single population with a mean volume of 0.71±0.04 pL. This volume 
equates to that of a cube of 8.9 μm per side.  
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Figure 2.3. Frequency distribution for the volumes of 175 choroid plexus cells. The individual points (■) 
represent the number of cells at a particular volume range (bin width=0.2 pL). The line fitted to the data 
by regression analysis is a Gaussian curve, which predicts a mean cell volume of 0.71±0.04 pL (r2=0.85). 
 
2.3.4. Choroid plexus cells maintain their volume when 
superfused with isotonic aCSF 
The ability of choroid plexus cells to maintain their volume in isotonic aCSF was 
investigated (Figure 2.4A). Cells were superfused for 10 minutes with the isotonic aCSF 
prior to the start of experiments. This allowed cells to acclimatise from room 
temperature to the experimental temperature of 36±1°C.  
Figure 2.4A shows that acutely isolated murine choroid plexus cells exposed to 
isotonic hepes buffered aCSF for 25 minutes maintain their approximate initial volume. 
After 25 minutes of superfusion with isotonic hepes buffered aCSF, cell volume was 
97.8±1.0% (n=6) compared to initial volume.  
Subsequent chapters describe the use of a range of lipophilic transport 
inhibitors. These compounds were dissolved in DMSO giving a final concentration of 
not greater than 0.1% DMSO v/v. The effect of 0.1% DMSO on cell volume was 
therefore investigated. Figure 2.4B shows the effects of exposing 8 cells to a 15 minute 
superfusion with 0.1% DMSO. After 1 minute application of 0.1% DMSO, cell volume 
was 98.0±0.6% and had reached 96.1±0.7% by the end of the 15 minute exposure. This 
compares with a volume of 100.3±0.3% after 3 minutes of isotonic hepes buffered 
aCSF perfusion falling to 98.2±1.3% after 17 minutes. Linear regression analysis 
indicates that application of 0.1% DMSO did not cause a significant change in cell 
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volume compared to cells exposed to isotonic hepes buffered aCSF alone (P>0.05, t 
test).  
 
Figure 2.4. Choroid plexus cells maintain their volume in isotonic aCSF (A, n=6). B) The black bar indicates 
application of isotonic aCSF + 0.1% DMSO (n=8). 
 
 
2.3.5. Choroid plexus cells change their volume when 
exposed to anisosmotic aCSF’s 
Choroid plexus epithelial cells were exposed to anisosmotic aCSF (described in 
Table 2.2). The volume of the epithelial cells increased and decreased when they were 
superfused with hypotonic and hypertonic solutions respectively. Figure 2.5 is a Boyle–
van't Hoff plot of cell volume (expressed relative to volume in the isotonic solution) as 
a function of superfusate osmolality (Wehner et al., 2003a). The line through the data 
was fitted to the data by linear regression analysis (r2=0.96). The plot shows that over 
the range of osmolalities employed (188 to 384 mOsm.Kg H2O
−1
) the cells behaved as 
osmometers, i.e. there was a linear relationship between superfusate osmolality and 
cell volume, confirming the imaging protocol as a suitable method for measuring 
changes in cell volume. Extrapolating this line to infinite osmotic strength 
(1/osmolality=0) gives the osmotically inactive space of 41.2±6.7%. 
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Figure 2.5. Boyle–van't Hoff plot of cell volume as a function of the reciprocal of superfusate relative 
osmolality (i.e. expressed as a fraction of the isotonic osmolality).  
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2.4. Discussion 
A cell preparation method for isolating single cells from the fourth ventricle 
choroid plexus has been described. The cells were found to belong to a single 
population with a mean volume of 0.71±0.04pL. Cell volume changed in response to 
challenge with anisosmotic aCSF. The cells were therefore suitable for further volume 
change experiments.  
 
2.4.1. Modifications to the cell isolation protocol 
The improvements made to the cell isolation protocol all involved finding the 
appropriate balance between sufficient disruption of the choroid plexus epithelial 
sheet to produce a cell suspension with many single cells without such harsh 
treatments that the cells were badly damaged and did not respond to anisosmotic 
challenge. The most effective protocol proved to be the combined use of several 
different techniques to break cell-cell interactions. Thus moderate mechanical 
disruption combined with mild enzymatic treatment followed by a short incubation in 
Ca
2+
 free aCSF proved the most effective way of increasing the yield of single, acutely 
isolated choroid plexus cells. The basement extracellular membrane underlying the 
choroid plexus tissue is known to thicken with age (Serot et al., 2001) so when isolating 
choroid plexuses from mice much older than 6-10 weeks of age, slightly longer dispase 
incubation and more vigorous trituration were required.  
The majority of the cell isolation protocol was conducted on ice to minimise the 
activity of cells and any potentially destructive enzymes released from cut cells at the 
start of the isolation process. The cut choroid plexus tissue and dispase were mixed 
and kept ice cold for 15 minutes to allow sufficient time for the dispase to fully diffuse 
into all spaces around the choroid plexus tissue. The enzyme was then ‘activated’ by 
warming to 37°C. Trypsin is commonly used to detach cells from culture dishes but 
would not have been suitable in this case since it cleaves peptides on the C-terminal 
side of lysine and arginine amino acid residues (Walsh, 1970) which could include 
those found in the extracellular part of some of the proteins of interest in the present 
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study. Collagenase, another commonly used enzyme for isolating cells (Kin et al., 2007; 
Shimoda et al., 2010; Yang Y. et al., 2010), caused serious damage to the choroid 
plexus epithelial cell sheets and single cells. 
 Removal of serum from cultures of choroid plexus cells increases the 
transepithelial resistance by tightening of cell-cell interactions (Hakvoort et al., 1998b) 
therefore the addition of newborn bovine serum following dispase enzymatic 
disruption of the tissue had the dual advantage of ‘quenching’ enzyme activity while 
promoting a reduction in tightness of cell-cell interactions . The cell suspension was 
then washed with Ca
2+
 free aCSF so, despite the removal of serum at this stage, the 
absence of Ca
2+
 ions promoted breaking of cell-cell junctions further. Tight junctions 
are not universally Ca
2+
 sensitive however (Kottra and Fromter, 1993). Claudins are 
integral membrane proteins which cause Ca
2+
 independent cell adhesion and can 
localise to tight junctions in mouse L-fibroblasts where they obliterate intercellular 
space (Kubota et al., 1999). Choroid plexus cells do express claudin 1 (Masseguin et al., 
2001) and this may explain why some small clumps of cells remained present in the cell 
preparation. It is highly likely that these small clumps of cells were not totally broken 
up into their constituent single cells because of the relatively gentle enzymatic 
treatment.  
The present study used epithelial cells freshly isolated from the choroid plexus 
which were preferred to cells in primary culture since they adhered loosely to poly-
lysine coated coverslips. Cells did adopt a spherical morphology and were loosely 
adhered to coverslips which was evident since cells sometimes twitched slightly with 
the fast flow of superfusing aCSF. Furthermore, freshly isolated cells do not have the 
opportunity to undergo major changes to their protein expression (Sandow and 
Grayson, 2009). In vivo choroid plexus tissue is small, inaccessible and fragile. Freshly 
isolated choroid plexus cells remained viable for cell volume measurement studies for 
approximately 2-3 hours following isolation as has been noted by other investigators 
(Menheniott et al., 2010). This was found to be a limitation in experiments in 
subsequent chapters. 
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2.4.2. Characterisation of the isolated choroid plexus 
cells 
It was important to determine whether the isolated cells were derived from the 
choroid plexus epithelium. One piece of evidence for this was that the isolated cells 
belonged to a single population on the basis of cell size. They are therefore likely to be 
epithelial cells because these are the predominant cell type in the choroid plexus. The 
volume of the single cells was also similar to that of epithelial cells in small sheets of 
epithelia which were also isolated from the choroid plexus by the dispase method (see 
Fig. 2.2A). Furthermore, the mean volume of the cells isolated was 0.71 pL, which is 
equivalent to the volume of a 8.9 μm cube. This value is consistent with the 
dimensions of the cuboidal epithelial cells measured in electron (Schumacher and 
Eroschenko, 1985) and light microscopic studies (Wolburg et al., 2001) of mouse 
choroid plexus.  
Finally, cells isolated from the choroid plexus using a similar method and 
maintained in primary culture, have been shown to exhibit properties which are 
characteristic of the epithelium, i.e. activation of 5HT2C receptors (Watson et al., 
1995) and nucleoside transport (Redzic et al., 2006). Thus the isolated cells do appear 
to be epithelial in origin. Immunocytochemical staining of the cells for transthyretin (a 
choroid plexus cell marker (Menheniott et al., 2010) would finally confirm the 
epithelial origin of the choroid plexus cells.  
The characteristics of the choroid plexuses isolated from the different 
ventricles have not been extensively studied (Harbut and Johanson, 1986) however 
some differences are known. The surface area of cells from the lateral ventricle 
choroid plexus is larger than those from the fourth ventricle (Speake and Brown, 2004) 
while lateral and fourth ventricle choroid plexus cell pH both responded similarly to 
change in plasma acid/base loading (Murphy and Johanson, 1990). There are slight 
differences in ionic composition between fourth and lateral ventricle choroid plexus 
epithelial cells (Harbut and Johanson, 1986; Pershing and Johanson, 1982). However, 
rat lateral ventricle choroid plexus cells have similar ion conductances and express 
similar K
+
 and Cl
-
 channels to choroid plexus cells from the fourth ventricle (Speake and 
Brown, 2004). Since the ion channels expressed in both group of cells are similar, the 
differences in ionic concentration are likely to be a function of transporter expression 
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(Speake and Brown, 2004). Characterising the expression and activity of transporters in 
these cells has proved extremely difficult due to the lack of available assays.  
 
2.4.3. Osmotic properties of cells 
The isolated choroid plexus cells responded to changes in extracellular 
osmolality as expected, i.e. volume increased in hypotonic solutions and decreased in 
hypertonic solutions. This behaviour of the cells as osmometers is summarised by the 
Boyle–van't Hoff plot in Figure 2.6, which shows that there is a linear relationship 
between cell volume and the osmolality of the extracellular solutions (Wehner et al., 
2003a). The Boyle– van't Hoff plot also shows that the cells have an osmotically 
inactive volume of 41%. This is the fraction of cell volume which does not respond to 
an osmotic challenge, and is thought to represent the presence of organelles, 
secretory vesicles and cytoskeletal proteins within the cell (Drewnowska and 
Baumgarten, 1991; Lucké and McCutcheon, 1932; Nakahari et al., 1992). The value 
41% is similar to the osmotically inactive spaces reported for a variety of other cell 
types e.g. cardiac myocytes (Drewnowska and Baumgarten, 1991), salivary gland acinar 
cells (Nakahari et al., 1992) and pancreatic acinar cells (Brown PD; unpublished 
observation).  
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2.5. Conclusions 
The cell isolation protocol described in this chapter produces a suitable cell 
suspension for studying volume regulation mechanisms in epithelial cells from the 
murine fourth ventricle choroid plexus. The cells suspension contains small clumps and 
single cells which belong to a single population of cells and remain viable for several 
hours after isolation. The isolated choroid plexus cells behave as osmometers. 
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Chapter Three                     
The choroid plexus cell 
regulatory volume increase 
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3.1. Introduction 
3.1.1. CSF secretion and volume regulation in choroid 
plexus cells 
 The prolific secretion of cerebrospinal fluid causes enormous ion fluxes across 
the choroid plexus epithelia. These fluxes must be carefully balanced to avoid changes 
in ion concentration resulting in changes in cell volume. Decreases in cell volume have 
been observed in salivary gland (Foskett et al., 1994) and lacrimal gland acinar cells 
(Speake et al., 1998) when stimulated by secretagogues such as acetylcholine. 
Whereas, the volumes of proximal tubule cells (Beck J. S. and Potts, 1990), and small 
intestinal enterocytes (MacLeod and Hamilton, 1991) increase during the absorption of 
glucose and amino acids. In the choroid plexus similar changes in the volume of the 
epithelial cells could compromise the integrity of the blood/CSF barrier by placing 
mechanical strain on the junctional complexes that link the cells. It is likely that the 
choroid plexus cells are able to volume regulate in the same way as many other types 
of cell (Hoffmann and Simonsen, 1989; Wehner et al., 2003a) to prevent the 
degradation of the blood/CSF barrier. 
 
3.1.2. The Regulatory Volume Increase (RVI) 
Loss of ions from a cell leads to loss of cell volume. A shrunken cell may then 
activate an RVI response by which its volume increases. All mechanisms of RVI cause 
the accumulation of intracellular organic or inorganic osmolytes which draw water into 
the cell by osmosis with a corresponding increase in cell volume.  
Ion transport into the cell can be mediated by a number of different 
transporters including NKCC1, or NHE functionally coupled to AE to rapidly import 
inorganic ions (Hoffmann and Simonsen, 1989; Wehner et al., 2003a). Following cell 
shrinkage, salivary cell intracellular Na
+
 concentration increases (mainly due to Na
+
H
+
 
exchange) and the cells exhibit a RVI (Foskett et al., 1994). In lacrimal gland cells 
Na
+
K
+
2Cl
−
 cotransport, Na
+
H
+
 exchange and Cl
-
HCO3
-
 exchange contribute to the RVI 
(Douglas and Brown, 1996). However, the potential contribution of transporters to the 
choroid plexus RVI has not previously been studied. Ion channels are also able to cause 
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a rapid increase in intracellular inorganic ion concentrations while organic osmolytes 
such as sorbitol cause a slower RVI. Not all cells exhibit an RVI and some, such as 
pancreatic α cells, only show a post-RVD RVI (Davies et al., 2009). 
 
3.1.2.1. NKCC1 in RVI 
Most evidence linking NKCC1 activity to a role in cell volume regulation has 
concentrated on the use of bumetanide, a specific inhibitor of NKCC1 activity. In 
human glioma cells, RVI inhibition by 200µM bumetanide was interpreted as the 
inhibition of NKCC1 activity (Ernest and Sontheimer, 2007). NKCC1 has also been 
proposed to contribute to a post-RVD RVI in A6 cells which behave like almost perfect 
osmometers and exhibit a post-RVD RVI which may be blocked with 100µM 
bumetanide implicating the contribution of NKCC1 (Grosse et al., 2003). Bumetanide is 
reported to cause half maximum inhibitory effects of NKCC1 at 0.2 µM (Cabantchik and 
Greger, 1992; Haas and McManus, 1983) so the high concentrations used in these 
studies will definitely inhibit any NKCC1 activity but non-specific effects of bumetanide 
cannot be ruled out.  
Several investigators have proposed a role for NKCC1 in choroid plexus cell 
volume maintenance (Bairamian et al., 1991; Keep et al., 1994; Wu et al., 1998). Keep 
and colleagues presented evidence for the apical location of NKCC1 in choroid plexus 
cells and indicated that it may be activated by a decrease in cell volume (Keep et al., 
1994). Bumetanide sensitive efflux of 
86
Rb from choroid plexus cells was observed and 
attributed to NKCC1 activity contributing to CSF secretion (Keep et al., 1994). However, 
it was subsequently noted that the driving forces for Na
+
 and Cl
-
 favour the influx of 
ions into choroid plexus cells from the CSF (Wu et al., 1998). The role of NKCC1, if it 
does indeed move ions from the CSF into the choroid plexus cells, may be to 
contribute to volume regulation via mediating an RVI and may mediate a K
+
 influx 
mechanism (Wu et al., 1998). 
 
3.1.2.2. NHE/AE in RVI 
Na
+
/H
+
 exchange in combination with Cl
-
/ HCO3
-
 exchange is a well established 
mechanism of RVI (Hoffmann and Simonsen, 1989). The Na
+
/H
+
 exchanger mediates 
the efflux of H
+
 through exchange down the Na
+
 gradient resulting in the intracellular 
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pH rising and the accumulation of Na
+
. The rise in intracellular pH is balanced by 
activation of the Cl
-
/ HCO3
-
 exchanger leading to efflux of HCO3
-
 and accumulation of Cl
-
. The increase in cell volume occurs because the Na
+
 entering the cell is osmotically 
active while the efficient intracellular pH buffering within the cell means that the H
+
 is 
not osmotically active while inside the cell. Water is osmotically obliged to enter the 
cell following Na
+
 and Cl
-
 entry, and so the cell swells (Hoffmann and Simonsen, 1989). 
This mechanism of RVI occurs in several cell types including rabbit parietal cells 
(Bachmann et al., 2007), rat lacrimal gland acinar cells (Douglas and Brown, 1996) and 
rat pancreatic α cells (Davies et al., 2009). 
A Na
+
/H
+
 exchanger, thought to be NHE1 was identified in rat, pig and human 
choroid plexus through RT-PCR methods combined with amiloride binding kinetics 
(Kalaria et al., 1998). However NHE1 protein has been difficult to detect (Alper et al., 
1994). Recently (during my PhD studentship) molecular localisation of the NHE1 to the 
apical membrane of the mouse and human choroid plexus epithelial cells was reported 
(Damkier et al., 2009).  
The anion exchanger 2 (AE2) was cloned from a rat choroid plexus library and 
its expression in COS-7 cells caused Cl
-
 and bicarbonate dependent changes in 
intracellular pH which were independent of Na
+
 (Lindsey et al., 1990). Alper and 
colleagues characterised AE2 isoform specific antibodies and confirmed that AE2 
protein is expressed on the basolateral membrane of CP cells (Alper et al., 1994).  
There is convincing molecular and protein evidence for the presence of AE2 in 
mammalian choroid plexus cells and its basolateral location supports its potential role 
in CSF secretion. There is also molecular evidence and some recent protein evidence 
for the presence of NHE in choroid plexus cells but there is very little evidence to 
confirm the function of either exchanger in these cells. The role of apical NHE1 is not 
obvious since it is unlikely to contribute directly to CSF secretion, however, apical 
NHE1 may contribute to either pH maintenance or volume regulation in the choroid 
plexus and so functional studies are needed to explore this further. 
 
3.1.2.3. Channels in RVI 
Non-selective cation channels mediate an RVI in some cell types; however, 
their molecular identity is unclear (Wehner, 2006). In choroid plexus cells, two K
+
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conductances are known. The delayed rectifying K
+
 conductance (Kotera and Brown, 
1994) is now known to be mediated by Kv1.1 and Kv1.3 (Speake et al., 2004). An 
inward rectifying K
+
 conductance is mediated by Kir7.1 in mammalian choroid plexus 
cells. Kir7.1 is highly expressed on the apical membrane of rat choroid plexus cells and 
may serve to remove K
+
 from the CSF (Doring et al., 1998; Nakamura et al., 1999). All 
known choroid plexus K
+
 channels are expressed in the apical membrane. Here they 
act as a leak pathway for K
+
 pumped in by Na
+
K
+
ATPase. They also contribute to the 
membrane potential which is an important driving force for other channels and 
transporters including Cl
-
 channels. At present there is no evidence for the presence of 
a cation channel activated by a decrease in volume in choroid plexus cells. 
The Volume Sensitive Anion Conductance (ICl-(swell), VSAC) (Speake et al., 2001) is 
similar to that detected in numerous cell types (Okada, 1997) where it is activated by 
cell swelling and may play a role in cell volume regulation (Kibble et al., 1997). VSAC is 
also called the Volume Regulated Anion Channel (VRAC) (Nilius and Droogmans, 2003) 
and its molecular identity remains to be elucidated. It is unlikely that Cl
-
 channels 
contribute to RVI in the choroid plexus since CSF has a lower Cl
-
 concentration with 
respect to the choroid plexus cell cytosol and so the opening of ion channels would 
result in Cl
-
 efflux rather than accumulation within the cytosol.  
 
3.1.2.4. Organic osmolytes in RVI 
Several organic molecule transporters have been studied in the choroid 
plexuses (Kusuhara and Sugiyama, 2004) however the role of organic osmolytes in cell 
volume regulation mechanisms in the choroid plexus has received very little attention. 
Organic osmolytes such as sorbitol, glycerophosphorylcholine, betaine and amino acids 
such as taurine, glutamic acid and s-alanine amongst others can contribute to RVI in 
mammalian cells (Beck F. et al., 1985; Beck F. X. et al., 1998; Yancey and Burg, 1989; 
Yancey et al., 1982). 
The accumulation of organic osmolytes instead of inorganic ions may be 
beneficial for cells whose physiology would be disrupted by the build up of charged 
ions which may, for example, disrupt membrane potential (Wehner et al., 2003a). The 
accumulation of organic osmolytes occurs mainly through uptake via specific transport 
systems and metabolic generation of osmolytes within the cell however both these 
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processes can take hours to days to initiate, much longer than the movement of 
inorganic ions (Wehner et al., 2003a). RVI via organic osmolytes is therefore commonly 
associated with chronic osmotic challenge observed in cells such as those of the kidney 
medulla rather than in epithelial cells. Certainly, in cells of the thick ascending loop of 
Henle, a RVI or RVD response is not seen for several days but when detected, it 
coincides with alteration of the intracellular concentration of the organic osmolytes, 
sorbitol, inositol, betaine, and glycerophosphorylcholine (Grunewald et al., 2001). Thus 
organic osmolytes may be more appropriately regarded as mediators of osmotic 
adaptation over time rather than as short term mediators of RVI (Wehner et al., 
2003a). 
 
3.1.3. Chapter aims 
− Investigate the ability of choroid plexus epithelial cells to regulate their 
volume in response to hypertonic challenge. 
− Investigate whether NKCC1 contributes to any RVI. 
− Investigate whether NHE/AE contribute to any RVI. 
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3.2. Methods 
3.2.1. Cell isolation and experimental aCSF’s 
Choroid plexus cells were prepared and selected for experiments as described 
in Chapter 2. The composition of the HCO3
-
 buffered aCSF’s used in most experiments 
are described in Table 3.1. Hepes buffered experimental aCSF’s were used in some 
experiments and are described in Table 3.2. 
Solute Hypertonic aCSF 
(mM) 
Isotonic aCSF 
(mM) 
Hypotonic aCSF 
(mM) 
NaCl 110 110 65 
NaHCO3 25 25 25 
Mannitol 120 20 0 
Glucose 4 4 4 
KCl 5 5 5 
CaCl2 1.2 1.2 1.2 
MgCl2 1 1 1 
Osmolality 382 mOsm.Kg H2O
-1
 283 mOsm.Kg H2O
-1
 187 mOsm.Kg H2O
-1
 
 
Table 3.1. HCO3
-
 buffered experimental aCSF’s.  
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Solute Hypertonic aCSF 
(mM) 
Hypertonic  
(high NaCl) aCSF 
(mM) 
Isotonic aCSF 
(mM) 
NaCl 140 200 140 
Hepes 5 5 5 
Mannitol 120 20 20 
Glucose 4 4 4 
KCl 5 5 5 
CaCl2 1.2 1.2 1.2 
MgCl2 1 1 1 
Osmolality 384 mOsm.Kg H2O
-1
 400 mOsm.Kg H2O
-1
 285 mOsm.Kg H2O
-
1
 
 
Table 3.2. Hepes buffered experimental aCSF’s.  
 
 
In most experiments using hypertonic aCSF, mannitol was used to increase the 
osmolality of isotonic aCSF to create hypertonic aCSF (see Tables 3.1 and 3.2). One 
series of experiments used hepes buffered aCSF made hypertonic by addition of NaCl 
(Table 3.2). Experiments to study the choroid plexus post-RVD RVI used hypotonic 
HCO3
-
 buffered aCSF (Table 3.1). 
 
3.2.2. Cell volume regulation protocols 
All cells were superfused for 10 minutes with isotonic aCSF prior to the start of 
experiments. This allowed cells to acclimatise from room temperature to the 
experimental temperature, and permitted cells isolated in hepes buffered aCSF to 
equilibrate with HCO3
-
 buffered experimental aCSF where appropriate. After the 
acclimatisation period, cells were superfused with control isotonic aCSF for 2 minutes 
prior to 15 minutes of experimental condition (usually a hypertonic challenge). A final 
5 minute recovery period followed with cells once again exposed to isotonic aCSF.  
Transport inhibitors were used to investigate the involvement of ion 
transporters in choroid plexus cell RVI. All inhibitors were dissolved in 100% DMSO to 
create stock solutions which were stored at -20°C and replaced regularly. Inhibitors 
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were diluted in aCSF on the day of experiments such that DMSO concentration did not 
exceed 0.1% v/v. Day-matched control experiments were performed. The following 
transport inhibitors were employed: 
Bumetanide 
Bumetanide is a specific blocker of the sodium chloride cotransporter family 
which includes NKCC1, NKCC2 and NCC. It is a carboxylic acid which mediates its 
actions through competition with Cl
- 
for an anionic receptor site on NKCC1 (Haas and 
McManus, 1983) Bumetanide is reported to cause half maximum inhibitory effects of 
NKCC1 at 0.2 µM (Cabantchik and Greger, 1992; Haas and McManus, 1983). Most 
dose–response studies indicate that 10 μM bumetanide is sufficient to inhibit the vast 
majority of NKCC1 activity (for a review see (Russell, 2000)), certainly, 10 µM 
bumetanide was sufficiently efficacious to abolish RVI in pancreatic β cells (Majid et al., 
2001) and therefore appears to be a suitable concentration to use in drawing 
conclusions regarding NKCC1 activity in choroid plexus cells. Bumetanide was dissolved 
in 100% DMSO to create a stock solution stored at -20°C and replaced regularly. 
Bumetanide was then diluted in aCSF on the day of experiments such that DMSO 
concentration did not exceed 0.1% v/v. 
EIPA 
5-(N-ethyl-N-isopropyl) amiloride is a derivative of amiloride known to have a 
high specificity for NHE (Kleyman and Cragoe, 1988). 10μM EIPA is known to inhibit RVI 
in mouse choroid plexus cells (Damkier et al., 2009), murine fibrosarcoma cells 
(Nylandsted et al., 2004) and rat hepatocytes (Wehner et al., 2000). EIPA was dissolved 
in 100% DMSO to create a stock solution stored at -20°C and replaced regularly. EIPA 
was then diluted in aCSF on the day of experiments such that DMSO concentration did 
not exceed 0.1% v/v. 
MIBA 
5-(N-methyl-N-isobutyl) amiloride (MIBA) is another amiloride derivative which 
specifically inhibits NHE (Kleyman and Cragoe, 1988); Talor et al., 1989). MIBA (10μM) 
is known to inhibit RVI in rat lacrimal acinar cells (Douglas and Brown, 1996) and rat 
pancreatic α cells (Davies et al., 2009) and so was used at this concentration in the 
present study. MIBA was dissolved in 100% DMSO to create a stock solution stored at -
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20°C and replaced regularly. MIBA was then diluted in aCSF on the day of experiments 
such that DMSO concentration did not exceed 0.1% v/v. 
Benzamil 
Among the amiloride derivatives, benzamil is one of the most specific blockers 
of the epithelial Na
+
 channel (ENaC) and the Na
+
/Ca
2+
 exchanger but it does not inhibit 
NHE activity (Kleyman and Cragoe, 1988). Benzamil (10μM) is therefore a useful 
diagnostic tool for distinguishing between NHE activity and other Na
+
 transporters 
(Davies et al., 2009; Kalaria et al., 1998; Mayer and Sanders-Bush, 1993; Wehner et al., 
2000). Benzamil was dissolved in 100% DMSO (Sigma) to create a stock solution stored 
at -20°C and replaced regularly. Benzamil was then diluted in aCSF on the day of 
experiments such that DMSO concentration did not exceed 0.1% v/v. 
DIDS 
Disodium 4,4′-diisothiocyanatostilbene-2,2′-disulfonate, commonly abbreviated 
to DIDS, is a member of the disulfonic stilbenes which are known to block AE. Used at 
100μM, DIDS caused 90±14% inhibition of anion exchange in human erythrocytes 
(Culliford et al., 2003). However it caused some inhibition of K
+
Cl
-
 and Na
+
K
+
Cl
-
 
cotransport and so results must be interpreted with care (Culliford et al., 2003). 
100μM DIDS inhibits RVI in rat pancreatic β cells (Miley et al., 1998) and rabbit 
collecting duct cells (Fu et al., 1993) so was used at this concentration in the present 
study. DIDS was dissolved in 100% DMSO to create a stock solution stored at -20°C and 
replaced regularly. DIDS was then diluted in aCSF on the day of experiments such that 
DMSO concentration did not exceed 0.1% v/v. 
Other transport processes blocked by DIDS include the two anion channels 
expressed in the choroid plexus (Kibble et al., 1997; Kibble et al., 1996) and two of the 
Na
+
 HCO3
−
 cotransporters (NBCE and NBCe2) expressed in the choroid plexus 
(Bouzinova et al., 2005; Praetorius, 2007). 
Forskolin 
Forskolin (10μM) causes a general cellular increase in cAMP concentration 
which increases protein kinase A activity and thus activates NKCC1 (Johanson C. et al., 
2004; Russell, 2000). Forskolin (10μM) induced cell shrinkage in rabbit parietal cells 
(Bachmann et al., 2007) and Rhesus eccrine clear cells (Bachmann et al., 2007; 
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Toyomoto et al., 1997). Forskolin was dissolved in 100% DMSO to create stock 
solutions which were stored at -20°C and replaced regularly.  
 
3.2.3. Statistical analysis of data 
All statistical analyses were performed on cells from a minimum of three 
preparations. Cell volumes, recorded once a minute, were normalised to the mean 
volume measured in isotonic aCSF at the start of each experiment and are expressed 
as % relative cell volume. For statistical analysis the rate of volume increase was 
determined for each individual experiment by linear regression of 8 min or 4 min of 
data from the minimum volume observed in the hypertonic RVI or the post-RVD RVI, 
respectively (Figure 3.1). Rates of volume increase were compared with One Way 
ANOVA and Dunnett’s post hoc test to compare three or more data sets while 
Student’s t tests were used to compare two data sets. 
 
Figure 3.1 Linear regression of 8 minutes of data from the minimum volume observed for 7 cells 
superfused with hepes buffered hypertonic aCSF. 
 
 
Three criteria were employed for including cells in statistical analysis: 1) cell 
volume must be stable during the isotonic control period at the beginning of the 
experiments, 2) cells must show a rapid change in cell volume when superfused with 
anisosmotic aCSF (i.e. the maximum volume change must occur within 5 min), and 3) 
On return to isotonic solution cells must show a rapid recovery of volume to or beyond 
initial control volume.  
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A small number of experiments were performed to investigate post-RVD RVI. 
For these experiments there was a consistent slow decrease in cell volume throughout 
the experiments observed by a slight difference in volume between the initial and final 
superfusions with isotonic aCSF. Data was corrected for this drift in volume. A line was 
fitted through the control and final isotonic aCSF time points by linear regression to 
give the rate of volume decrease. A correction was added to the data at each time 
point. 
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3.3. Results  
3.3.1. Choroid plexus cells show a RVI following 
hypertonic challenge in HCO3
-
 buffered aCSF 
The RVI exhibited by choroid plexus cells prepared by the method described in 
Chapter 2 was characterised.  
 
Figure 3.2. Choroid plexus cells show a RVI following hypertonic challenge. The black bar indicates 
superfusion by hypertonic aCSF containing 120mM mannitol (n=14). 
 
 
Figure 3.2 shows the complete time course of the volume changes in 14 cells 
superfused with hypertonic HCO3
−
 buffered aCSF for 15 minutes. Mean cell volume 
prior to hypertonic challenge was 0.82pL. Following acclimatisation in isotonic HCO3
−
 
buffered aCSF, the cells shrank to a minimum volume of 87.5±1.5% within 3 minutes of 
exposure to the hypertonic aCSF. Cell volume then increased gradually over the 
remaining 12 minutes of superfusion with the hypertonic aCSF so that at 15 minutes 
the volume was 92.9±1.2%. This increase in cell volume is described as a RVI 
(Hoffmann and Simonsen, 1989). On return to the isotonic superfusate, cell volume 
quickly increased showing a brief overshoot before returning to control values. A RVI 
such as that in Figure 3.1 is normally caused by the accumulation of intracellular ions 
which draw water into the cell by osmosis. Statistical comparison of the rate of RVI for 
control cells shown in Figure 3.2 with that of cells in Figures 3.3, 3.4 and 3.6 were 
performed with a One Way Anova test (F=8.08).  
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3.3.2. Choroid plexus cell RVI is not inhibited by 
bumetanide 
Ion transport into the cell during RVI can be mediated by a number of different 
transporters including NKCC1, or Na
+
/H
+
 exchange functionally coupled to anion 
exchanger (Hoffmann and Simonsen, 1989; Wehner et al., 2003a). A previous ion flux 
study indicated that NKCC1 in choroid plexus cells may be activated by a decrease in 
cell volume (Keep et al., 1994). Experiments were therefore performed to investigate 
the role of NKCC1 in RVI using the inhibitor bumetanide (Figure 3.3). 
 
Figure 3.3. Bumetanide does not inhibit the RVI in choroid plexus cells. RVI induced by exposure to 
hypertonic aCSF containing 10 μM bumetanide (indicated by black bar) (n=5). 
 
 In the presence of 10 μM bumetanide, cell volume decreased to 81.5±1.8% 
(n=5) in the hypertonic HCO3
−
 buffered aCSF. A RVI was still observed so that the 
volume after 15 minutes had recovered to 89.0±1.0%. Thus the RVI in the presence of 
10 μM bumetanide is not significantly different from control (P>0.1, Dunnett’s post hoc 
test).  
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3.3.3. Amiloride derivatives EIPA and MIBA but not 
benzamil inhibit choroid plexus RVI 
 The sodium proton exchanger (NHE) and anion exchanger (AE) act together in 
several cell types to cause an RVI in response to cell shrinkage. The involvement of 
NHE1 and AE2 in RVI was examined using transport inhibitors (Figure 3.4).  
Figure 3.4. Choroid plexus RVI is inhibited by the amiloride derivatives A) EIPA (n=8) and B) MIBA (n=5) 
but not by C) benzamil (n=5). Black bars indicate application of 10μM inhibitor in hypertonic HCO3
-
 
buffered aCSF. 
 
 
Figure 3.4A shows that RVI was inhibited by 10 μM EIPA. Cells shrank to 
88.2±2.2% on perfusion with HCO3
-
 hypertonic solution + 10μM EIPA. After a 15 min 
exposure, mean cell volume was 89.1±2.4% which was not a significantly different 
change (P>0.05, paired t test). On return to isotonic superfusing aCSF, cell volume 
recovered to starting volume. Comparing rates of RVI with control (Figure 3.5A), RVI 
was significantly reduced in the presence of EIPA (P<0.05, Dunnett’s post hoc test). In 
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control experiments, 10 μM EIPA did not affect cell volume in isotonic aCSF (n=6, data 
not shown). 
RVI was also significantly reduced (P<0.05, Dunnett’s post hoc test) by 10 μM 
MIBA. The mean volume changes when 5 cells are superfused with HCO3
-
 buffered 
hypertonic aCSF + 10μM MIBA are shown in Figure 3.4B. Within 3 minutes cells had 
shrunk to 91.0±1.4% and after 15 minutes cell volume was 83.5±3.6%. Figure 3.5A 
shows that RVI was significantly reduced in the presence of MIBA (P<0.05, Dunnett’s 
post hoc test). 
Amiloride and its derivatives block epithelial sodium channel (ENaC) and the 
sodium calcium exchanger (NCX) in addition to NHE1. To confirm that inhibition of RVI 
by EIPA and MIBA was the result of NHE1 activity rather than non-specific effects on 
ENaC or NCX, the effect of 10µM benzamil (which blocks ENaC and NCX but not NHE) 
was investigated. Cells shrank to 86.8±1.5% within 1 minute of hypertonic exposure 
and after 15 minutes they have recovered to a mean volume of 93.6±0.9% (Figure 
3.4C). Figure 3.5A shows that the rate of volume recovery in the presence of benzamil 
was not significantly different from control (P>0.1, Dunnett’s post hoc test). This 
suggests that choroid plexus RVI is not dependent on ENaC activity. 
 
Figure 3.5. A) Rate of volume recovery in control (hypertonic) aCSF and in the presence of 10μM EIPA, 
MIBA and benzamil. B) Mean minimum volume attained by cells in control (hypertonic) aCSF and in the 
presence of 10μM EIPA, MIBA and benzamil. The stars (*) indicates that rate of recovery is significantly 
reduced in the presence of transport inhibitors (P<0.05, Dunnett’s post hoc test). 
 
 
The different rates of volume recovery induced by derivatives of amiloride 
cannot be attributed to a variation in cell shrinkage, because the minimum volumes 
attained in the presence of the transport inhibitors were not significantly different (F= 
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1.52, P>0.05, One Way ANOVA with Dunnett’s post hoc test, Figure 3.5B). Taken 
together, the inhibition of choroid plexus cell RVI by EIPA and MIBA but not by 
benzamil strongly suggests a functional role for NHE1 in choroid plexus RVI.  
 
3.3.4. DIDS inhibits choroid plexus RVI 
Where RVI involves Na
+
/H
+
 exchange, the activity of the NHE is usually 
physiologically coupled to anion exchange (Hoffmann and Simonsen, 1989). Thus the 
involvement of AE2 in choroid plexus cell RVI was investigated using the anion 
transport inhibitor 100μM DIDS.  
 
Figure 3.6. Choroid plexus RVI is abolished by 100µM DIDS. The black bar indicates perfusion with 
hypertonic HCO3
-
 buffered aCSF + 100µM DIDS, n=5. 
 
 
Mean volume changes over time for 5 cells are shown in Figure 3.6. Within two 
minutes of superfusion with HCO3
- 
buffered hypertonic aCSF +100µM DIDS, cells had 
shrunk to 88.4±2.5%. After 15 minutes of this treatment cell volume was 88.1±3.1% of 
resting volume. Comparison of rates of volume change show that 100µM DIDS 
abolished RVI (P<0.05, Dunnett’s post hoc test) suggesting that AE2 is necessary for a 
choroid plexus RVI. 
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3.3.5. Choroid plexus cells do not show a RVI in 
nominally HCO3
-
 free conditions 
To further investigate the possible contribution of NKCC1 to RVI, choroid plexus 
cells were exposed to hypertonic aCSF buffered with hepes. These aCSF’s were 
nominally HCO3
-
 free to reduce the activity of NHE1 and AE2 (Douglas and Brown, 
1996).   
Figure 3.7. Choroid plexus cells shrink when exposed to hepes buffered hypertonic aCSF but do not show 
an RVI. Black bars indicate perfusion with hypertonic aCSF for A) 10 minutes (n=10), B) 15 minutes (n=8) 
and C) 20 minutes (n=4). 
 
In hepes buffered hypertonic aCSF (Figure 3.7A), cells exposed to hypertonic 
challenge shrink rapidly to 89.2±1.2% (n=10) of their original volume within 1 minute. 
This shrinkage is sustained over the course of hypertonic challenge. When hypertonic 
challenge is removed, cells re-swell to within 5% of their initial volume.  There was no 
evidence of an RVI when cells were exposed to hypertonic hepes buffered aCSF for 10 
minutes so the length of hypertonic challenge was increased.  
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Cells superfused with hypertonic hepes buffered aCSF for 15 minutes also 
showed no RVI (Figure 3.7B). Mean cell volume prior to hypertonic challenge was 
1.02pL. Superfusion with hypertonic hepes buffered aCSF induced cells to shrink to a 
mean volume of 92.0±0.6% within 1 minute. Cells then maintained their volume to 
reach a mean volume of 93.0±0.7% after 15 minutes of hypertonic challenge. On 
return to superfusion with isotonic aCSF, cells swelled towards their initial volume. 
Superfusion with hypertonic hepes buffered aCSF induced cells to shrink to a 
mean volume of 89.8±2.6% within 1 minute (Figure 3.7C). Cell volume then drifted 
slightly such that a mean volume after 20 minutes of hypertonic challenge was 
84.4±2.6%. On return to isotonic superfusion, cells recovered towards their initial 
volume to 93.7±0.7% after 5 minutes superfusion with isotonic hepes buffered aCSF.  
There was no significant difference between the initial shrink of choroid plexus 
cells (P>0.05, ANOVA). No RVI was observed during superfusion with hepes buffered 
hypertonic aCSF, the rate of volume increase was less than 0.002%.min
-1
 for all 
hypertonic challenge durations. This suggests that NHE and AE2 are the major factor in 
choroid plexus RVI with little role for NKCC1. 
 
3.3.6. Increasing the driving force for NKCC1 does not 
stimulate a RVI 
In a further attempt to show a role for NKCC1 in choroid plexus RVI, the driving 
force for Na
+
 movement into cells was increased to promote NKCC1 activity. Cells were 
exposed to hepes buffered aCSF made hypertonic by the addition of 60mM NaCl. 
Figure 3.8A shows the time course for control cells in high mannitol hypertonic aCSF, 
the rate of volume change was compared with the data in Figure 3.8B and 3.11 by One 
Way ANOVA with Dunnett’s post hoc test (F=3.16). Figure 3.8B shows the time course 
for 8 cells exposed to high NaCl hypertonic hepes buffered aCSF. 
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Figure 3.8.  Choroid plexus cells do not show a RVI in high NaCl hypertonic aCSF. Black bars show A) 
application of high mannitol hypertonic aCSF (384 mOsm.Kg H2O
-1
), (n=8). B) application of high NaCl 
hypertonic aCSF (400 mOsm.Kg H2O
-1
), (n=6). 
 
On exposure to hepes buffered aCSF made hypertonic with additional NaCl, 
cells shrank within 1 minute to 94.1±0.4% (n=6). There was a small but significant 
difference (P<0.05, t test) between these cells and those exposed to hepes buffer 
made hypertonic with mannitol which shrank to 92.0±0.6%. There was no significant 
difference between rate of volume change of cells exposed to hepes hyper mannitol 
and hepes hyper (high NaCl) (P>0.05, Dunnett’s post hoc test). So it can be concluded 
that cells exposed to high NaCl hypertonic aCSF show no more RVI than those 
superfused with high mannitol hypertonic hepes buffered aCSF. 
The data therefore support the hypothesis that NKCC1 does not contribute to 
RVI in choroid plexus cells.  
 
3.3.7. The post-regulatory volume decrease RVI is 
inhibited by EIPA but not bumetanide 
In some cells the ion transporters involved in RVI are only activated following a 
regulatory volume decrease (RVD) in hypotonic solutions, in a phenomenon known as 
a post-RVD RVI (Hoffmann and Simonsen, 1989). In Ehrlich ascites tumour cells this 
phenomenon involves the activation of NKCC1 which remains quiescent in cells during 
cell shrinkage caused by exposure to hypertonic solutions (Hoffmann et al., 1983). The 
potential role of NKCC1 in a post-RVD RVI in choroid plexus cells was therefore 
investigated. 
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Figure 3.9. Post-RVD RVI in choroid plexus cells is likely to involve NHE. Cells were superfused with 
hypotonic solution of 187 mOsm.Kg H2O
−1
 (solid bar) for 15 min. Superfusing aCSF was then exchanged 
for A) isotonic aCSF, n=5, B) isotonic aCSF +10μM bumetanide (open bar) n=4 and C) isotonic aCSF 
+10μM EIPA (open bar), n=7. All experiments were performed in HCO3
-
 buffered aCSF’s. 
 
 
Figure 3.9A shows the effects of exposing 5 cells to the hypotonic aCSF (187 
mOsm.Kg H2O
−1
). Following the initial cell swelling to a maximum volume of 
105.0±1.09%, the cells exhibited a RVD to a final volume of 101.8±0.9% after 15 
minutes in the hypotonic aCSF. When the superfusate was switched back to the 
isotonic aCSF the volume decreased to 98.2±0.3% before recovering to 101.1±0.8%.  
 Figure 3.9B shows the effects of exposing 4 cells to the hypotonic HCO3
-
 
buffered aCSF (187 mOsm.Kg H2O
−1
). Following an initial cell swelling and RVD, when 
the superfusate was switched back to the isotonic aCSF +10μM bumetanide the 
volume decreased to 96.3±0.6% before recovering to 99.8±0.3%, similar to results 
observed in control experiments.  
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7 cells were exposed to isotonic HCO3
-
 buffered aCSF + 10μM EIPA following 
hypotonic challenge (Figure 3.9C). The volume decreased to 97.4±1.16% before 
recovering to 99.9±0.27%.  
Figure 3.10 shows the rates of post-RVD RVI in control (isotonic HCO3
-
 buffered 
aCSF) and with the presence of either 10μM bumetanide or 10μM EIPA. The data does 
not support a role for NKCC1 in choroid plexus post-RVD RVI. 
 
Figure 3.10.Rates of volume change during the post-RVD RVI 
 
 
3.3.8. Promoting NKCC1 activity by kinase activation has 
no significant effect on RVI. 
NKCC1 activation is increased by phosphorylation (Russell, 2000). Forskolin 
causes a general cellular increase in cAMP concentration which increases protein 
kinase A activity and thus activates NKCC1 (Johanson C. et al., 2004; Russell, 2000). 
Experiments were therefore performed in the presence of 10 μM forskolin (Figure 
3.11) in an effort to promote NKCC1 activity.  
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Figure 3.11. Forskolin (10μM) does not cause a statistically significant increase in RVI.  Black bars 
indicate superfusion of cells with A) hepes buffered hypertonic aCSF (n=8), B) hepes buffered hypertonic 
aCSF +10μM forskolin (n=7). C) Rates of volume recovery following cell shrinkage in control aCSF and in 
the presence of 10μM forskolin. The star (*) indicates that rate of recovery is significantly increased in 
the presence of 10μM forskolin (P<0.05, Dunnett’s post hoc test). 
 
 
Figure 3.11A shows the volume changes in 8 cells exposed to hypertonic hepes 
buffered aCSF. These cells shrank to a minimum volume of 92.0±0.6% compared to 
90.1±1.67% for cells superfused with hypertonic aCSF + 10μM forskolin (Figure 3.11B). 
Control cells did not show a RVI although some cells exposed to 10μM forskolin 
showed a slight increase in cell volume. Figure 3.11C shows the rates of cell volume 
recovery following onset of hypertonic challenge. Application of 10µM forskolin 
caused a small, significant increase in RVI in choroid plexus cells exposed to hypertonic 
challenge (P<0.05, Dunnett’s post hoc test). 
 
* 
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3.3.9. Effects of bumetanide on volume in isotonic aCSF 
Wu and colleagues suggested that NKCC1 contributes to choroid plexus cell 
volume maintenance on the basis of experiments using bumetanide in isotonic aCSF 
(Wu et al., 1998). By contrast, in the present studies I have not found any functional 
evidence to support this theory. To further examine this question I chose to repeat 
some experiments of Wu et al. Choroid plexus cells superfused with isotonic solutions 
were exposed to 10μM bumetanide (as used in the present study) or 100μM 
bumetanide (as used by Wu et al, 1998). 
 
Figure 3.12.  Cell volume changes in choroid plexus cells superfused with isotonic aCSF + bumetanide. 
Open bars indicate the addition of bumetanide. A) Cells superfused with HCO3
-
 buffered aCSF +10μM 
bumetanide (n=7) or +100μM bumetanide (n=3). B) Cells superfused with hepes buffered aCSF +10μM 
bumetanide (n=5) or +100μM bumetanide (n=8).  
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Figure 3.12A shows that 100μM bumetanide (    ) caused a reduction in volume 
to 80.7±9.2% in 10 minutes. By contrast 10μM bumetanide (   ) had no significant 
effect on cell volume (Figure 3.13). These experiments were conducted in HCO3
- 
buffered aCSF as were the experiments of Wu and colleagues (Wu et al., 1998). In 
similar experiments in hepes buffered aCSF (Figure 3.12B), the effects of 100μM 
bumetanide were reduced compared with results in HCO3
- 
buffered aCSF. The effect of 
10μM bumetanide in hepes buffered aCSF was similar to that in HCO3
- 
buffered aCSF. 
The data is summarised in Figure 3.13. Neither 10μM nor 100μM bumetanide induced 
a significant choroid plexus cell volume change in hepes buffered aCSF but in HCO3
- 
buffered aCSF, 100μM bumetanide caused a significant decrease in cell volume similar 
to that observed by Wu and colleagues. The data suggest that the effect observed by 
Wu et al may be due to non-specific effects. Furthermore, this non-specific effect is 
dependent on HCO3
-
. 
 
Figure 3.13. A comparison of cell volume change induced by 10 minute superfusion with bumetanide in 
isotonic hepes buffered or HCO3
-
 buffered aCSF. The star (*) indicates that cell volume change is 
significantly greater after 10 minutes of superfusion with isotonic HCO3
-
 buffered aCSF +100μM 
bumetanide compared with other conditions (P<0.05, Dunnett’s post hoc test). 
 
3.3.10. HCO3
-
 buffered solutions do not cause significant 
changes to resting cell volume 
Hepes buffered solutions are used during the choroid plexus cell isolation 
procedure. It is possible that switching the cells to HCO3
-
 buffered solutions for 
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experiments may alter their resting volume. Bouzinova and colleagues showed that a 
change to HCO3
-
 buffered solutions caused an increase in Na
+
 influx by NBC’s 
(Bouzinova et al., 2005) which could lead to a change in cell volume. To explore the 
possibility that HCO3
-
 makes a contribution to volume in isotonic conditions, 
experiments were performed in which superfusate was changed from hepes buffered 
isotonic aCSF to HCO3
-
 buffered isotonic aCSF. 
 
Figure 3.14. Choroid plexus cell resting volume remains approximately the same when isotonic aCSF 
superfusing the cells is changed from hepes buffered to HCO3
-
 buffered. The open bar indicates 
application of HCO3
-
 buffered isotonic aCSF (n=4). 
 
 
Figure 3.14 shows that 5 minutes after changing the isotonic superfusing 
solution from hepes buffered to HCO3
-
 buffered, mean cell volume was 97.5±1.65% 
which is not statistically different from the mean cell volume observed after 3 minutes 
of hepes buffered aCSF perfusion (P>0.2, paired t test). This suggests that superfusing 
cells with isotonic HCO3
-
 buffered aCSF does not change cell volume.  
 
3.3.11. 10µM Bumetanide is sufficient to inhibit RVI in 
pancreatic β cells 
Pancreatic β cells were isolated from Sprague-Dawley rats and prepared for 
experiments as described previously (Miley et al., 1997). β cells were selected for 
experiments based on their large size and typically granular appearance. To test the 
efficacy of 10µM bumetanide in inhibition of NKCC1, experiments were conducted 
with pancreatic β cells. The pancreatic β cell response to hypertonic challenge has 
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been well studied by the Brown lab group (Davies et al., 2007; Majid et al., 2001; Miley 
et al., 1997) and NKCC1 is known to make a major contribution to the RVI in these 
cells.  
Figure 3.15.Pancreatic β cells exhibit a RVI which is bumetanide sensitive. Black bars indicate A) 
hypertonic challenge (n=7), B) hypertonic challenge + 10μM bumetanide (n=3). Rates of recovery are 
compared in Figure 3.15C. The star (*) indicates that rate of recovery is significantly reduced in the 
presence of 10μM bumetanide (P<0.05, unpaired t test). 
 
 
Primary rat pancreatic β cells were subjected to the same hypertonic challenge 
protocol as described previously for the choroid plexus cell experiments and the 
complete time course is shown in Figure 3.15A. Mean cell volume prior to hypertonic 
challenge was 2.17pL. Superfusion with hypertonic hepes buffered aCSF induced cells 
to shrink to a mean volume of 85.5±1.5% within 2 minutes. Cells then exhibited an RVI 
to reach a mean volume of 95.5±1.8% after 15 minutes of hypertonic challenge. On 
return to isotonic superfusion, cells swelled before recovering towards their initial 
volume.  
Cells superfused with hypertonic hepes buffered aCSF + 10μM bumetanide 
shrank to a mean volume of 84.0±3.7% after 2 minutes which is similar to the shrink in 
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control β cells (P>0.05, t test). However in the presence of 10μM bumetanide, cell 
volume recovery was greatly attenuated so that the mean cell volume after 15 minutes 
of hypertonic challenge was 87.3±1.4%. On return to isotonic superfusion, cells 
recovered towards their initial volume. 
β cell RVI was significantly inhibited by 10μM bumetanide (P<0.05, unpaired t 
test). The remaining small RVI may be attributed to the actions of NHE and AE which 
are known to contribute to RVI in pancreatic β cells (Miley et al., 1997). 
 The data indicate that 10μM bumetanide is sufficient to inhibit NKCC1 activity 
in pancreatic β cells and therefore it can be concluded that NKCC1 is not involved in 
the choroid plexus epithelial cell RVI. 
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3.4. Discussion 
3.4.1. RVI in choroid plexus is mediated by a 
combination of NHE and AE activity.  
3.4.1.1. RVI is HCO3
−
 dependent 
In nominally HCO3
− 
free conditions, no RVI was observed in choroid plexus cells 
when aCSF was made hypertonic by the addition of either mannitol or NaCl. These 
data suggest that NHE and AE (which do not contribute to RVI in the absence of HCO3
−
; 
(Hoffmann and Simonsen, 1989) may be involved in the choroid plexus RVI. The RVI of 
some other cell types such as rat lacrimal acinar cells are also HCO3
-
 dependent 
(Douglas and Brown, 1996). HCO3
-
 dependent RVI usually involves a combination of 
NHE and AE (Hoffmann and Simonsen, 1989; Wehner et al., 2003a). 
 
3.4.1.2. RVI is blocked by amiloride derivatives and DIDS 
Evidence for the involvement of NHE in choroid plexus was provided by the 
observation that the amiloride derivatives EIPA and MIBA (which have high efficacies 
for NHE) (Talor et al., 1989), both inhibited the RVI in choroid plexus cells. On the other 
hand the RVI was not affected by benzamil which inhibits ENaC, but has little effect on 
NHE (Kleyman and Cragoe, 1988). The data therefore strongly support a role for NHE in 
the RVI, but suggest that ENaC which is expressed in choroid plexus (Amin et al., 2005) 
is not involved.  
The data on NHE activity are important because the expression of NHE in 
choroid plexus has, until quite recently, been somewhat controversial. This 
controversy has arisen because although there was much functional data to support 
the expression of NHE transporters in the basolateral membrane of choroid plexus 
epithelium cells (Mayer and Sanders-Bush, 1993; Murphy and Johanson, 1990), the 
molecular evidence was less convincing, i.e. mRNA for NHE1 has been identified 
(Kalaria et al., 1998), but there were no data to support the expression of NHE proteins 
(Alper et al., 1994)., Recently however, Damkier and colleagues have now shown that 
NHE1 is expressed in the apical membrane of the choroid plexus using 
immunocytochemical methods (Damkier et al., 2009). Furthermore, an unidentified 
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amiloride-insensitive NHE may also be expressed (Damkier et al., 2009). The fact that 
the RVI was almost completely inhibited by EIPA and MIBA indicates that only the 
amiloride sensitive NHE contributes to RVI.  
By contrast to NHE1, the expression of AE2 in the basolateral membrane of the 
choroid plexus is well established (Lindsey et al., 1990; Wu et al., 1998). The 
pharmacological tools available to study AE activity, however, are only poorly 
developed (Culliford et al., 2003). This study found that DIDS inhibited the RVI in 
choroid plexus cells. DIDS is an effective inhibitor of AE, but it also inhibits a wide range 
of other anion transport processes including NKCC1 (100µM DIDS causes 10±7% 
inhibition of NKCC1 in human erythrocytes) (Culliford et al., 2003). In addition, DIDS is 
more prone to degradation than some similar drugs and so conclusions drawn based 
entirely on DIDS inhibition must be treated with caution (Cabantchik and Greger, 
1992). Other transport processes blocked by DIDS include the two anion channels 
expressed in the choroid plexus (Kibble et al., 1997; Kibble et al., 1996) and two of the 
Na
+
 HCO3
−
 cotransporters (NBCE and NBCe2) expressed in the choroid plexus 
(Bouzinova et al., 2005; Praetorius, 2007). Thus the possible involvement of NBC's and 
anion channels in volume regulation cannot be completely dismissed. However, the 
electrochemical gradient for Cl
−
 favours ion efflux so that ion channels are unlikely to 
play a role in volume increase. A role for NBC’s is also unlikely since there are no data 
from any other type of cell to suggest that they play any role in volume regulation 
(Wehner et al., 2003a). Furthermore we found that changing the superfusate from a 
HCO3
−
 free (hepes-buffered) to the HCO3
−
 buffered solution did not cause any 
significant change in cell volume (Figure 3.14), yet this manoeuvre is known to 
stimulate NBC activity in the choroid plexus (Bouzinova et al., 2005). The HCO3
−
 
dependence together with the effects of DIDS, MIBA and EIPA on RVI strongly favours 
a role for AE2 and NHE1 in volume regulation in choroid plexus cells. The RVI in 
hypertonic aCSF was completely blocked by DIDS, MIBA and EIPA, indicating that NHE1 
and AE2 alone are responsible for the RVI.  
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3.4.1.3. Choroid plexus RVI is not affected by 10μM bumetanide 
The RVI of some cells such as pancreatic β cells (Miley et al., 1998) is mediated 
by NHE/AE with the additional contribution of NKCC1. This can be ruled out in the case 
of choroid plexus cells as no effect of bumetanide on RVI was seen. 
 
3.4.2. NKCC1 does not contribute to choroid plexus RVI 
NKCC1 is strongly expressed in choroid plexus epithelial cells (Plotkin et al., 
1997; Wu et al., 1998) and so it was surprising that no effect of bumetanide was 
observed. Keep and colleagues described an ‘increase in NKCC1 activity’ in hypertonic 
conditions (Keep and Xiang, 1995) and Wu and colleagues described NKCC1 as 
contributing to volume maintenance in isotonic conditions (Wu et al., 1998). It is 
possible that these contrasts with the data presented in the present study may be due 
to species differences since both previous studies used rats. However this is unlikely 
since NKCC1 is also known to be expressed in mouse choroid plexus cells (Piechotta et 
al., 2002) and it was possible to replicate Wu and colleagues experiments with 
bumetanide in the present study (discussed further in section 3.4.3). 
Efforts to promote NKCC1 activity have failed. The three methods used were 1) 
promoting driving force for ion entry with an initial cell swell phase to induce a post-
RVD RVI; 2) increasing the external driving force for ion entry with increased 
extracellular NaCl concentration; 3) promoting kinase activity to phosphorylate and 
therefore activate NKCC1. 
 
3.4.2.1. Post RVD-RVI. 
The post-RVD RVI was only partially inhibited by EIPA indicating that NHE1 is 
highly likely to make a contribution, most probably in combination with AE2 activity. 
However the post-RVD RVI was not abolished by EIPA thus another non-amiloride 
derivative sensitive mechanism also contributes. The identity of this mechanism has 
not been determined in this study but NKCC1 does not appear to play a role since 
10μM bumetanide had no effect on post-RVD RVI. However, NKCC1 is known to 
contribute to the post-RVD RVI in Ehrlich ascites tumour cells (Hoffmann and 
Simonsen, 1989) and so simultaneous application of 10μM EIPA with 10μM 
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bumetanide may help to finally confirm that NKCC1 does not participate in choroid 
plexus cell post-RVD RVI as has been observed in pancreatic α cells where NKCC1 does 
not contribute to the HCO3
-
 sensitive post RVD-RVI (Davies et al., 2009).  
It may be argued that correcting the slow cell volume drift over the course of 
the experiments could be influencing the evidence of a post-RVD RVI. This is unlikely 
since transport inhibitors were used which may be expected to decrease post-RVD RVI. 
The application of a scaled correction for cell drift in volume would tend to diminish 
rather than potentiate the transport inhibitors effects. 
 Another potential mechanism for post-RVD RVI is the activation of amiloride- 
insensitive cation channels (Wehner et al., 2003a), however, there are no 
electrophysiological data to support the expression of these channels in the choroid 
plexus. Furthermore it is difficult to explain why these channels, if present, might 
contribute to the post-RVD RVI but remain inactive in hypertonic solutions. Another 
possibility is that the RVI involves the retention of ions due to a reduction in the 
activity of transporters which may normally be involved in reducing cell volume, e.g. K
+
 
and Cl
−
 channels or K
+
Cl
–
 cotransporters. Such transporters will presumably be very 
active during the RVD, but may quickly inactivate when the cells are returned to the 
isotonic media. However, it is difficult to speculate further because the mechanism of 
RVD in the choroid plexus remains to be elucidated.  
 
3.4.2.2. Promoting NKCC1 activity by increasing the driving force for ion 
entry. 
Literature on the potential role of NKCC1 in choroid plexus cells is somewhat 
confused. Keep and colleagues first suggested that NKCC1 may mediate ion efflux in 
the choroid plexus to contribute to CSF secretion (Keep et al., 1994). These conclusions 
were based on reported concentrations of intracellular Na
+
, K
+
 and Cl
-
 ions and are 
therefore dependent on the accuracy of these measurements. Experiments with the 
NKCC1 inhibitor bumetanide (10 or 30μM) showed 75% inhibition of K
+
 efflux from rat 
choroid plexus cells (Keep et al., 1994). However, in contrast to the studies of Keep and 
colleagues, experiments where the radioactive tracer 
86
Rb is substituted for K
+
 showed 
that influx into choroid plexus cells could be inhibited by 50μM bumetanide (Plotkin et 
al., 1997) and 100μM bumetanide induced cell shrinkage (Wu et al., 1998). This data 
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supports the hypothesis that NKCC1 plays a role in ion influx in line with earlier studies 
(Bairamian et al., 1991). The direction of NKCC1 cotransport is therefore unclear but 
will depend on the driving forces for movement of Na
+
, K
+
 and Cl
-
 ions. 
Increased extracellular concentration of NaCl would be expected to increase 
the driving force for Na
+
 entry into the choroid plexus cells and therefore promote 
NKCC1 mediated influx of ions to contribute to an RVI. However the absence of an RVI 
during this manoeuvre indicates that NKCC1 is not contributing to ion influx. 
 
3.4.2.3. Promoting NKCC1 activity by increasing hypertonic challenge 
length and increasing kinase activity. 
Subjecting choroid plexus cells to hypertonic challenge increasing from 10 
minutes to 15 minutes then to 20 minutes did not result in a RVI being observed. At 
present the ability of choroid plexus cells to mediate a slow onset RVI has not been 
investigated. However prolonged exposure to hypertonic challenge in the present 
study appeared to have a detrimental effect on choroid plexus cells ability to recover 
their volume. Slow onset RVI’s commonly occur through the import or synthesis of 
organic metabolites such as taurine or sorbitol. Taurine transport pathways have not 
been investigated in the choroid plexus. As has been previously discussed, choroid 
plexus cells are most likely to have their cell volume challenged by imbalances of ion 
fluxes which may be rapidly resolved (Diamond, 1982) rather than extended osmotic 
challenge as occurs in the inner medullary kidney cells (Wehner et al., 2003a).  
Ion transport may be regulated by a variety of receptors which are coupled to 
adenylate cyclase (Johanson C. et al., 2004). Forskolin has been widely used in this 
context to activate NKCC1 through increased cAMP mediated phosphorylation. 
Forskolin caused a slight increase in RVI in some cells, just achieving statistical 
significance. Further investigations with more specific kinases would be helpful. 
NKCC1 is activated when phosphorylated by kinases such as the STE20/SPS1-
related proline/alanine-rich kinase (SPAK) which is abundantly expressed in the 
choroid plexus where NKCC1 is also detected (Delpire and Gagnon, 2006). Forskolin 
increases the intracellular cAMP concentration, stimulating an extended intracellular 
signalling cascade to result in NKCC1 phosphorylation and so forskolin cannot be 
regarded as a specific activator of NKCC1 (Hoffmann and Pedersen, 2007). Calyculin A 
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was recently identified as a more specific activator of NKCC1 (Hoffmann and Pedersen, 
2007; Matskevich et al., 2005). PP1 is able to directly inhibit NKCC1 activity by 
dephosphorylating it and to inhibit NKCC1 indirectly by dephosphorylating and 
therefore deactivating SPAK (Gagnon and Delpire, 2010) so calyculin A is able to 
promote NKCC1 activity by relieving this inhibition. Experiments investigating the role 
of NKCC1 in volume change could be repeated using calyculin A however further 
studies into the intracellular signalling cascade which regulates NKCC1 are outside the 
scope of this study. 
 
3.4.3. Dose dependent effect of bumetanide on resting 
cell volume 
The present study contradicts previous work which suggested that NKCC1 
contributes to the maintenance of cell volume (Wu et al., 1998). This earlier 
conclusion, however, was based mainly on experiments in which high concentrations 
(100 μM) of bumetanide caused a reduction of cell volume in isotonic solutions 
buffered with HCO3
-
. Bumetanide has long been regarded as an invaluable tool for 
investigating activity of the NKCC cotransporters for which it is generally regarded as a 
specific inhibitor (Hannaert et al., 2002). Repeating the experiments described by Wu 
and colleagues shows similar effects of 100μM bumetanide on cell volume. However, 
there was no reduction in cell volume when cells were superfused with 10 μM 
bumetanide in isotonic aCSF so the cell shrink induced by 100μM bumetanide is 
unlikely to be solely mediated by NKCC1. Furthermore, 100μM bumetanide had little 
effect on volume in the absence of HCO3
-
 thus the results of Wu et al may be 
attributed to non-specific, HCO3
-
 dependent effects of 100μM bumetanide. All these 
experiments from both lab groups were performed using video imaging techniques to 
study an isolated rodent choroid plexus cell preparation where the bumetanide was 
applied in extracellular isotonic solution. These data are significant because 
bumetanide is reported to cause half maximum inhibitory effects of NKCC1 at 0.2 µM 
(Cabantchik and Greger, 1992; Haas and McManus, 1983). Most dose–response 
studies indicate that 10 μM bumetanide is sufficient to inhibit the vast majority of 
NKCC1 activity (for a review see (Russell, 2000)), certainly, 10 µM bumetanide was 
sufficiently efficacious to abolish RVI in pancreatic β cells and therefore appears to be a 
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suitable concentration to use in drawing conclusions regarding NKCC1 activity in 
choroid plexus cells. 
The observed HCO3
−
 sensitivity of isotonic bumetanide cell volume change is 
unlikely to be an artefact of HCO3
-
 superfusing solutions since switching superfusing 
isotonic aCSF from hepes buffered to HCO3
-
 buffered does not cause a major change in 
resting cell volume on its own as shown in Figure 3.15. Switching from a HCO3
-
 
buffered isotonic bathing solution to a hepes buffered one has been reported to cause 
transient acidification in mouse pancreatic islets (Shepherd and Henquin, 1995). Since 
the solution exchange was from hepes buffered to HCO3
-
 buffered and all cells in the 
present study were allowed to acclimatise for 10 minutes prior to experimentation 
(except those shown in Figure 3.15) it is unlikely that a similar situation occurred in the 
present study. 
NKCC1 activity is unlikely to be directly inhibited by hepes buffering of 
experimental solutions, since the same solutions elicited a clear bumetanide sensitive 
RVI in pancreatic β cells. However it is possible that NKCC1 may be damaged or 
inhibited by the cell isolation protocol and its activity is therefore not seen. This is 
unlikely since in these circumstances, NHE and AE would also not be functional. 
However comparing the results of the current study with similar experiments 
performed on cells isolated from NKCC1 knockout mice would finally clarify this point. 
Taken together, the data suggests that NKCC1 is not active under control 
conditions in which choroid plexus cells are superfused with isotonic aCSF. It is likely 
that cell shrinkage previously attributed to inhibited NKCC1 activity may actually be 
caused by a different HCO3
-
 sensitive, non-specific effect of high (100μM) bumetanide 
concentrations. 
The effects of 100 μM bumetanide on cell volume may be due to non-specific 
actions on other ion transporters such as AE2 or K
+
Cl
−
 cotransporters (Culliford et al., 
2003). While it was noted that 100µM bumetanide causes 93±5% inhibition of Na
+
K
+
Cl
-
 
cotransport in human erythrocytes, it also caused 32±2% inhibition of K
+
Cl
-
 cotransport 
and 67±7% inhibition of anion exchange in human erythrocytes (Culliford et al., 2003). 
However neither KCC’s nor AE2 are likely to be active during resting, isotonic 
conditions in choroid plexus epithelial cells. 
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High concentrations of bumetanide may also affect other ion transport-related 
processes in the choroid plexus such as the carbonic anhydrase family of enzymes. 
Carbonic anhydrase II is found in the cytoplasm of choroid plexus cells (Masuzawa et 
al., 1984; Sly and Hu, 1995) along with CAIII (Nogradi et al., 1993) and the membrane 
bound CAIV (Maren et al., 1997). Bumetanide inhibits CAIV along with several other 
CA’s but does not inhibit CAII or CAIII (Temperini et al., 2008). Since these enzymes 
catalyse the conversion of water and carbon dioxide to bicarbonate ions, the rate of 
this reaction may have important consequences for cell volume. It would be 
interesting to see if wild type choroid plexus cell shrinkage could be reproduced when 
a carbonic anhydrase inhibitor such as acetazolamide (Bartolo et al., 2009) was applied 
in isotonic hepes buffered aCSF. 
 
3.4.4. The physiological importance of RVI for choroid 
plexus cells.  
Maintaining the integrity of the blood/CSF barrier is critical for brain 
homeostasis. Changes in cell volume can be a consequence of altered intracellular 
osmolality if the ion fluxes that occur during CSF secretion across the apical and 
basolateral membranes of the epithelia cells are not balanced. Such changes in cell 
volume are well documented in other epithelia and the RVI mechanism described 
would allow choroid plexus cells to recover their volume when necessary. This data 
supports the proposed role for NHE1 in homeostasis rather than CSF secretion 
(Praetorius, 2007). The physiological role of NKCC1 is not yet clear since it does not 
contribute to the choroid plexus RVI. 
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3.5. Conclusions 
In conclusion, choroid plexus epithelial cells exhibit a HCO3
-
 dependent volume 
regulation in response to cell shrinkage induced by exposure to hypertonic aCSF or 
following a regulatory volume decrease. The evidence presented here indicates that 
NKCC1 does not contribute to the RVI under normal physiological conditions. By 
contrast, the combined activities of NHE1 and AE2 are responsible for the RVI in 
hypertonic solutions. NHE1 is likely to contribute to a post-RVD RVI to which AE2 is 
also likely to contribute however there is also another, non NKCC1 component.  
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Chapter Four                        
The choroid plexus cell 
regulatory volume decrease 
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4.1. Introduction 
4.1.1. The importance of RVD in cell function 
Choroid plexus cells are exposed to massive fluxes of ions as they secrete 
cerebrospinal fluid (Wright, 1978). As has already been seen, they are able to regulate 
their volume in response to extracellular hypertonic challenge (Chapter 3). An increase 
in cell volume can occur due to imbalance of ion fluxes or, experimentally, by exposure 
to hypotonic extracellular solutions. However, the ability of choroid plexus cells to 
exhibit an RVD has never been systematically studied. Cell swelling is potentially 
especially dangerous for the choroid plexuses which float in the cerebrospinal fluid 
filled ventricles. The lack of mechanical constraint makes it important for each cell to 
be able to regulate its volume to defend the integrity of the blood/CSF barrier.  
 
4.1.2. Many cell types exhibit a RVD 
Many cells are known to exhibit a regulatory volume decrease in response to 
the varied stimuli which may induce a cell to swell (Hoffmann and Dunham, 1995). A 
RVD may occur when acute loss of K
+
 and Cl
-
 occurs with the osmotically obliged efflux 
of water resulting in cell shrink (Hoffmann and Dunham, 1995). The loss of organic 
molecules such as taurine may also contribute to a RVD response (Wehner et al., 
2003a). The acute loss of K
+
 and Cl
-
 may be mediated by K
+
 and Cl
-
 channels or K
+
 and 
Cl
-
 cotransporters, in human glioma cells, Ernest and colleagues estimated the relative 
contribution of channels compared with transporters in RVD to be about 60-70% to 30-
40% respectively (Ernest et al., 2005).  
 
4.1.3. Mechanisms of RVD 
4.1.3.1. Channels which contribute to RVD 
There are three major families of K
+
 channels – the inward rectifying K
+
 
channels, the voltage gated K
+
 channels (which includes the Ca
2+
 activated K
+
 channels) 
and the twin pore K
+
 channels (Wehner, 2006). The inward rectifying K
+
 channels are 
so named because a characteristic inward movement of K
+
 into cells is observed at 
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negative membrane potentials which is progressively inhibited with membrane 
depolarisation (Doring et al., 1998). Voltage gated K
+
 channels display characteristic K
+
 
current at depolarising membrane voltages and do contribute significantly to RVD in 
cell types such as rat lacrimal gland cells (Park et al., 1994) and cerebral artery smooth 
muscle cells (Earley et al., 2005) among others. Expression of the voltage sensitive 
Kv1.3 channel in T-lymphocytes was able to induce an RVD response which is absent in 
the non-transfected cells (Deutsch and Chen, 1993). Twin pore K
+
 channels obtain their 
name from the double pore arrangment found in their primary pore forming subunit 
and are most likely to form dimers rather than the usual tetramer arrangement of Kv 
or Kir channels (Alexander et al., 2009). 
The volume-regulated anion channel (VRAC) (Nilius and Droogmans, 2001) is 
also sometimes referred to as the volume-sensitive outwardly rectifying Cl
-
 channel 
(Okada, 1997). It appears to be ubiquitously expressed (Okada, 1997; Strange et al., 
1996) however the molecular identity of these channels has not yet been established 
(Wehner et al., 2003a). Calcium activated Cl
-
 channels (CaCC) also commonly 
contribute to RVD (Wehner et al., 2003a) in cells such as rat lacrimal gland acinar cells 
(Kotera and Brown, 1993). VRAC and CaCC channels both contribute to the RVD in 
Ehrlich ascites tumour cells (Pedersen et al., 1998) and a mouse inner medullary 
collecting duct cell line (Boese et al., 2000). 
 
4.1.3.2. Channels which may contribute to RVD in choroid plexus cells 
Choroid plexus cells express a number of K
+
 channels which may contribute to 
RVD. The inward rectifying K
+
 conductance mediated by Kir7.1 is highly expressed on 
the apical membrane of rat choroid plexus cells but, as may be expected on the basis 
of K
+
 driving forces, does not contribute to the RVD (Doring et al., 1998; Nakamura et 
al., 1999). Among the voltage gated K
+
 channels, Kv1.1 and Kv1.3 contribute to the 
delayed rectifying K
+
 conductance observed in rat choroid plexus cells (Speake et al., 
2004). BKCa channels are functionally evident in the apical membrane of Necturus third 
ventricle choroid plexus as assessed by patch clamp techniques (Brown et al., 1988; 
Christensen, 1987). This channel is highly K
+
 selective with an opening potential highly 
effected by intracellular Ca
2+
 concentration, pH and membrane potential (Brown et al., 
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1988). However BKCa channels have not been detected in the mammalian choroid 
plexuses (Millar et al., 2007). 
Two Cl
-
 conductances have been identified by electrophysiological methods in 
choroid plexus cells: 1) an inwardly rectifying anion conductance and 2) a volume 
sensitive anion conductance (Kibble et al., 1996; Kotera and Brown, 1994). The 
inwardly rectifying anion conductance (Kibble et al., 1997; Speake et al., 2002) is 
thought to be the main route by which Cl
-
 and HCO3
-
 cross the membrane during CSF 
secretion but is not involved in choroid plexus RVD (Speake et al., 2002; Speake et al., 
2001). The volume sensitive anion conductance (ICl-(swell)) (Speake et al., 2001) is similar 
to that detected in numerous cell types (Wehner et al., 2003a) and may play a role in 
choroid plexus cell volume regulation by causing initial depolarisation of the cell 
membrane which would open Kv channels, causing an efflux of K
+
 and Cl
-
. 
 
4.1.3.3. Transporters which contribute to RVD 
In addition to K
+
 and Cl
-
 channels, several transporter proteins are also known 
to be involved in RVD in other cell types, most notably the KCC family which mediate 
electroneutral coupled movement of K
+
 and Cl
-
 (Adragna et al., 2004). The ability of 
KCC1 to contribute to red blood cell RVD in numerous species is now well documented 
(Adragna et al., 2004). KCC1 also contributes to RVD in corneal epithelial cells (Capo-
Aponte et al., 2007a). Capo-Aponte and colleagues detected expression of KCC3 and 
KCC4 in corneal epithelial cells from several species but did not functionally investigate 
their contribution to RVD (Capo-Aponte et al., 2007a). KCC’s 1, 3 and 4 are therefore 
worthy of attention as potential mediators of RVD in epithelial cells while KCC2 is a 
neuronal specific isoform (Payne et al., 1996). 
 
4.1.3.4. Transporters which may contribute to RVD in choroid plexus 
cells 
Several members of the KCC family have been detected in mammalian adult 
choroid plexuses although no functional studies have reported on their role in these 
cells. KCC1 mRNA has been detected in the adult rat choroid plexus (Kanaka et al., 
2001). KCC3a protein is expressed in a number of sites in the mouse brain including in 
the base of the choroid plexus epithelium, presumed to be the basolateral epithelial 
membrane where it is proposed to play a role in K
+
 reabsorption (Pearson et al., 2001). 
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KCC4 is expressed in the apical membrane of adult mouse choroid plexus cells 
(Karadsheh et al., 2004). The presence of KCC3 and KCC4 in the adult rat choroid 
plexus has since been confirmed independently (Le Rouzic et al., 2006), however, the 
molecular identification of these proteins has not been matched with corresponding 
functional evidence of their contribution to RVD in choroid plexus cells.  
4.1.4. Chapter Aims 
− Investigate the ability of choroid plexus cells to regulate their volume in 
response to hypotonic challenge. 
− Investigate the role of ion channels and KCC’s in any choroid plexus cell 
RVD. 
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4.2. Methods 
4.2.1 Cell isolation and experimental aCSF’s 
Choroid plexus cells were prepared and selected for experiments as described 
in Chapter 2. Except where stated, all experiments used aCSF’s which were buffered 
with HCO3
-
 (see Table 4.1). In a few experiments, a hypotonic hepes buffered aCSF was 
used which contained 85mM NaCl, 5mM KCl, 5mM hepes, 4mM glucose, 1.2mM CaCl2 
and 1mM MgCl2 (190 mOsm.Kg H20
-1
). The isotonic hepes buffered aCSF contained an 
additional 55mM NaCl and 20mM mannitol (302 mOsm.Kg H20
-1
). In many 
experiments, hypotonic aCSF was modified by addition of ion transport inhibitors 
(section 4.2.3.). 
Solute Isotonic aCSF 
(mM) 
Hypotonic aCSF 
(mM) 
NaCl 110 65 
NaHCO3 25 25 
Mannitol 20 0 
Glucose 4 4 
KCl 5 5 
CaCl2 1.2 1.2 
MgCl2 1 1 
Osmolality 283 mOsm.Kg H2O
-1
 187 mOsm.Kg H2O
-1
 
 
Table 4.1. HCO3
-
 buffered experimental aCSF’s.  
 
4.2.2. Cell volume regulation protocol 
All cells were superfused for 10 minutes with the isotonic aCSF prior to the start 
of experiments. This allowed cells to acclimatise from room temperature to the 
experimental temperature, and permitted cells isolated in hepes buffered aCSF to 
equilibrate with the HCO3
-
 buffered experimental aCSF. After the acclimatisation 
period, cells were superfused with isotonic aCSF for a further 2 minutes prior to the 
challenge with hypotonic aCSF. In initial experiments, hypotonic challenge was for 15 
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minutes. However, the RVD was complete within 10 minutes so in the majority of 
experiments, hypotonic challenge was for 10 minutes. A final 5 minute recovery period 
followed with cells once again exposed to isotonic solution.  
 
4.2.3. Addition of ion transport inhibitors to hypotonic 
aCSF 
Experiments were performed in hypotonic aCSF containing inhibitors of KCC, K
+
 
channels, anion channels. TEACl and BaCl2 were dissolved in deionised water while 
DIOA, 4AP, DIDS and NPPB were dissolved in 100% DMSO to create stock solutions 
which were stored at -20°C and replaced regularly. Transport inhibitors were diluted in 
aCSF on the day of experiments such that DMSO concentration did not exceed 0.1% 
v/v and day-matched control experiments were performed.  
 
4.2.3.1. KCC inhibitor 
[(dihydroindenyl)oxy]alkanoic acid (DIOA), is a selective blocker of the KCC 
family of K
+
 Cl
-
 cotransporters (Garay et al., 1988). The selectivity of DIOA is however, 
concentration dependent (Culliford et al., 2003; Garay et al., 1988). DIOA has an IC50 
for KCC’s of 5μM (Garay et al., 1988). At concentrations higher than 40µM (Ernest et 
al., 2005) DIOA is known to interfere with Cl
-
 and K
+
 channel activity (Brauer et al., 
2003) and cause considerable inhibition of erythrocyte anion exchange and NKCC1 
(Culliford et al., 2003; Garay et al., 1988). Therefore DIOA was used at 10μM in this 
study.  
 
4.2.3.2. K
+
 channel inhibitors 
Tetraethyl ammonium ions (TEA
+
), barium ions (Ba
2+
) and 4-aminopiridine (4AP) 
block a broad spectrum of K
+
 channels (Alexander et al., 2009).  
TEA
+
 
TEA
+
 blocks the voltage gated K
+
 channel superfamily (Alexander et al., 2009). 
TEA
+
 (5mM) inhibited the voltage dependent, outward K
+
 current observed in rat 
choroid plexus cells from the lateral ventricle (Speake and Brown, 2004) and so 5mM 
TEA
+
 was used in the present study.  
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Ba
2+
 
Ba
2+
 can causes blockade of delayed rectifying and inwardly rectifying K
+
 
channels and, when used at 5mM, is an effective blocker of K
+
 conductance in choroid 
plexus cells (Wu et al., 1998).  
4AP 
4AP blocks Kv channels with varying specificity (Kirsch et al., 1993) and was 
used at 10μM in the present study. Subsequent reading indicates that this 
concentration is likely to be too low to fully block Kv’s present in choroid plexus cells 
(Kirsch et al., 1993). 
 
4.2.3.3. Anion channel inhibitors 
DIDS is the commonly used abbreviation for Disodium 4,4′-
diisothiocyanatostilbene-2,2′-disulfonate and NPPB is the short form of 5-Nitro-2-(3-
phenylpropylamino)benzoic acid. DIDS and NPPB are both known to also block anion 
exchange. Used at 100μM, DIDS caused 90±14% inhibition of anion exchange, while 
NPPB caused 97±2% inhibition of anion exchange in human erythrocytes (Culliford et 
al., 2003). However both drugs caused some inhibition of K
+
Cl
-
 and Na
+
K
+
Cl
-
 
cotransport (Culliford et al., 2003).  
 
4.2.4. Statistical analysis of RVD data 
All statistical analyses were performed on cells from a minimum of two 
preparations. Cells included in any analysis conformed to the following criteria: 
1) Cells had a stable volume in the first two minutes when superfused with 
isotonic aCSF. 
2) Cells displayed a rapid increase in cell volume on exposure to hypotonic 
aCSF (maximum volume was achieved within four minutes). 
3) Cell volume recovered towards initial control volume during the final 
superfusion with isotonic aCSF. 
To compare volume regulation in different experimental conditions ‘volume 
recovery’ was calculated as maximum volume in hypotonic aCSF minus the mean 
volume over the last 3 minutes in hypotonic aCSF. Volume recovery was used rather 
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than ‘rate of recovery’ assessed by linear regression (see Chapter 3) because RVD did 
not exhibit a linear phase. One way ANOVA was used to compare three or more data 
sets. In a few cases, Student’s t tests were used to compare two data sets. Volume 
recovery was expressed as mean ± standard error of the mean.  
Figure 4.1 shows that the initial cell swelling in response to hypotonic aCSF was 
not different from control in the presence of any ion transport inhibitors (F= 0.89, 
P>0.05, One Way ANOVA with Dunnett’s post hoc test). 
  
Figure 4.1. A comparison of maximum cell swelling in hypotonic aCSF in the presence of 10μM DIOA, 
10μM 4AP, 5mM TEA
+
, 5mM Ba
2+
, 100μM DIDS or 100μM NPPB. The n numbers are shown in brackets. 
 
  
  
Alexandra Hughes                                                                                                Page 112 of 174 
4.3. Results 
4.3.1. Choroid plexus cells swell and exhibit a RVD in 
hypotonic aCSF’s 
Preliminary experiments examined the effects of HCO3
-
 and hepes buffered 
aCSF’s on choroid plexus cell volume. 
Figure 4.2. Choroid plexus cells superfused with hypotonic aCSF swell and demonstrate a HCO3
-
 sensitive 
RVD. Black bars indicate perfusion with hypotonic aCSF buffered with either A) HCO3
-
 (n=9) or B) hepes 
(n=6). C) RVD measured as % change in volume between the maximum volume achieved by each cell and 
the volume after 15 minutes of hypotonic challenge The star (*) indicates significantly different data 
(P<0.05,unpaired  t test). Data is expressed as mean±SEM. These preliminary data were produced by Jun 
Shi and Antonina Pakhamova in the Brown laboratory. 
 
 
Figure 4.2A shows the complete time course of volume changes which result 
when 9 choroid plexus cells were exposed to HCO3
-
 buffered aCSF. The cells 
maintained a constant volume when bathed in isotonic aCSF. On exposure to a 
hypotonic HCO3
-
 buffered aCSF, the cells swelled over 4 minutes to a maximum mean 
volume of 124.2±3.6%. Cells then exhibited a RVD reaching 106.9±3.3% by the end of 
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the 15 minute exposure to hypotonic HCO3
-
 buffered aCSF. Cells shrank to 91.8±3.6% 
of their initial volume on return to isotonic HCO3
-
 buffered aCSF. 
A similar initial increase in cell volume was observed with hypotonic hepes 
buffered aCSF (Figure 4.2B). Cells swelled to a mean volume of 126.5±3.7% within 3 
minutes of exposure to hypotonic challenge. Unlike in HCO3
-
 buffered aCSF, however, 
cells did not exhibit a RVD in hepes buffered aCSF and at the end of the 15 minute 
exposure to hypertonic challenge the mean cell volume remained similar at 
126.0±4.2%. Cells returned to their approximate mean starting volume of 104.5±3.7% 
when they were superfused with isotonic aCSF once more. 
Thus a RVD was only observed in cells exposed to HCO3
-
 buffered aCSF (Figure 
4.2C) so all subsequent experiments to investigate RVD in choroid plexus cells were 
carried out in HCO3
-
 buffered aCSF.  
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4.3.2. Choroid plexus cells in the present study exhibit 
reduced volume changes and a RVD in hypotonic aCSF. 
Cells used in the present study were isolated by a slightly different method to 
those whose data are presented in Figure 4.2 with the most important difference being 
the addition of a Ca
2+
 free incubation.  
 
Figure 4.3. Choroid plexus cells prepared for experiments by a method including a Ca
2+
 free incubation, 
swell on exposure to hypotonic aCSF and then show a RVD, (n=16). The black bar indicates hypotonic 
challenge. 
 
 
Figure 4.3 shows the effects of exposing 16 such cells to hypotonic aCSF.  Mean 
cell volume prior to hypertonic challenge was 0.81pL. Following the initial cell swelling 
to a maximum volume of 105.1±0.5%, the cells exhibited a RVD to 101.5±0.5% within 
10 minutes of hypotonic superfusion. After a further 5 minutes of superfusion with 
hypotonic aCSF, the mean volume was unchanged (101.4±0.5%). When the 
superfusate was switched back to isotonic aCSF the volume decreased to 97.4±0.5% 
before recovering to 99.6±0.5% after 5 minutes in isotonic aCSF. It was concluded that 
choroid plexus cells isolated by the method described in Chapter 2 show a clear RVD 
and post-RVD RVI. The RVD resulted in cells reaching a stable volume within 10 
minutes of hypotonic aCSF exposure so all subsequent experiments to investigate RVD 
used a 10 minute hypotonic challenge. Statistical comparison of the rate of RVD for 
control cells shown in Figure 4.3 with that of cells in Figures 4.4, 4.5, 4.6 and 4.7 were 
performed with a One Way Anova test (F=7.55). 
 Swell attained by choroid plexus cells prepared as described in Chapter 2 
(Figure 4.2) is compared with the results of preliminary experiments (Figure 4.3). The 
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maximum swelling attained by these cells exposed to hypotonic HCO3
-
 buffered aCSF is 
shown in Figure 4.4. 
 
Figure 4.4. Maximum swelling of choroid plexus cells in hypotonic HCO3
-
 buffered aCSF. Data are 
presented as mean ± SEM. Cells were isolated with no Ca
2+
 free step (preliminary data) and with a Ca
2+
 
free step (present study).The star (*) indicates significantly different data (P<0.05, Dunnett’s post hoc 
test).  
 
 
Cells in the present study swelled to a maximum volume which was significantly 
less (P<0.05, t test) than that in the preliminary experiments. The reasons for this 
difference are unclear. However choroid plexus cells prepared by the method 
described in Chapter 2 did show consistent cell swell followed by a RVD. Cells also 
exhibited a robust post-RVD RVI. 
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4.3.3. Effect of the KCC inhibitor DIOA on RVD 
The K
+
Cl
-
 cotransporter family play a role in the RVD of several cell types 
(Adragna et al., 2004). To investigate whether KCC’s play a role in the RVD of choroid 
plexus cells, the inhibitor DIOA (10µM) was applied to four cells during hypotonic 
challenge (Figure 4.5).  
 
Figure 4.5. The KCC inhibitor DIOA causes no significant attenuation of choroid plexus RVD. The black bar 
indicates hypotonic challenge + 10μM DIOA, (n=4). 
 
 
After 1 minute of exposure to hypotonic aCSF +10µM DIOA, cells had swelled to 
105.0±0.9%. Cells had reached a mean volume of 99.4±1.2% after 10 minutes exposure 
to hypotonic aCSF +10µM DIOA. On return to isotonic aCSF cells shrank to 94.4±1.4% 
and showed a small recovery towards initial starting volume. 
DIOA had no significant effect on choroid plexus cell RVD compared with 
control cells (P>0.05, Dunnett’s post hoc test) so the effect of drugs which block K
+
 flux 
were investigated. 
 
4.3.4. The K
+
 channel blockers TEA
+
, Ba
2+
 and 4AP have 
no effect on choroid plexus RVD 
K
+
 contributes to RVD in many cell types and so the effect of the K
+
 channel 
blockers 5mM TEA
+
, 5mM Ba
2+
 and 10µM 4AP when applied to choroid plexus cells in 
hypotonic aCSF were investigated.  
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Figure 4.6. The effects of K
+
 transport blockers on choroid plexus RVD. Black bars indicate A) hypotonic 
aCSF +5mM TEA
+
 (n=7), B) hypotonic aCSF +5mM Ba
2+
 (n=6) and C) hypotonic aCSF +10μM 4AP (n=4). D) 
Volume recovery in the presence of K
+
 channel blockers. 
 
 
Figure 4.6A shows that after 1 minute of exposure to hypotonic aCSF +5mM 
TEA
+
 (osmolality = 201 mOsm.Kg H2O
-1
), 7 cells had swelled to 104.8±0.4% of starting 
volume. Cells returned to 99.9±1.2% of their initial volume after 10 minutes exposure 
to hypotonic aCSF +5mM TEA
+
. On return to isotonic aCSF, cells shrank within 1 minute 
to 97.1±1.2%. 
6 cells were exposed to hypotonic aCSF +5mM Ba
2+
 (Figure 4.6B) (osmolality = 
212 mOsm.Kg H2O
-1
).  After 1 minute, cells had swelled to 102.6±0.8% of starting 
volume. Cell volume was 99.9±0.7% after 10 minutes exposure to hypotonic aCSF 
+5mM Ba
2+
. On return to isotonic aCSF cells shrank to 95.6±1.8% and showed a small 
post-RVD RVI. 
Figure 4.6C shows how four cells exposed to hypotonic aCSF +10µM 4AP 
swelled to 104.8±1.1% after 1 minute. Cells then exhibited a RVD with mean volume 
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after 10 minutes in hypotonic aCSF +10µM 4AP decreased to 97.4±0.8% of initial 
volume. On return to isotonic aCSF, cell volume decreased to 91.2±2.0 before a post-
RVD RVI. 
Figure 4.6D shows that the K
+
 efflux blockers TEA
+
, Ba
2+
 and 4AP had no 
significant effect on choroid plexus cell volume recovery (P>0.05, Dunnett’s post hoc 
test). 
 
4.3.5. The anion transport blockers DIDS and NPPB do 
not inhibit choroid plexus RVD 
 
Figure 4.7. The effects of anion transport blockers on choroid plexus RVD. Black bars indicate A) 
hypotonic aCSF +100μM DIDS (n=7) and B) hypotonic aCSF +100μM NPPB (n=7) on choroid plexus cell 
RVD. C) Volume recovery in the presence of anion channel blockers.  
 
 
Figure 4.7A shows the time course for the volume change of 7 cells exposed to 
hypotonic aCSF +100μM DIDS. After 1 minute of exposure to hypotonic aCSF +100µM 
DIDS, cells had swelled to 105±1.2% of starting volume. Cells had reached a mean 
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volume of 101.8±1.2% after 10 minutes exposure to hypotonic aCSF +100µM DIDS. On 
return to isotonic aCSF cells shrank and showed a small post-RVD RVI. 
The mean time course for volume changes of 7 cells exposed to hypotonic aCSF 
+100µM NPPB is shown in Figure 4.7B. After 1 minute the cells had swelled to 
102.6±1.2% of starting volume. Cells had reached a mean volume of 96.4±2.0% after 
10 minutes exposure to hypotonic aCSF +100µM NPPB. On return to isotonic aCSF cells 
shrank and showed a small recovery towards initial starting volume.  
The data with anion transport inhibitors are summarised in Figure 4.7C. There 
was no significant difference between control RVD and that in the presence of DIDS or 
NPPB, (P>0.05, Dunnett’s post hoc test). 
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4.4. Discussion 
The ability of choroid plexus cells to swell and exhibit a RVD has not previously 
been studied systematically. The data presented here shows that these cells do swell 
when exposed to hypotonic challenge and then exhibit a RVD. Inhibitor studies did not 
find clear evidence to support or reject the involvement of KCC’s or K
+
 or Cl
-
 channels 
in RVD in choroid plexus cells. However the RVD was dependent on the presence of 
HCO3
-
 in the aCSF. 
 
4.4.1. Choroid plexus RVD is HCO3
-
 dependent 
Investigations of short term cell volume regulation (RVD within a few minutes) 
have focussed on the movement of K
+
 and Cl
-
 ions, few other ions have been studied. 
This makes the observed dependence of RVD on HCO3
-
 in these studies particularly 
interesting and is discussed further in Chapter 6. Removing HCO3
-
 ions through 
buffering with hepes abolished RVD. At present there is no explanation for how 
removal of HCO3
-
 ions by buffering solutions with hepes abolishes RVD. It cannot be 
completely ruled out that hepes may be directly affecting volume regulation 
mechanisms perhaps by altering cellular pH. The role of H
+
 has not been directly 
studied in choroid plexus cell volume regulation. Direct effects of hepes are unlikely 
however since switching between the two buffering systems does not alter resting cell 
volume (Figure 3.13).  
In light of the evidence of the HCO3
-
 dependency of RVD, the carbonic 
anhydrase (CA) enzymes and the Na
+
/ HCO3
-
 cotransporters present in the choroid 
plexus must be further considered as potential mediators of RVD. CAII is found in 
choroid plexus cells (Masuzawa et al., 1984; Sly and Hu, 1995) along with CAIII 
(Nogradi et al., 1993) and CAIV (Maren et al., 1997). Since these enzymes catalyse the 
conversion of water and carbon dioxide to bicarbonate ions and protons the rate of 
this reaction may have important consequences for the HCO3
-
 sensitive aspects of cell 
volume regulation.  
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The two members of the Na
+
/ HCO3
-
 cotransporter family that are expressed 
and functional in choroid plexus cells are the electrogenic Na
+
/ HCO3
-
 cotransporter 
NBCe2 in the apical membrane (Bouzinova et al., 2005; Praetorius et al., 2004) and the 
putative Na
+
 dependent Cl
-
/HCO3
-
 exchanger (NDCBE) which is located in the 
basolateral membrane (Chen et al., 2008). NDCBE is unlikely to contribute to an RVD 
but NBCe2 mediates the efflux of Na
+
 and HCO3
-
 with a 1:3 stoichiometry and may 
therefore contribute to the efflux of ions required to create a RVD in choroid plexus 
cells (Millar and Brown, 2008). NBCe2 is closely related to NBCe1 which is proposed to 
mediate HCO3
-
 dependent RVD in kidney proximal tubule cells of Necturus and mouse 
(Lopes and Guggino, 1987; Robson and Hunter, 1994; Volkl and Lang, 1988). NBCe2 
showed some sensitivity to DIDS but 500μM was required to abolish its activity (Millar 
and Brown, 2008) which, if it does make an important contribution to choroid plexus 
RVD, would go some way to explaining the lack of effect of 100μM DIDS in the present 
study.  
 
4.4.2. Lack of transport inhibitor effect 
None of the transport inhibitors studied caused a significant difference in the 
maximum swell achieved by the choroid plexus cells. They also had no significant 
effect on the subsequent RVD. This may be due to multiple mechanisms of RVD 
existing in choroid plexus cells and using the transport inhibitors in combination may 
help to clarify the situation.  
The data do not support a role for KCC involvement in choroid plexus RVD. The 
Kv channel blocker 4AP did not cause an inhibition of RVD in the present study. 
However the concentration used (10μM) is somewhat lower than the IC50 value for the 
Kv channels known to be in the choroid plexus (Grissmer et al., 1994; Stephens et al., 
1994) and so full channel blockade is unlikely to have been achieved in the present 
study. As such, the involvement of Kv channels in choroid plexus RVD requires further 
study and testing several concentrations of 4AP would be a helpful first step. 
At present it is not possible to make firm conclusions as to the relative 
contribution of ion channels and transporters to choroid plexus RVD. All ion transport 
inhibitors used in the present study were applied only in the hypotonic aCSF rather 
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than prior to hypotonic challenge. This protocol had proved successful in studying 
transporters involved in choroid plexus RVI and so was expected to be similarly 
successful for investigating choroid plexus RVD. Further investigations using higher 
(less specific) concentrations of the transport inhibitors or preincubating cells with 
them may be necessary. However, studies of ion transport mechanisms contributing to 
choroid plexus RVD were hindered by the small volume change induced by hypotonic 
challenge. 
It is difficult to interpret the inhibitor studies since choroid plexus cells swelled 
a small amount. This small swell was highly consistent even when the volume 
regulation experiments were conducted by different members of the Brown lab group. 
It is unclear why cells used in the present study did not swell to such large volumes as 
those isolated for preliminary experiments. As has been mentioned, cells in early 
experiments were isolated by a slightly different protocol to those used in the present 
study, most notably a Ca
2+
 free step was included to increase the yield of single cells 
suitable for volume regulation experiments. Such a step is common in many cell 
isolation protocols however the effects of a Ca
2+
 free incubation on subsequent cell 
volume changes has not previously been systematically studied although this will be 
the subject of further discussion in Chapter 5. 
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4.5. Conclusions 
− Mouse choroid plexus cell RVD is HCO3
-
 dependent.  
− The relative contribution of ion channels and transporters to choroid 
plexus RVD remains to be fully elucidated. 
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Chapter Five                       
Ca
2+
 as a messenger in 
choroid plexus cell RVD 
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5.1. Introduction 
5.1.1. Ca
2+
 as a regulator of RVD 
Christensen, working with amphibian choroid plexus, was among the first to 
suggest a mechanism by which Ca
2+
 controls RVD.  He proposed that hyposmotic 
challenge leads to membrane deformation and activation of stretch activated Ca
2+
 
channels. Ca
2+
 enters the cell through the stretch activated Ca
2+
 channels resulting in 
activation of ‘maxi’ Ca
2+
 activated K
+
 channels (BKCa) channels (Christensen, 1987). 
Remarkably Christensen did not test his theory by studying actual cell volume 
regulation. However since this study, many investigators have observed a similar influx 
of Ca
2+
 leading to RVD (Pierce and Politis, 1990). BKCa channels act alongside Ca
2+
 
sensitive Cl
-
 channels to mediate a RVD in rat lacrimal acinar cells in response to 
hypotonic challenge (Kotera and Brown, 1993; Park et al., 1994). Stretch activated Ca
2+
 
channels were proposed to mediate the Ca
2+
 entry to initiate RVD in these cells too 
(Speake et al., 1998). Stretch activated Ca
2+
 channels also play a role in the RVD of 
bovine articular chondrocytes (Yellowley et al., 2002) and Ehrlich ascites tumour cells 
(Christensen and Hoffmann, 1992). The precise molecular identity of the stretch 
activated Ca
2+
 channels contributing to RVD however, has not been defined in all cell 
types. Several members of the TRP superfamily have been identified as proteins 
responsible for stretch activated Ca
2+
 movement in smooth muscle, when over 
expressed in oocytes and CHO cells and in HeLa cells (Guibert et al., 2008; Maroto et 
al., 2005; Numata et al., 2007). 
 
5.1.2. TRP channels may act as stretch activated Ca
2+
 
channels with a role in osmosensation 
The 28 mammalian members of the TRP superfamily are mainly non-specific 
cation channels with a pore forming loop between their fifth and sixth membrane 
spanning domains. All TRP channels allow permeation of monovalent cations (e.g. Na
+
, 
Cs
+
, Li
+
, K
+
) with varying selectivities and the majority permit Ca
2+
 movement. Almost 
all TRP channels are thought to be located on the plasma membrane and thus are 
suitably placed to be involved in mechanisms to transduce extracellular alterations in 
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environment into intracellular physiological reactions. Several members of the TRP 
superfamily have been linked with stretch activated Ca
2+
 entry in volume regulation 
and osmosensing. 
Within the TRPC family, TRPC1 and TRPC6 were initially thought to be 
mechanosensitive channels however electrophysiological studies and work with knock 
out mice have suggested this may not be the case (Gottlieb et al., 2008). Two members 
of the TRPM family are osmosensitive. Increased Ca
2+
 influx was detected when 
HEK293 cells expressing TRPM3 were exposed to lowered osmolarity (Grimm et al., 
2003; Grimm et al., 2005) while TRPM4 mediates pressure-induced smooth muscle cell 
depolarization (Earley et al., 2004). Among the TRPV family members, TRPV2  is 
activated by hypotonicity induced cell swelling and cell stretching (Muraki et al., 2003). 
A study looking for rat, mouse, human and chicken homologs of a known osmosensor 
in Caenorhabditis elegans, OSM-9, identified the vanilloid receptor-related osmotically 
activated channel (VR-OAC) which is now known as TRPV4 (Liedtke et al., 2000). 
Recent data shows that two of these TRP channels (TRPM3 and TRPV4) are expressed 
in mammalian choroid plexus epithelial cells.  
 
5.1.2.1. TRPM3 
TRPM3 mRNA and protein localisation studies carried out by Oberwinkler and 
colleagues demonstrated abundant TRPM3 expression in the brain, particularly in the 
choroid plexuses (Oberwinkler et al., 2005). Whole cell patch clamp studies carried out 
on fragments of choroid plexus tissue from the fourth ventricle of mice have also 
demonstrated a TRPM3-like current which shows pharmacological sensitivity similar to 
that reported for TRPM3 (Millar et al., 2007). Very little is known about the functions 
of TRPM3 in any cell type (Harteneck and Reiter, 2007) except pancreatic β cells where 
it acts as a zinc entry pathway (Wagner et al., 2010). TRPM3’s function in choroid 
plexus cells is yet to be elucidated. 
 
5.1.2.2. TRPV4 
 TRPV4 mRNA (Liedtke et al., 2000) and protein (Liedtke and Friedman, 2003; 
Mizuno et al., 2003) was detected in the choroid plexus epithelial cells of mouse lateral 
ventricles. It is reported to be basolaterally expressed (supplementary data, (Imura et 
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al., 2007) but little else is known about its location or, more importantly, its function in 
choroid plexus cells. In functional studies, vertebrate TRPV4 expressed in vitro was 
concluded to be a poorly selective cation channel capable of mediating influx of Ca
2+
 
ions which is gated by osmotic challenge of physiological relevance (Liedtke et al., 
2000).  
An ever growing number of studies have suggested that TRPV4 mediates the 
Ca
2+
 signal observed following cell swelling in a variety of cell types, in fact Arniges and 
colleagues conclude that TRPV4 is the only pathway mediating the swell activated Ca
2+
 
entry which is required for full RVD in human tracheal epithelial cells following 
hypotonic challenge (Arniges et al., 2004). Immortalized human keratinocytes (which 
strongly express endogenous TRPV4) show an increase in intracellular Ca
2+
 
concentration simultaneously with rapid RVD when subjected to a hypotonic challenge 
(Becker et al., 2005). TRPV4 is expressed in immortalised human corneal epithelial cells 
where it plays a role in RVD response (Pan et al., 2008). Chinese hamster ovary cells 
(CHO’s) do not express TRPV4 endogenously and do not show RVD on exposure to 
hypotonic challenge. However, a RVD can be induced along with a simultaneous 
increase in intracellular Ca
2+
 concentration if CHO’s are transfected with TRPV4 (Liu et 
al., 2006). The potential involvement of TRPV4 in triggering choroid plexus RVD has not 
been investigated.  
 
5.1.3. Ca
2+
 and control of RVD in mammalian choroid 
plexus cells 
Christensen’s work on amphibian choroid plexus cells suggested a role for Ca
2+
 
influx through stretch activated Ca
2+
 channels in RVD (Christensen, 1987), but a similar 
mechanism has not been investigated in mammalian choroid plexus cells. There is very 
little literature available on the role of the choroid plexuses in overall brain Ca
2+
 
homeostasis since most literature focuses on Ca
2+
 transport and currents in neurons 
with some more recent studies focussing on glial cells. Changes in Ca
2+
 concentration 
of the CSF will effect neuronal excitability (Borke et al., 1989) and so it is highly 
relevant to investigate Ca
2+
 handling by the choroid plexus and to investigate the 
question of the Ca
2+
 dependence of mammalian choroid plexus RVD. 
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In the amphibian choroid plexus, RVD is initiated by the influx of Ca
2+
 activating 
BKCa channels (Christensen, 1987). Functional evidence of BKCa channels has also been 
detected in the choroid plexus of Necturus maculosus (Brown et al., 1988; Loo et al., 
1988) however electrophysiological evidence indicates that these channels are not 
present in mammalian choroid plexus (Kotera and Brown, 1994). A low level of 
immunoreactivity for intermediate conductance Ca
2+
 activated K
+
 channels (IKCa) 
channels was reported in rat choroid plexus (Thompson-Vest et al., 2006) although 
previous electrophysiological studies did not detect IKCa activity (Kotera and Brown, 
1994). 
Despite the lack of directly Ca
2+
 activated transporters in the mammalian 
choroid plexus, Ca
2+
 influx may have indirect effects on transporters and channels 
which could play a role in choroid plexus volume regulation. Activation of KCC’s 
(Adragna et al., 2004) and a number of ion channels (Okumura et al., 2009; Shen et al., 
2001) are modulated through phosphorylation and dephosphorylation events 
mediated by Ca
2+
 dependent kinases and/or phosphatases (Jakab et al., 2002). Ca
2+ 
and 
protein kinase C are positive modulators of RVD in a number of cell types (Chou et al., 
1998; Light et al., 1998; Robson and Hunter, 1994; Roman et al., 1998). Certainly, 
protein kinase C is known to have important regulatory effects on ion transport in 
mammalian choroid plexus (Fisone et al., 1998; Fisone et al., 1995; Kajita et al., 2000). 
Ca
2+
 dependent phosphatases as regulators of RVD have also been identified 
previously (Lohr and Yohe, 1994) although the potential role of protein kinase C and 
Ca
2+
 dependent phosphatases such as PP1 as regulators of RVD have not yet been 
investigated in the choroid plexus. 
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5.1.4. Chapter Aims 
The initial aims of this Chapter were: 
- To investigate the role of Ca
2+
 in RVD in choroid plexus cells. 
- To study the potential contribution of TRP channels to RVD in choroid plexus 
cells. 
These initial aims were subsequently superseded after initial experiments 
showed that the removal of extracellular Ca
2+
 attenuated the magnitude of change in 
volume during hypotonic challenge. An additional aim therefore was to characterise 
the dependency of choroid plexus cell volume changes on Ca
2+
. 
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5.2. Methods 
5.2.1. Cell isolation and experimental aCSF’s 
Choroid plexus cells were prepared and selected for experiments as described 
in Chapter 2.  All experimental aCSF’s used in this chapter were buffered with        
HCO3
-
/CO2 and their compositions are described in Table 5.1.  
Solute Isotonic aCSF 
(mM) 
Hypotonic 
aCSF (mM) 
Isotonic Ca
2+
 
free aCSF 
(mM) 
Hypotonic Ca
2+
 
free aCSF 
(mM) 
NaCl 110 65 110 65 
NaHCO3 25 25 25 25 
Mannitol 20 0 20 0 
Glucose 4 4 4 4 
KCl 5 5 5 5 
CaCl2 1.2 1.2 0 0 
MgCl2 1 1 1 1 
EGTA 0 0 1 1 
Osmolality 283 mOsm.Kg 
H2O
-1
 
187 mOsm.Kg 
H2O
-1
 
288 mOsm.Kg 
H2O
-1
 
194 mOsm.Kg 
H2O
-1
 
 
Table 5.1. HCO3
-
 buffered experimental aCSF’s.  
 
 
A few experiments used hypertonic aCSF which was made by adding 100mM 
mannitol to increase the osmolality of isotonic aCSF to 382 mOsm.Kg H2O
-1
 (see 
Chapter 3). Ca
2+ 
free solutions were prepared in two ways. In most experiments, Ca
2+
 
free solutions had 0mM CaCl2 plus 1mM EGTA to remove any contaminating Ca
2+
 
impurities found in other chemicals (which can be as much as 2.7μM Ca
2+
). 
Other experiments were performed with aCSF from which the Ca
2+
 had been 
‘scrubbed’. Chelex® 100 chelating resin consists of styrene divinylbenzene beads with 
paired iminodiacetate ions which are chelating groups able to bind polyvalent metal 
ions. The sodium form of Chelex® 100 (50-100 mesh) ‘scrubs’ several divalent metal 
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ions including Ca
2+
 from solutions (Coulis et al., 2004) with a 1000 fold preference over 
Na
+
. Ca
2+
 was ‘scrubbed’ from aCSF as described previously (Mitrović et al., 1998). 
Briefly, HCO3
-
 buffered isotonic and hypotonic aCSF were prepared as described in 
Table 5.1 with the exception that CaCl2 and MgCl2 were omitted. aCSF’s were prepared 
in plastic containers the day before use in experiments and stirred overnight with one 
gram of Chelex® 100 resin per litre to allow Ca
2+
 to be ‘scrubbed’ from the aCSF. On 
the day of experiments, scrubbed aCSF was passed through a column of fresh Chelex® 
100 resin beads at a rate of approximately 0.3ml/minute. MgCl2 was added to the aCSF 
which was then warmed to give an experimental temperature of 36±1°C, gassed with 
95%/5% O2/CO2 and the pH was adjusted to 7.4 as normal. A great deal of care was 
taken to prevent contamination of scrubbed aCSF’s, all glassware used in the normal 
preparation of aCSF’s and experiments were replaced with plastic to prevent leaching 
of Ca
2+
 ions from the glass during and after scrubbing. Plastic tubes to gas aCSF, the pH 
meter and other equipment which came into contact with the aCSF were first washed 
thoroughly in deionised water then washed repeatedly with extra isotonic Ca
2+
 
scrubbed aCSF before use. 
 
5.2.2. Experimental protocols  
5.2.2.1. The effect of Ca
2+
 free aCSF and increased Ca
2+
 concentration on 
RVD in choroid plexus cells 
All cells were superfused for 10 minutes with the relevant isotonic aCSF prior to 
the start of experiments. After the acclimatisation period, cells were superfused with 
control isotonic aCSF for 2 minutes prior to a 10 minute superfusion with hypotonic 
aCSF. In some experiments, hypotonic challenge was in the presence of Gd
3+
, 
ruthenium red, 2APB, serotonin (5HT), 3mM Ca
2+
 or in the absence of Ca
2+
. A final 5 
minute recovery period followed with cells once again exposed to isotonic aCSF. Day-
matched control experiments were also performed. 
In a few experiments Ca
2+
 free conditions were established prior to hypotonic 
challenge.  After the acclimatisation period, cells were superfused with control isotonic 
aCSF for 2 minutes followed by superfusing cells with isotonic Ca
2+
 free aCSF for 2 
minutes prior to 10 minutes of hypotonic challenge. A final 5 minute recovery period 
followed with cells once again exposed to isotonic aCSF. 
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Some experiments were performed where, after the acclimatisation period, 
cells were superfused with control isotonic aCSF for 2 minutes followed by superfusing 
cells with isotonic Ca
2+
 free aCSF for 2 minutes. Cells were then subjected to a 2 minute 
perfusion with hypotonic Ca
2+
 free aCSF followed by superfusion with hypotonic aCSF 
with a Ca
2+
 concentration of 1.2mM. A final 5 minute recovery period followed with 
cells once again exposed to isotonic aCSF. In related experiments, after the 
acclimatisation period, cells were superfused with control isotonic aCSF for 2 minutes 
followed by superfusing cells with isotonic Ca
2+
 free aCSF for 5 minutes. Cells were 
then superfused with isotonic aCSF with a normal Ca
2+
 concentration of 1.2mM for 2 
minutes before 10 minutes of hypotonic challenge in the presence of Ca
2+
. A final 5 
minute recovery period followed with cells once again exposed to isotonic aCSF. 
In a few experiments Ca
2+
 concentration of both isotonic and hypotonic aCSF 
was increased to 3mM to investigate the effect of high extracellular Ca
2+
 concentration 
on choroid plexus RVD. 5HT (1μM) was used as a tool to increase intracellular Ca
2+
 in a 
few experiments. 5HT acts via the 5HT2C receptor to cause a biphasic increase in 
intracellular Ca
2+
 in rat choroid plexus cells (Watson et al., 1995). In these experiments 
5HT was applied extracellularly at a concentration of 1μM. The biphasic nature of the 
increase in intracellular Ca
2+
 is due to an initial release of Ca
2+
 from stores followed by 
a subsequent influx from the extracellular compartment (Watson et al., 1995). 5HT 
was dissolved in de-ionised water to create a fresh stock solution for each 
experimental day. 
 
5.2.2.2. The effect of transport inhibitors on RVD in choroid plexus cells 
After the 10 minute acclimatisation period, cells were superfused with control 
isotonic aCSF for 2 minutes prior to a 10 minute superfusion with hypotonic aCSF 
containing Ca
2+
 transport inhibitors. A final 5 minute recovery period followed with 
cells once again exposed to isotonic aCSF. The following Ca
2+
 transport inhibitors were 
used: 
Gd
3+
 
Gd
3+
 is a potent blocker of  stretch-activated Ca
2+
 channels (Yang X. C. and 
Sachs, 1989). In the present study Gd
3+
 was used at a concentration of 20μM which has 
proved successful in inhibiting RVD in rat lacrimal acinar cells (Speake et al., 1998). 
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GdCl3 was dissolved in deionised water to create stock solutions which were stored at    
-20°C, replaced regularly and diluted in aCSF on the day of experiments. 
Ruthenium Red 
Ruthenium red is a widely used TRP channel blocker which has different effects 
on TRPV4 and TRPM3. TRPV4 is inhibited by micromolar concentrations of ruthenium 
red (Reiter et al., 2006; Watanabe et al., 2003), whereas Ca
2+
 influx due to TRPM3 
expressed in HEK293 cells is not affected by application of ruthenium red (Grimm et 
al., 2003). Ruthenium red was applied at a concentration of 10μM in the present study. 
Ruthenium red was dissolved in 100% DMSO to create stock solutions which were 
stored at -20°C, replaced regularly and diluted in aCSF on the day of experiments such 
that DMSO concentration did not exceed 0.1% v/v.  
2APB 
Store operated Ca
2+
 entry is inhibited by 10μM 2APB (Bootman et al., 2002). 
TRPV4 is insensitive to 2APB (He et al., 2007) whereas TRPM3 activity is only slightly 
reduced by 100μM 2APB (Xu et al., 2005). 2APB was used at a concentration of 10μM 
in the present study. 2APB was dissolved in 100% methanol to create stock solutions 
which were stored at -20°C, replaced regularly and diluted in aCSF on the day of 
experiments such that methanol concentration did not exceed 0.1% v/v. Methanol at a 
concentration of 0.1% v/v had no effect on choroid plexus cell volume (Figure 5.1). 
 
Figure 5.1. Methanol (0.1% v/v) does not cause a significant change in resting choroid plexus cell volume 
(n=3). Cells were superfused with isotonic HCO3
-
 buffered aCSF; the black bar indicates application of 
0.1% v/v methanol. 
 
 
  
Alexandra Hughes                                                                                                Page 134 of 174 
5.2.2.3. Ca
2+
 imaging experiments with Fura-2  
Intracellular Ca
2+
 signalling events can be estimated and visualised with the 
Fura family of Ca
2+
 sensitive dyes (Grynkiewicz et al., 1985). Investigations into the role 
of Ca
2+
 in choroid plexus cell swelling and RVD could be furthered by the use of Fura-2. 
Preliminary experiments were therefore performed to develop a Fura-2 loading 
protocol for freshly isolated choroid plexus cells. Cells were prepared as described in 
Chapter 2 but on return to Ca
2+
 containing aCSF, cells were loaded with 6μM Fura-2AM 
dissolved in aCSF in the dark for 15 minutes at room temperature. The Fura-2 
fluorescence was measured by mounting the coverslips to form the base of a perfusion 
chamber (Harvard Apparatus, Edenbridge, UK). The cells were excited by light at 340 
and 380 nm with a cycle time of 1.3 s using a monochromator (TILL Photonics, Planegg, 
Germany), attached to an Axiovert epifluorescence microscope (Zeiss, Jena, Germany). 
Images were collected by a Quantix CCD camera (Roper Scientific, Bucks, UK) using the 
Metafluor software (Roper, UK). 
 
5.2.3. Statistical analysis 
Cells included in analysis had a stable volume during the initial 2 minutes 
perfusion with isotonic aCSF. Cells normally showed a rapid change in volume in 
hypotonic aCSF and returned towards starting volumes during the final 5 minute 
perfusion with isotonic aCSF. For experiments performed with Ca
2+
 free + EGTA aCSF’s 
or the Ca
2+
 scrubbed aCSF’s however, it was not appropriate to consider the latter two 
criteria. 
Volume recovery was calculated as described in Chapter 4. All data are 
expressed as mean ± standard error of the mean. One way ANOVA with Dunnett’s post 
hoc test was used to compare three or more data sets while Student’s t tests were 
used to compare two data sets.  
Figure 5.2 shows that the maximum volume attained in hypotonic HCO3
-
 
buffered aCSF was unaffected by the Ca
2+
 transport inhibitors/activators used in this 
chapter (P>0.1, ANOVA). 
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Figure 5.2. A comparison of maximum cell volume in hypotonic aCSF with maximum cell swell in the 
presence of 20μM Gd
3+
, 10μM ruthenium red, 10μM 2APB, 1μM 5HT or 3mM Ca
2+
. 
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5.3. Results 
5.3.1. The effect of Ca
2+
 free solutions on RVD in choroid 
plexus cells 
Figure 5.3. Choroid plexus cell RVD is not inhibited by removal of extracellular Ca
2+
. A) Control response 
to hypotonic aCSF with physiologically normal 1.2mM Ca
2+
 (n=11). B) The effect on volume when cells are 
superfused with Ca
2+
 free hypotonic aCSF (n=5). Black bars indicate application of hypotonic aCSF, the 
white bar indicates nominally Ca
2+
 free hypotonic aCSF (Table 5.1). 
 
 
Figure 5.3A shows the mean effects of exposing 11 cells to control hypotonic 
aCSF for 10 minutes. Mean cell volume prior to hypertonic challenge was 0.98pL. Cells 
swell to a maximum volume of 105.3±1.1% followed by a RVD to a final volume of 
99.1±0.6% after 10 minutes in the hypotonic aCSF. When the superfusate was 
switched back to the isotonic aCSF, the volume decreased to 95.7±0.6% before 
recovering to 97.5±0.6% after 5 minutes. Statistical comparison of the rate of RVD 
for control cells shown in Figure 5.3A with that of cells in Figures5.3B, 5.6, 5.8 and 5.9 
were performed with a One Way Anova test (F=1.47).  
Figure 5.3B shows the results for 5 cells exposed to Ca
2+
 free hypotonic aCSF to 
which 1mM EGTA had been added. The cells swelled to 103.4±1.4% which is not 
significantly different from swell in the presence of Ca
2+
 (P>0.05, Dunnett’s post hoc 
test). 
). After 10 minutes in Ca
2+
 free hypotonic aCSF, cells had decreased to a mean 
volume of 97.4±0.6% and on return to isotonic aCSF cell volume was 96.5±1.5%. Cells 
did not show a post-RVD RVI and after 5 minutes exposure to isotonic aCSF the cell 
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volume was 95.2±1.9%. Thus exposing cells to Ca
2+
 free hypotonic challenge did not 
inhibit their ability to RVD. However, since the switch of aCSF in the cell bath is not 
instantaneous, there may be a small amount of residual Ca
2+
 left in the bath during the 
initial stages of nominally Ca
2+
 free hypotonic challenge. This may have been sufficient 
to support the RVD. To examine this possibility, experiments were performed in which 
cells were superfused with isotonic Ca
2+
 free aCSF before exposure to the Ca
2+
 free 
hypotonic aCSF. 
 
Figure 5.4. Removing Ca
2+
 from the superfusate abolishes hypotonicity induced swelling in choroid plexus 
cells. A) aCSF was rendered Ca
2+
 free by the addition of 1mM EGTA (n=10) or B) by ‘scrubbing’ the aCSF 
with Chelex® resin (n=7). Open bars indicate Ca
2+
 free aCSF and black bars indicate hypotonic challenge. 
C) A summary of the maximum swell achieved by cells. 
 
 
Figure 5.4A shows that when 10 cells were exposed to Ca
2+
 free isotonic aCSF 
for two minutes to remove Ca
2+
 from the bathing aCSF prior to hypotonic challenge, 
their mean volume was 99.9±0.4%. However, when hypotonic Ca
2+
 free aCSF was 
applied, no cell swelling was observed. After 1 minute of Ca
2+
 free hypotonic aCSF cell 
volume was 98.9±0.5% compared to initial volume. Over the course of the 10 minute 
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perfusion with Ca
2+
 free hypotonic aCSF, cells decreased in volume to 94.7±0.6%. The 
Ca
2+
 free aCSF used in these experiments contained 1mM EGTA.  
To exclude the possibility that EGTA rather than the Ca
2+
 free conditions may 
be inhibiting cell swelling, the effect of Ca
2+
 scrubbed aCSF was examined. Isotonic 
aCSF containing 1.2mM Ca
2+
 was applied to 7 cells for 2 minutes. This was followed by 
a 2 minute perfusion of isotonic Ca
2+
 scrubbed aCSF (Figure 5.4B). At the end of the 2 
minute exposure to Ca
2+
 scrubbed aCSF the mean cell volume was 100.3±0.9% 
compared to starting cell volume. Cells were then exposed to hypotonic Ca
2+
 scrubbed 
aCSF for 10 minutes during which time the maximum volume reached was 101.3±1.3% 
of starting volume after 4 minutes. At the end of the 10 minute period, mean cell 
volume was 98.8±1.0%. After cells were returned to isotonic aCSF (1.2mM Ca
2+
) they 
shrank briefly to 96.2±1.1% and after 5 minutes superfusion with isotonic aCSF, had 
reached 97.9±0.9% of starting volume. 
The data demonstrates the surprising observation that removal of extracellular 
Ca
2+
 abolishes the cell swelling response to hypotonic challenge of choroid plexus cells 
(Figure 5.4C). Evidence that cell swelling can be prevented in Ca
2+
 free solutions has 
not, to my knowledge, been previously reported in any type of cell. I therefore 
designed additional experiments to examine this phenomenon. 
 
5.3.2. Preincubation in Ca
2+
 free aCSF inhibits 
subsequent cell swelling 
Figure 5.5A shows the time course for cells exposed to a preincubation with 
isotonic Ca
2+
 free aCSF for 2 minutes prior to switching to hypotonic Ca
2+
 free aCSF 
followed by hypotonic aCSF with a Ca
2+
 concentration of 1.2mM. After two minutes of 
isotonic Ca
2+
 free aCSF, the mean volume of four cells was 98.9±0.4% and remained 
similar on application of hypotonic Ca
2+
 free aCSF for 2 minutes (98.9±0.8%). Hypotonic 
aCSF was then applied. After 1 minute, cell volume had not changed (99.2±0.9%) 
although cells had shrunk by the end of hypotonic challenge to 96.3±1.7%. When 
superfusing aCSF was switched back to isotonic aCSF, mean cell volume decreased to 
92.6±1.4% and after 5 minutes volume was 94.0±0.6%. 
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Figure 5.5. Isotonic Ca
2+
 free aCSF inhibits subsequent cell swelling induced by hypotonicity. A) The 
hypotonic challenge starts during Ca
2+
 free conditions before replacement of Ca
2+
 (n=4). B) Ca
2+
 is 
replaced before hypotonic challenge (in the presence of Ca
2+
, n=8). Open bars indicates Ca
2+
 free aCSF 
perfusion (1mM EGTA), black bars indicates superfusion with hypotonic aCSF. 
 
 
Figure 5.5B shows the time course for 8 cells which received a 5 minute 
perfusion with isotonic Ca
2+
 free aCSF. Extracellular Ca
2+
 was replaced for 2 minutes 
before cells were superfused with hypotonic aCSF (1.2mM Ca
2+
). After 5 minutes of 
isotonic Ca
2+
 free aCSF, mean cell volume was 96.9±1.1% but recovered to 98.9±1.4% 
when Ca
2+
 was returned to the bathing aCSF. After 1 minute of hypotonic challenge, 
cell volume was 98.2±1.3% and by the end of the 10 minute exposure to hypotonic 
aCSF cell volume was 96.9±1.1%. When the cells were returned to isotonic aCSF they 
shrank slightly to 94.7±1.4 and were 95.8±1.1% after 5 minutes. 
This data shows that Ca
2+
 free incubation inhibits subsequent cell swelling 
response to hypotonic challenge. It is not clear whether this is a general inhibition of 
cell volume change or a specific inhibition of cell swelling. 
 
5.3.3. Neither cell swelling nor RVD is affected by 
increasing intracellular or extracellular Ca
2+
 
concentrations  
The data presented in Figure 5.4 and 5.5 suggest that cell swelling in choroid 
plexus cells may be dependent on Ca
2+
. The effects of increasing intracellular and 
extracellular Ca
2+
 concentrations were therefore studied. To increase intracellular 
[Ca
2+
], experiments were performed in the presence of 1μM 5HT. The volume of cells 
exposed to hypotonic aCSF + 1μM 5HT are shown in Figure 5.6A (n=3), aCSF Ca
2+
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concentration was 1.2mM throughout these experiments. There was no significant 
difference between maximum cell volume in these cells which swelled to 104.4±1.9% 
and that observed in control cells (P>0.05, Dunnett’s post hoc test). After 10 minutes 
of hypotonic aCSF + 1μM 5HT cell volume was 98.1±1.6%. When cells were once again 
superfused with isotonic aCSF, they shrank to 93.7±2.0% and showed a small recovery.  
Figure 5.6. Cell swelling and RVD are not significantly different in the presence of 1μM 5HT or 3mM Ca
2+
. 
The black bars indicate hypotonic challenge in the presence of A) 1μM 5HT (n=3) or B) 3mM Ca
2+
 (n=4). 
 
 
The effects on four cells of increasing extracellular Ca
2+
 concentration to 3mM 
and then exposing cells to hypotonic challenge are shown in Figure 5.6B. Cells swell to 
105.3±0.7% within 1 minute of exposure to hypotonic aCSF (3mM Ca
2+
) and after 10 
minutes reach 100.1±1.3% before shrinking slightly to 96.2±1.1% when returned to 
isotonic (3mM Ca
2+
) aCSF. These data show that neither cell swelling nor RVD are 
significantly affected by the application of 1μM 5HT or by elevated extracellular [Ca
2+
] 
(P>0.05, Dunnett’s post hoc test). 
 
5.3.4. Cell shrinkage in hypertonic aCSF is not Ca
2+
 
dependent 
To understand whether exposing cells to Ca
2+
 free solutions prevents all types 
of volume change or whether it is specific to cell swelling, cells were exposed to an 
isotonic Ca
2+
 free preincubation for 2 minutes followed by hypertonic Ca
2+
 free 
challenge. Figure 5.7A shows control experiments where choroid plexus cells were 
superfused with hypertonic HCO3
-
 buffered aCSF. Cells shrank to a minimum of 
87.5±1.5% before exhibiting a RVI to 91.8±1.3% after 10 minutes exposure to 
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hypertonic challenge. In Figure 5.7B cells were superfused with isotonic Ca
2+
 free aCSF 
for 3 minutes and shrank slightly to 96.8±0.6%. The bathing aCSF was then switched to 
hypertonic Ca
2+
 free aCSF. Cells shrank within a minute to 89.3±2.1% and had a mean 
volume of 90.7±1.4% by the end of the 10 minute hypertonic challenge. 
Figure 5.7. Choroid plexus cell RVI is not significantly altered in the absence of extracellular Ca
2+
. A) Time 
matched control cells exposed to hypertonic challenge (n=5); B) Cells received a preincubation with 
isotonic Ca
2+
 free aCSF prior to hypertonic Ca
2+ 
free challenge (n=4). Black bars represent application of 
hypertonic challenge, the white bar indicates Ca
2+
 free conditions (1mM EGTA). C) Mean minimum 
volume in hypertonic aCSF. D) Rate of volume recovery in control and Ca
2+
 free aCSF.  
 
 
Thus, under Ca
2+
 free conditions, neither the magnitude of cell shrinkage in 
hypertonic aCSF nor the subsequent RVI were statistically different from control 
(P>0.05, unpaired t test). It is highly significant that cell shrink was not inhibited by 
hypertonic Ca
2+
 free aCSF since it indicates that extracellular Ca
2+
 free conditions 
inhibit cell swell specifically rather than generic volume change mechanisms.  
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5.3.5. The effect of inhibitors of Ca
2+
 transport on RVD in 
choroid plexus cells 
Figure 5.8.TRP channel blockers Gd
3+
 and ruthenium red do not abolish RVD in choroid plexus cells. The 
black bars indicate hypotonic challenge with A) 20μM Gd
3+
 (n=12) or B) 10μM ruthenium red (n=4). 
 
 
Gd
3+
 ions and ruthenium red are well known to block several TRP channels 
including TRPV4 so their actions on RVD in choroid plexus cells were investigated. The 
mean volume changes of 12 cells exposed to hypotonic challenge +20µM Gd
3+
 are 
shown in Figure 5.8A. Cells swelled to a maximum volume of 103.5±0.8% within 1 
minute of hypotonic challenge +20µM Gd
3+
, and then show a RVD to 98.3±0.6% after 
10 minutes. On return to isotonic aCSF for 5 minutes, cell volume was 95.8±0.7%.  
In Figure 5.8B, four cells were superfused with hypotonic aCSF +10µM 
ruthenium red, an inhibitor of TRPV4. After 1 minute of superfusion with hypotonic 
aCSF +10µM ruthenium red the cells had swelled to 103.8±0.8%. The cells exhibited a 
RVD over the 10 minute incubation with hypotonic aCSF + 10µM ruthenium red to 
reach 96.9±2.1%. On return to superfusion with isotonic aCSF, a final volume of 
95.5±0.8% was reached. 
When volume recoveries were compared, neither 20μM Gd
3+
 nor 10μM 
ruthenium red caused a significant attenuation of choroid plexus RVD compared to 
controls (P>0.05, Dunnett’s post hoc test). Store operated Ca
2+
 entry is inhibited by 
2APB (Bootman et al., 2002) but it has no effect on TRPV4 activation so its effects on 
choroid plexus cell RVD were investigated. The effects of hypotonic aCSF +10μM 2APB 
on 5 cells are shown in Figure 5.9. A minute after application of hypotonic aCSF +10μM 
2APB cell volume was 101.9±1.1%. Volume then decreased to 95.1±0.4% over 10 
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minutes. Cells stopped loosing volume when they were once more superfused with 
isotonic aCSF and their final volume was 94.4±1.2%. Cell swelling in the presence of 
10μM 2APB appeared small but was not statistically different from control (P>0.1, t 
test). The cells used in the experiments with 2APB, however, displayed a steady 
decrease in volume over the course of the experiments which makes precise 
interpretation of the data difficult.  
 
Figure 5.9.The store operated Ca
2+
 entry inhibitor 2APB does not significantly inhibit choroid plexus cell 
RVD (P>0.05, Dunnett’s post hoc test). The black bar indicates application of hypotonic aCSF +10μM 
2APB (n=5). 
 
 
5.3.6. Ca
2+
 imaging experiments with Fura-2 
To investigate the role of Ca
2+
 in volume changes and RVD in choroid plexus 
cells, experiments were performed to investigate intracellular Ca
2+
 concentration using 
Fura-2. Figure 5.10 shows examples of choroid plexus cells suitable for volume 
regulation experiments compared with time matched cells and small cell clumps 
loaded with Fura-2. In row A, the single cells with and without Fura-2 are 
approximately round and have a clearly discernable cell membrane. It is possible to 
distinguish between individual cells with a ‘cobble stone’ morphology in the small cell 
clump in the lower part of the picture where the epithelial sheet is parallel to the plane 
of view. As time post Fura-2 loading increases, Fura-2 loaded cells lose their defined 
cell membrane compared to time matched controls. Fura-2 loaded single cells in 
panels D and E have lost the rounded morphology of healthy cells and parts of the 
cytoplasm are stretched out in the lower areas of the pictures with large vacuoles 
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present. Cells loaded with Fura-2 did not appear to survive for much more than an 
hour after Fura-2 loading.  
 
Figure 5.10. Fura-2 loading has a negative effect on cell viability. The left panels show representative 
single choroid plexus cells suitable for volume regulation experiments which have not been loaded with 
Fura-2 dye. The centre panels’ show time matched, Fura-2 loaded cells and small clumps of cells are 
shown in the right panels. All images were taken at x400 magnification except for cell clumps in panels A 
and B for which x100 magnification was used. Images are representative of 9 experiments.  
 
 
In conclusion, these experiments show that Fura-2 had detrimental effects on 
choroid plexus cells even with a relatively short incubation. It was decided that it was 
impractical to measure intracellular Ca
2+
 concentration with Fura-2 loaded freshly 
isolated choroid plexus cells. 
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5.4. Discussion 
5.4.1. Choroid plexus RVD is not Ca
2+
 dependent 
Choroid plexus RVD was not affected by superfusion with Ca
2+
 free aCSF 
(without preincubation) nor by increasing aCSF Ca
2+
 concentration. Christensen first 
hypothesised the involvement of Ca
2+
 permeable, stretch activated channels in RVD in 
choroid plexus tissue (Christensen, 1987). By contrast, the present study has found no 
evidence that the choroid plexus RVD is sensitive to Ca
2+
. However, Christensen’s 
studies were performed in amphibian choroid plexus which does express BKCa 
channels. The absence of these channels in mammalian choroid plexus cells may 
explain the observed lack of RVD sensitivity to Ca
2+
 in the present study. 
Blockers of Ca
2+
 entry also had no effect on RVD. As with the transport blockers 
used in Chapter 4, the small degree of cell swelling and corresponding small RVD 
makes detection of RVD inhibition very difficult. Further investigations using higher 
(less specific) concentrations of these inhibitors or preincubating cells with them may 
be necessary as discussed in Chapter 4. It is hard to answer the question of the role of 
TRP’s without identifying the ion transporters responsible for K
+
 and Cl
-
 efflux first. 
Further studies into the involvement of TRP channels may benefit from a newly 
developed TRPM3 channel blocker which is reported to be specific for TRPM3 over 
other TRP’s such as C5, V4 and M2 (Naylor et al., 2008).  
 
5.4.2. Ca
2+
 sensitive volume changes in response to 
hypotonic aCSF 
The most novel observation in this project was that a short preincubation with 
Ca
2+
 free aCSF had a lasting impact on the ability of choroid plexus cells to swell in 
response to hypotonic challenge. This has not been reported in any previous study to 
my knowledge. As such this phenomenon will be discussed further in Chapter 6. There 
are several possibilities why cells may not change their volume in response to 
hypotonic challenge in the absence of extracellular Ca
2+
. 
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5.4.2.1. Cell death 
It could be argued that the absence of cell swelling may be due to cell death 
with the cells unable to swell rather than actively regulating their volume. This is 
possible but unlikely since when hypotonic challenge is removed, cells consistently 
shrink and show a small post-RVD RVI – hallmarks of transporter activity. It is unlikely 
that Ca
2+
 free conditions are killing the cells since they were able to shrink and regulate 
their volume normally when exposed to Ca
2+
 free hypertonic conditions. Cells also 
responded normally when not preincubated with Ca
2+
 free aCSF prior to hypotonic 
challenge. 
 
5.4.2.2. EGTA rather than Ca
2+
 free aCSF inhibits cell swelling response to 
hypotonic challenge 
The possibility that EGTA directly altered the ability of cells to change their 
volume may be excluded since similar results were observed when Ca
2+
 was ‘scrubbed’ 
from solutions with Chelex® resin. The resin itself is unlikely to cause a direct inhibition 
of cell swell since it is not soluble in aCSF and was removed from aCSF prior to 
experiments.  
 
5.4.2.3. Inhibition of water permeability 
The absence of cell swell could perhaps be attributed to a change in the 
membrane permeability to H2O. This is also unlikely since cells were able to shrink and 
RVI under Ca
2+
 free conditions. Water permeability is dependent on the presence of 
members of the aquaporin class of water channels. Aquaporin 1 is highly expressed in 
choroid plexus cells (Nielsen et al., 1993) however there is no evidence in the literature 
of regulation of any aquaporins by extracellular Ca
2+
. However intracellular Ca
2+
 does 
influence trafficking of members of the aquaporin family to the plasma membrane in 
inner medullary collecting duct cells but this continued despite the absence of 
extracellular Ca
2+
 (Petrovic et al., 2006). 
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5.4.3. The influence of a Ca
2+
 free incubation during cell 
isolation on subsequent cell volume change 
Chapter 2 described the modifications made to the cell isolation protocol, 
including a Ca
2+
 free isolation. In Chapter 4, a clear discrepancy in response of the cells 
to hypotonic aCSF is described between cells prepared by the original and the modified 
protocols. This difference was in the magnitude of the initial change in volume when 
cells were superfused with hypotonic aCSF which was greatly reduced in cells prepared 
by the method including a Ca
2+
 free incubation. In this chapter, it was observed that 
there is a decrease in cell volume change in Ca
2+
 free conditions. A possible 
explanation for the reduced cell swelling during hypotonic challenge described in 
Chapter 4 may be the Ca
2+
 free step introduced into the cell isolation protocol. 
Exposing cells to Ca
2+
 free incubation prevents a subsequent cell swell when 
the cell is challenged with hypotonic aCSF.  
 
Figure 5.11. A comparison of hypotonic challenge induced maximum cell swelling achieved by choroid 
plexus epithelial cells with varying exposure to Ca
2+
 free aCSF. ‘Preliminary study’ refers to cells which 
were not exposed to Ca
2+
 free aCSF. ‘Present study’ refers to cells isolated by the protocol described in 
chapter 2 which included incubation in Ca
2+
 free aCSF. ‘Ca
2+
 free’ refers to cells isolated by the method in 
chapter 2 and subsequently exposed to Ca
2+
 free hypotonic challenge with an isotonic Ca
2+
 free 
preincubation. 
 
 
Figure 5.11 shows a comparison of cell swell attained by cells in preliminary 
studies in the Brown lab, cells in the present study and cells in the present study 
preincubated with isotonic Ca
2+
 free aCSF prior to Ca
2+
 free hypotonic challenge. All 
three conditions are significantly different to each other (P<0.0001, ANOVA). The main 
difference between cells prepared for preliminary experiments and those prepared for 
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the present study is that a Ca
2+
 free step was included when preparing cells for the 
present study. It is possible that the unexpected Ca
2+
 sensitivity of the choroid plexus 
cell swell accounts for the reduced maximum cell swell achieved by cells in the present 
study. In light of the observed dependence of cell swell on extracellular Ca
2+
, this step 
in the cell preparation method needs re-examination.  
A Ca
2+
 free step is used in numerous cell isolation protocols, the consequences 
of which may extend further than previously thought. It is therefore important to 
ascertain whether the elimination of cell swell by Ca
2+
 free conditions is a cell type 
specific effect or an artefact of the cell preparation process. Future experiments should 
investigate the threshold concentration of Ca
2+
 required to permit cells to swell. 
Another important question for further study is whether a Ca
2+
 free incubation 
permanently alters a cells ability to swell or if sufficient time in the presence of Ca
2+
 
can return normal swelling ability. In addition, experiments to study transporter 
involvement in RVD should be repeated in cells isolated by the unmodified method 
which did not involve a Ca
2+
 free incubation. 
The volume regulation techniques used in the present study could not fully 
explore whether the absence of cell swell was directly caused by absence of 
extracellular Ca
2+
 or whether it was linked to intracellular Ca
2+
 handling. Ca
2+
 imaging 
experiments will be required to explore this fully. However a useful first step would be 
to use a Ca
2+
 chelating agent which can act intracellularly such as BAPTA as described 
previously in rat lacrimal acinar cells (Speake et al., 1998) to explore whether cell 
swelling is dependent on increasing intracellular Ca
2+
 concentration rather than influx 
of Ca
2+
 from the extracellular compartment. 
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5.5. Conclusions 
- There is no evidence thus far that Ca
2+
 plays a role in choroid plexus RVD. 
- No evidence has been found for TRP channel involvement in choroid plexus 
RVD. 
- Preincubation with Ca
2+
 free aCSF reduces the change in cell volume on 
exposure to hypotonic challenge. 
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Chapter Six                                    
General Discussion: 
Unresolved questions and 
future directions 
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6.1. Overview  
In this project I have made a series of novel observations about volume 
regulation in choroid plexus epithelial cells from mice. These include: 1) Demonstrating 
that choroid plexus cells exhibit a RVI mediated by NHE and AE, in hypertonic aCSF; 2) 
Identifying that choroid plexus cells display a HCO3
-
 dependent RVD in hypotonic aCSF 
and 3) Showing that osmotically induced cell swelling is abolished in Ca
2+
 free 
hypotonic aCSF.  
Each of these phenomena has been discussed in the appropriate results 
chapter of this thesis. In this general discussion I will therefore identify some of the 
major unresolved questions in this thesis and discuss potential experimental 
approaches to study these questions. The three topics to be discussed are: 1) the 
function of NKCC1 in the choroid plexuses, 2) the HCO3
-
 dependence of RVD and 3) the 
role of Ca
2+
 in cell volume changes. 
 
6.2. The function of NKCC1 in choroid plexus cells 
6.2.1 NKCC1 and cell volume regulation 
Chapter 3 shows that choroid plexus RVI involves NHE and AE. No role for 
NKCC1 was identified. This observation is something of a surprise as NKCC1 contributes 
to RVI in many cells (Capo-Aponte et al., 2006; Capo-Aponte et al., 2007b; Cossins and 
Gibson, 1997; Douglas and Brown, 1996; Ernest and Sontheimer, 2007; Miley et al., 
1998; Walcott et al., 2005). Furthermore, and more specifically,  evidence has been 
reported previously to suggest that NKCC1 contributes to maintenance of choroid 
plexus volume in isotonic solutions (Wu et al., 1998) and that the bumetanide sensitive 
fluxes of K
+ 
are stimulated by a decrease in cell volume (Keep et al., 1994). As discussed 
in Chapter 3, these conclusions rely heavily on data produced using high 
concentrations of bumetanide. These previous reports may therefore be due to effects 
on proteins other than NKCC1. However, it is important to consider other functions for 
NKCC1 in the choroid plexus.  
One possibility is that NKCC1 does contribute to volume regulation in vivo but 
that it is inhibited for some reason in the isolated cell preparation utilized in this study. 
Such inhibition could be caused by damage to the protein, or the signalling 
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mechanisms which regulate it due to tissue digestion with the enzyme dispase. This 
explanation, however, can be countered in at least two ways by data from this and 
other studies. First, if there is any disruption to the cytoskeleton, this is insufficient to 
affect the activity of NHE and AE. Furthermore, Damkier and colleagues have shown 
that dispase treatment inhibits neither NHE1 nor the activity of two Na
+
HCO3
-
 
cotransporters (NBCn1 and NBCE) in mouse choroid plexus (Damkier et al., 2009). 
Second, NKCC1 is known to contribute to volume regulation in other types of cell 
isolated by more aggressive enzyme treatments, e.g. lacrimal gland acinar cells isolated 
using trypsin and collagenase (Douglas and Brown, 1996) or cardiac myocytes isolated 
using collagenase (Matsui et al., 2007).   
Other studies have shown that NKCC1 is not functionally active in RVI in all cell 
types where it is expressed. For instance, Wehner and colleagues did not detect any of 
the predicted NKCC1 activity in HeLa cells,  and concluded that a hypertonicity induced 
cation channel was the more important mechanism for RVI (Wehner et al., 2003b). 
Furthermore Delpire and Gagnon have demonstrated that NKCC1 cotransporter 
regulation is not a simple process and may be influenced by  stimuli other than 
changes in  osmolality alone, e.g. oxidative stress, cytokines and hormones (Delpire 
and Gagnon, 2006). In the present study I attempted to examine the hypothesis that 
NKCC1 activity in choroid plexus requires additional stimuli. Forskolin was used to 
elevate intracellular concentrations of cAMP.  This strategy met with limited success 
with a slight trend towards an RVI being observed in hepes-buffered solutions (Figure 
3.12). In future experiments, more specific approaches could be used in an attempt to 
activate NKCC1 such as treatment with the phophatase inhibitor calyculin A which is 
known to enhance NKCC1 activity (Gagnon and Delpire, 2010; Hoffmann and Pedersen, 
2007; Matskevich et al., 2005). Calyculin A acts to enhance NKCC1 activity by inhibiting 
PP1, a protein which inhibits NKCC1 (Gagnon and Delpire, 2010). 
NKCC1 knock out mice have been bred (Flagella et al., 1999) however the 
physiology of the choroid plexus has not been extensively studied in these animals. 
NKCC1 null mice choroid plexuses were generally of normal appearance in a 
histological study with the exception of a single null animal whose choroid plexuses 
were swollen and contained vacuoles. A subsequent investigation saw similar 
vacuolated choroid plexuses in some NKCC1 knock out mice (personal communication, 
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F J Alvarez-Leefmans). The physiological cause and relevance of the disrupted choroid 
plexus in some animals is unclear but it is possible that other mechanisms are 
providing some compensation for the missing NKCC1 protein in some knock out 
animals in a similar manner to that observed in the choroid plexus of Ncbe/Nbcn2 null 
mice (Damkier et al., 2010; Damkier et al., 2009).  
 
6.2.2. Non-volume regulation roles of NKCC1  
Even if it proves possible that NKCC1 can be activated by phosphorylation in 
the choroid plexus, it would still seem unlikely that it is a major contributor to cell 
volume regulation. Other potential roles for NKCC1 must therefore be investigated. 
Keep et al  suggested that NKCC1 may actually contribute to  Cl
-
 efflux in the choroid 
plexus (Keep et al., 1994). This suggestion was based upon an analysis of intracellular 
Na
+
 and Cl
-
 concentrations in CP cells which are higher than in most other cells. These 
high intracellular concentrations coupled to a relatively low K
+ 
concentration in the CSF 
contribute to a theoretical driving force for ion efflux. This argument is supported by 
the circumstantial evidence that there are few other pathways mediating Cl
-
 efflux in 
the apical membrane (Damkier et al., 2010). However at the present time there is little 
practical evidence to support this theory. Indeed, in my own experiments, the lack of 
effect of 10 μM bumetanide on cell volume in isotonic aCSF argues against ion efflux, 
i.e. if NKCC1 does mediate efflux then an increase in cell volume might be expected in 
the presence of bumetanide. No increase in volume was observed on application of 
bumetanide, thus other roles must be considered. 
Another potential role for NKCC1 is in the removal of NH3/NH4
+
 from the CSF 
which is highly neurotoxic. NH3, or more accurately NH4
+
, can substitute for K
+
 
transported by NKCC1, and so this protein could be a means of clearing the CSF of NH3. 
This hypothesis is supported by the work of Evans et al who showed that NH4
+
 
stimulates NKCC1 activity in salivary gland cells (Evans R. L. and Turner, 1998). 
Furthermore there is evidence that NKCC1 expressed in glial cells clears the brain 
interstitial fluid of NH3 (Kahle et al., 2009; Ringel et al., 2000). A similar role may also 
be envisaged in the middle ear epithelial cells (Kim et al., 2007). Future experiments 
could test this hypothesis by examining the effects of NH4
+
 on cell volume and possibly 
by measuring changes in intracellular pH using fluorescent probes such as BCECF. 
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6.3. The HCO3
-
 dependence of RVD in choroid plexus 
epithelial cells  
One of the major findings in this thesis is that choroid plexus cells do 
demonstrate a RVD but that this RVD is observed only in the presence of HCO3
-
. This 
property is unusual but not completely without precedent. Both RVD and RVI in ZR-75-
1 epithelial-derived human breast cancer cells show HCO3
-
 dependency (Nicholl et al., 
2002) and in a sub-population of murine freshly isolated renal proximal tubule cells, 
RVD is HCO3
-
 dependent (Millar et al., 2004). The dependence of RVD on HCO3
-
 in 
choroid plexus cells is not studied in any detail here because previous studies have 
failed to elucidate precise mechanisms. Thus it is not obvious how to approach this 
topic, particularly since the ion transport proteins responsible for RVD have not been 
identified using pharmacological methods.  
None of the potential mechanisms for RVD examined in Chapter 4 (KCC3 and 
KCC4, VRAC, Kv and Kir) are known to have any dependence on HCO3
-
 for their activity. 
Contribution of these transporters to RVD cannot be discounted for the technical 
reasons discussed in Chapter 4.  However, lack of evidence for contribution could 
indicate that other transport proteins, which are HCO3
-
 dependent, could be involved. 
One such protein is NBCe2 which mediates Na
+
 and HCO3
-
 efflux. A closely related and 
functionally identical protein, NBCe1 is proposed to mediate HCO3
-
 dependent RVD in 
kidney proximal tubule cells of Necturus and mouse (Lopes and Guggino, 1987; Volkl 
and Lang, 1988). While this hypothesis could explain some HCO3
-
 involvement, it is not 
supported by experimental data which show DIDS (which blocks NBCe2 in addition to 
most other anion transporters) had no effect on RVD. Future experiments to 
investigate NBCe2 in choroid plexus RVD should use higher concentrations of DIDS 
consistent with electrophysiological studies (Millar and Brown, 2008) to be certain of 
inhibiting NBCe2 activity. Other experiments could investigate the role of carbonic 
anhydrases (CA) in choroid plexus RVD. CA was first identified on choroid plexus apical 
microvilli (Masuzawa et al., 1981). CAII is now known to be expressed in choroid plexus 
cells (Masuzawa et al., 1984; Sly and Hu, 1995) along with CAIII (Nogradi et al., 1993) 
and CAIV (Maren et al., 1997). Since these enzymes catalyse the conversion of water 
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and carbon dioxide to HCO3
-
 ions and H
+
 the rate of this reaction may have important 
consequences for HCO3
-
 sensitive aspects of cell volume regulation.  
Alternate explanations for the role of HCO3
-
 in choroid plexus cells could be 
related to pH dependence of transport proteins involved. Choroid plexus intracellular 
pH has been reported to be much lower  when perfused with hepes buffered solutions 
(pH=7.14) compared to HCO3
-
 buffered solutions (pH>7.35) (Bouzinova, 2007). It is 
therefore possible that some of the transporters involved in RVD may be inhibited by 
lower than normal pH, however this is very difficult to study further until the proteins 
involved have been identified. Further study of the pH dependence of choroid plexus 
RVD with pH sensitive dyes and electrophysiological techniques could take place once 
the proteins involved have been identified.  
 
6.4. Role of Ca
2+
 in cell volume changes  
The most novel observation in this project was that a short preincubation with 
Ca
2+
 free aCSF had a lasting impact on the ability of choroid plexus cells to swell in 
response to hypotonic challenge. At present it is unclear by what mechanism choroid 
plexus cell swelling occurs but the possibility that it may be Ca
2+
 dependent must be 
explored.  
An increase in cell volume is usually mediated by unfolding of cell surface 
membrane invaginations with no actual increase in membrane area – this occurs in 
cultured rat astrocytes (Pangrsic et al., 2006). Cell membrane swelling can occur via 
insertion of additional membrane (Heuser and Reese, 1981; Smith and Betz, 1996). 
Choroid plexus cells have a very dynamic membrane with a high turnover of channels 
and transporters (Damkier et al., 2010; Damkier et al., 2009) suggesting that they also 
have a high turnover of membrane. A small shift in the membrane insertion/removal 
equilibrium could therefore quickly result in cell volume changes. Insertion of 
membrane is known to be effected by intracellular Ca
2+
 concentration (Kilic, 2002; 
Smith and Betz, 1996) and it may be expected that an increase in intracellular Ca
2+
 
concentration may lead to an increase in membrane area. Increase in membrane area 
could be assessed electrophysiologically by measuring capacitance as has been 
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demonstrated previously (Kilic, 2002; Speake and Brown, 2004). It would also be 
helpful to know how intracellular Ca
2+
 concentration changes with anisosmotic stimuli.  
Ca
2+
 induced fusion of exocytotic vesicles with a corresponding increase in 
membrane capacitance has been reported previously (Zimmerberg and Whitaker, 
1985). A mechanism of exocytosis involving cytoskeletal reorganisation of fodrin and 
actin which is initiated by a Ca
2+
 influx has been described previously (Aunis and Bader, 
1988). Fodrin and actin interact in a Ca
2+
 dependent manner (Aunis and Perrin, 1984) 
and are expressed in choroid plexus cells where the fodrin/actin cytoskeletal network 
contributes to maintaining the polarised nature of the choroid plexus epithelium 
(Alper et al., 1994). Certainly, reorganisation of the actin microfilament network occurs 
during RVD in Ehrlich ascites tumour cells however the actin microfilament 
reorganisation is abolished in the absence of extracellular Ca
2+
 (Cornet et al., 1993). 
The involvement of the cytoskeleton in cell swelling of choroid plexus cells should 
therefore be explored further. 
Future investigations should also consider a very new area of study connecting 
Ca
2+
 homeostasis and TRP channel regulation – the influence of the protein Klotho 
which is able to regulate the expression of some ion channels including members of 
the TRP superfamily (Huang, 2010). Klotho is a membrane spanning protein which was 
quickly recognised as an important protein for Ca
2+
 homeostasis (Nabeshima, 2002). 
Despite only being expressed in brain (especially in the choroid plexuses), kidney, 
reproductive organs, pituitary gland and parathyroid gland, knocking-out the klotho 
protein causes numerous phenotypes including: skin and gonad atrophy, 
arteriosclerosis, pulmonary emphysema, neural degeneration with associated 
cognition impairment and calcification of soft tissues. The klotho knock out mouse is 
used as a model of aging (Li S. A. et al., 2004). Klotho protein mainly localises to the 
apical membrane of the choroid plexus cells where it is highly expressed (Li S. A. et al., 
2004). Interestingly, in addition to the membrane bound Klotho, a form of Klotho is 
also secreted into blood, urine and CSF (Huang, 2010). Secreted klotho is able to 
regulate expression in the cell surface membrane of TRPV5 (Chang et al., 2005), TRPV6 
(Lu et al., 2008) and the renal outer medullary potassium channel 1 (Cha et al., 2009). 
Secreted Klotho disrupts channel endocytosis thereby causing the channels to 
accumulate at the cell membrane (Cha et al., 2009; Chang et al., 2005). The secreted 
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form of Klotho is found abundantly in CSF (Imura et al., 2004) and the possibility that 
Klotho may mediate similar regulatory effects on the expression of channels and 
transporters in the choroid plexus cells must be explored further. 
Understanding the role of Ca
2+
 in choroid plexus cell swell will be greatly 
assisted through the use of electrophysiological techniques to measure cell 
capacitance and the use of Fura-2 Ca
2+
 sensitive dye. Freshly isolated choroid plexus 
cells are extremely delicate and un-suited to these invasive technique and attempts to 
measure intracellular Ca
2+
 concentration with Fura-2 proved very difficult with the 
present cell preparation. Perhaps the only solution will be to use freshly isolated cells 
maintained in a short term primary culture system such as that used previously 
(Watson et al., 1995) to pursue further fluorescence imaging experiments. Choroid 
plexus cells grown in vitro on porous filters are among the many epithelial cell types 
able to form a barrier which has many features of the in vivo barrier (Abbott, 2005). 
Several investigators have developed such culture systems where choroid plexus tissue 
is isolated from animals such as pig (Angelow et al., 2004; Gath et al., 1997), cows 
(Crook et al., 1981), rat (Southwell et al., 1993) and then cultured. These can provide 
good models of some aspects of choroid plexus physiology for example, a rat choroid 
plexus epithelial cell culture transports thyroxine to result in a concentration in the 
apical compartment which is twice that in the basolateral compartment (Southwell et 
al., 1993). However this particular culture system has a very low transepithelial 
resistance compared to that measured ex vivo (Southwell et al., 1993). More recently it 
was noted that withdrawal of serum dramatically increases the transepithelial 
resistance of cultured porcine choroid plexus epithelial cells to 1500 ohm.cm
2
 when 
cells are grown as monolayers on semi-permeable transwell inserts (Hakvoort et al., 
1998b). This value of transepithelial resistance is somewhat higher than that recorded 
for ex vivo choroid plexus epithelial sheets from amphibians (Zeuthen and Wright, 
1981) but may be closer to the physiological situation in mammals (Hakvoort et al., 
1998b). At present it is not known how accurate as models of in vivo protein 
expression these cultured choroid plexus cells are and as their proliferative properties 
are limited, inevitably the cells grown represent a sub-population (Menheniott et al., 
2010). However, if used alongside freshly isolated epithelial cells, use of these culture 
systems may prove beneficial to further the study of choroid plexus physiology.  
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6.5. Conclusions 
The study of the polarised ion transporters expressed in choroid plexus 
epithelial cells represents an important step in improving our understanding of brain 
homeostasis. Because of the dynamic nature of cell protein expression which has not 
been fully characterised in choroid plexus cells, it is necessary to acutely isolate and 
study choroid plexus epithelial cells as rapidly as possible rather than culturing them 
for extended periods of time. The preparation method described in Chapter 2 
produces a suitable cell suspension for studying volume regulation mechanisms in cells 
from the murine fourth ventricle choroid plexus. The cells suspension contains small 
clumps and single cells which belong to a single population of cells and remain viable 
for several hours after isolation. The isolated choroid plexus cells behave as 
osmometers. Choroid plexus epithelial cells exhibit a HCO3
-
 dependent volume 
regulation in response to cell shrinkage induced by exposure to hypertonic solutions or 
following a regulatory volume decrease.  
The evidence presented here indicates that NKCC1 does not contribute to the 
RVI under normal physiological conditions. By contrast, the combined activities of 
NHE1 and AE2 are responsible for the RVI in hypertonic solutions. NHE1 is likely to 
contribute to a post-RVD RVI to which AE2 may also contribute however there is also 
another, non-NKCC1 component. Choroid plexus cell RVD is also HCO3
-
 dependent but 
no evidence was found to support the activity of ion channels or KCC transporters in 
choroid plexus RVD. Ca
2+
 does not appear to play a role in choroid plexus cell RVD. 
However removal of extracellular Ca
2+
 completely abolished cell swell in response to 
hypotonic challenge. This sensitivity of volume change to Ca
2+
 was specific to cell 
swelling as cell shrinkage in hypertonic aCSF was unaffected by removal of 
extracellular Ca
2+
.  
The present study contributes new knowledge to the growing understanding of 
the mechanisms of brain homeostasis. Improved knowledge of the channels and 
transporters expressed in the choroid plexuses will enable a better understanding of 
the pathophysiology leading to potential therapeutic strategies for disorders as varied 
as meningitis, Alzheimer’s disease and hydrocephalus. 
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